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1 Summary 
 
Throughout my graduate work I was highly interested in the structure and function of 
protein complexes involved in the post-transcriptional regulation of gene expression, in 
particular in those which are involved in RNA interference (RNAi) and deadenylation.  
RNAi is an evolutionarily conserved mechanism that is triggered by different 
classes of small RNAs (siRNAs, miRNAs, piRNAs), which associate with one member of 
the Argonaute family of proteins to form RNA-induced silencing complexes (RISCs). 
RISCs utilize these small RNAs as guides to silence sequence specific mRNA targets 
either by inducing their degradation and/or translational repression. Degradation of 
mRNA targets can be achieved directly through endonucleolytic cleavage by the 
Argonaute protein or indirectly by facilitating the recruitment of the CCR4-NOT and 
PAN2-PAN3 deadenylation complexes via the interaction with an essential bridging 
factor termed GW182 (or TNRC6 proteins in vertebrates). Members of the GW182 
protein family interact with a subset of Argonaute proteins and also bind directly to 
both deadenylase complexes. Deadenylated mRNAs in turn can be decapped and are 
then degraded by the 5´-3´ exonuclease XRN1 in the miRNA-mediated gene silencing 
pathway. 
In the first half of my thesis, I solved the crystal structures and characterized both 
the MID domain in isolation as well as the MID-PIWI lobe of the eukaryotic Argonaute 
protein QDE-2 from the filamentous fungi Neurospora crassa. The high resolution 
structures allowed the identification and characterization of certain eukaryotic specific 
insertions, such as a helix-turn-helix motif which is absent in prokaryotic counterparts 
but its presence is highly conserved in eukaryotes. In addition, by using RNA binding 
studies, I was able to demonstrate that in eukaryotic Argonaute proteins, the integrity of 
the interface between the MID and PIWI domains is crucial for RNA-guide binding. 
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In the second half of my thesis, I worked on the two major cytoplasmic 
deadenylase complexes in eukaryotes, the CCR4-NOT complex and the PAN2-PAN3 
complex. I solved the crystal structure of the folded domains of the adaptor protein 
PAN3, which is crucial in regulating the deadenylation activity of the PAN2-PAN3 
complex. The PAN3 structure led to the identification of the binding site of the catalytic 
subunit PAN2 and unveiled the presence of a tryptophan-binding pocket, which is 
important for the interaction with GW182/TNRC6 proteins.  
In collaborative projects, I also determined the crystal structures of several sub-
complexes of the CCR4-NOT complex, thereby uncovering molecular insights into the 
assembly of this large multi-subunit complex. Surprisingly, the structure of the NOT-
module core (consisting of the C-terminal regions of CNOT1, CNOT2 and CNOT3) 
revealed a unique structural arrangement where intrinsically disordered regions (IDR) 
orchestrate complex assembly. The crystal structure is of particular interest because 
many RNA-binding proteins recruit the CCR4-NOT complex to target mRNAs, by 
binding to the NOT-module subunits. Furthermore, all the complex components were 
also crystallized in isolation, enabling us to describe structural rearrangements upon 
complex formation.  
Finally, I solved the crystal structures of the CNOT1 MIF4G domain and the 
CNOT1 DUF3819 domain, in complex with DDX6 and the CNOT9 subunit of the CCR4-
NOT complex, respectively. These two complexes provide insights into the recruitment 
of the CCR4-NOT complex to miRNA targets by GW182/TNRC6s proteins and further 
connect translational repression and possibly also decapping mediated by DDX6 to the 
CCR4-NOT complex.  
In essence, my work provides an extensive structural and functional framework 
on the assembly of the two major cytoplasmic deadenylases. Furthermore, I provide 
structural evidence on how the deadenylases are recruited to miRNA targets. Finally, I 
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determined the first high-resolution crystal structure of the MID-PIWI lobe of a 
eukaryotic Argonaute protein (the key factor of all RNA induced silencing pathways). 
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1 Zusammenfassung 
Während meiner Doktorarbeit interessierte ich mich für die Struktur und Funktion von 
Proteinkomplexen die an der post-transkriptionellen Regulation der Genexpression 
beteiligt sind, insbesondere solche, die an den Prozessen der RNA Interferenz (RNAi) 
und der Deadenylierung beteiligt sind. 
RNAi ist ein evolutionär konservertier Mechansimus, der durch verschiedene 
Klassen von kleinen RNAs (siRNAs, miRNAs, piRNAs) ausgelöst wird, die an ein 
Mitglied der Familie der “rgonaute Proteinen binden, um so genannte „RN“-induced 
silencing complexesȃ (RISCs) zu formen. RISCs benutzen diese kleinen RNAs als 
Wegweiser, um Sequenz-spezifische mRNAs still zu legen, entweder durch die 
Einleitung ihres Abbaus und/oder durch die Unterdrückung ihrer Translation. Der 
Abbau von Ziel-mRNAs kann entweder durch das endonukleolytische Spalten der Ziel-
mRNA durch das Argonaut Protein direkt erfolgen oder indirekt durch das Rekrutieren 
der CCR4-NOT und PAN2-PAN3 Deadenylierungskomplexe, durch die Interaktion mit 
einem unverzichtbaren Brückenfaktor der GW182 (oder TNRC6 Proteine in 
Wirbeltieren) genannt wird. Mitglieder der GW182 Proteinfamilie interagieren mit 
bestimmen Mitgliedern der Argonaut Proteinfamilie und können außerdem auch direkt 
an die beiden Deadenylierungskomplexe binden. Deadenylierte mRNAs wiederum 
werden dann Entkappt und unwiederbringlich abgebaut durch die 5´-3´ Exonuklease 
XRN1 im miRNA-vermittelten Gen-Stillegung Stoffwechselweg. 
Während der ersten Hälfte meiner Doktorarbeit löste ich die Kristallstrukturen 
und charakterisierte sowohl die MID-Domäne alleine, als auch den ersten 
eukaryotischen MID-PIWI Flügel des Argonaut Proteins QDE-2 vom fadenförmigen Pilz 
Neurospora crassa. Die hoch aufgelösten Strukturen ermöglichten die Identifizierung und 
Charakterisierung bestimmter eukaryotischer Insertionen, wie zum Beispiel ein Helix-
Turn-Helix Motiv, welches in den prokaryotischen Pendants fehlt, aber das 
Vorhandensein stark konserviert ist in Eukaryoten. Zusätzlich konnte ich mit Hilfe von 
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RNA Bindungsstudien zeigen, dass in eukaryotischen Argonaut Proteinen die 
Unversehrtheit der Berührungsfläche zwischen der MID und der PIWI Domänen für die 
RNA Bindung notwendig ist. 
Während der zweiten Hälfte meiner Doktorarbeit arbeitete Ich an den beiden 
wichtigsten zytoplasmatischen Deadenylierungskomplexen in Eukaryoten, dem CCR4-
NOT Komplex und dem PAN2-PAN3 Komplex. Hier war es mir möglich die 
Kristallstruktur der gefalteten Domänen des Adapterproteins PAN3, welches 
entscheidend für die Regulation der Deadenylierungsaktivität des PAN2-PAN3 
Komplexes ist, zu lösen. Die PAN3 Struktur führte zur Identifizierung der 
Bindungsstelle zur katalytischen Untereinheit PAN2 und enthüllte auch die Existenz 
einer Tryptophan-Bindungstasche, die wichtig ist für die Interaktion mit GW182/TNRC6 
Proteinen.  
In gemeinschaftlichen Projekten löste ich auch die Kristallstrukturen von 
verschiedenen Unterkomplexen des CCR4-NOT Komplexes und konnte dadurch 
molekulare Erkenntnisse über die Assemblierung dieses großen und aus vielen 
Einheiten bestehenden Komplexes gewinnen. Überaschenderweise enthüllte die 
Struktur des NOT-Moduls (welches minimal aus den C-terminalen Regionen von 
CNOT1, CNOT2 und CNOT3 besteht) ein einzigartigen strukturellen Aufbau, welcher 
zeigt, dass sogenannte intrinsisch ungeordnete Regionen (IDRs) notwendig sind für die 
Assemblierung des Komplexes. Diese Kristallstruktur ist von besonderem Interesse, da 
viele RNA-bindende Proteine den CCR4-NOT Komplex zu Ziel-mRNAs rekrutieren, 
indem sie an die NOT-Modul Einheiten binden. Außerdem wurden alle 
Komplexbestandteile auch isoliert kristallisiert, was es uns ermöglichte, strukturelle 
Neuanordnungen nach Komplexbildung zu analysieren.  
Zuletzt löste ich die Komplexstruktur der CNOT1 MIF4G Domäne und der 
CNOT1 DUF3819 Domäne, in Komplex mit den zugehörigen Bindungspartnern DDX6 
und der integralen Untereinheit CAF40 des CCR4-NOT Komplexes. Diese zwei 
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Strukturen ermöglichten Einblicke in die Rekrutierung des CCR4-NOT Komplexes zu 
miRNA Zielen durch GW182/TNRC6 Proteine und verbinden außerdem durch DDX6 
die Unterdrückung der Translation und möglicherweise auch Entkappung der Ziel-
mRNA mit dem CCR4-NOT Komplex.        
Im Wesentlichen stellt meine Arbeit einen umfangreichen strukturellen und 
funktionellen Rahmen über die Struktur und den Aufbau der beiden zentralen 
zytoplasmatischen Deadenylierungskomplexe dar. Weiterhin konnte ich strukturelle 
Informationen gewinnen, wie die Deadenylierungskomplexe zu miRNA Zielgenen 
rekrutiert werden. Schließlich bestimmte ich die erste hoch-aufgelöste Kristallstruktur 
des MID-PIWI Flügels eines eukaryotischen Argonaut Protein (der zentrale Faktor aller 
RNA induzierten Stilllegungsstoffwechselwege). 
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2 Introduction 
 
The concentration and the quality of mRNAs available for translation in the eukaryotic 
cell depends on both the rate of synthesis and the rate of decay. In recent years, the 
mechanisms that control mRNA decay rates have come more and more into the 
scientific focus, in particular since the discovery of small RNA-induced silencing 
pathways in the early 1990s; these pathways, together with additional post-
transcriptional control mechanisms, are now known to promote rapid mRNA 
degradation, thereby allowing the cell to rapidly adapt to environmental changes or 
stress conditions. Proteins that are required only for a short period, e.g. cytokines, often 
have mRNAs with short half-lives (less than 1 hour), whereas house-keeping genes, in 
contrast, often have very stable transcripts (more than 1 day) (see Figure 1).  
 
 
 
 
 
 
 
 
 
Figure 1: Frequency distribution of mRNA half-lives among all genes in mouse embryonic stem cells. 
(modified from Sharova et al., 2009). 
 
Additionally, global analyses have shown that ~20-50% of changes in gene 
expression rather depend on variations in mRNA stability (Neff, 2013) instead of on a 
modification in transcription rates, further underlining the importance of these 
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processes. In the following chapters, I will give an overview on post-transcriptional gene 
regulation and the molecular mechanisms and protein complexes they depend on. 
 
2.1 mRNA processing and translation  
 
In the eukaryotic cell, almost all protein-coding mRNAs are modified in the nucleus 
before being exported into the cytoplasm for translation. These modifications include 
the addition of a 5´-m7GpppN cap structure and adding a poly(A) tail at the 3´-end, a 
mechanism commonly known as polyadenylation; only a few mRNAs are not 
polyadenylated, i.e. histone mRNAs (Marzluff et al., 2008). The length of the poly(A) tail 
is species-dependent with an average length of approximately 70 residues in yeast and 
around 200-250 nucleotides in human (Eckmann et al., 2011; Wahle and Winkler, 2013). 
The poly(A) tail is bound with high affinity by members of a specific protein family 
termed poly(A) binding proteins or PABPs. This highly conserved protein family has 
been subdivided into two classes, nuclear and cytoplasmic, based on their intracellular 
localization (PABPN1 and PABPC1 are the most common representatives, respectively). 
The cap structure and the poly(A) tail have been shown to be important for both, the 
regulation of the mRNA stability (Bernstein et al., 1989; Bernstein and Ross, 1989; 
Filipowicz, 1978; Furuichi et al., 1977) by protecting the mRNA body from degradation 
through cytoplasmic exonucleases, as well as for efficient translation (see below). 
Moreover, non-coding regions or so-called introns are spliced out from the pre-mRNA, 
a process which occurs co-transcriptionally, before the mature mRNA gets exported.  
Once the mRNA is exported into the cytoplasm, PABPN1 (Wahle, 1991) is 
replaced by its major cytosolic version PABPC1. Despite the common ability to bind 
poly(A) sequences, PABPN1 possesses only low structural and functional similarity to 
its cytosolic counterpart. Whereas PABPN1 is important for polyadenylation of the 
mRNA, PABC1 promotes mRNA stability and translation efficiency. Although a poly(A) 
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tail is not essential for translation, mRNAs lacking a poly(A) tail are less efficiently 
translated compared to their polyadenylated counterparts under ribosome-limiting 
conditions (Gallie, 1991; Munroe and Jacobson, 1990; Proweller and Butler, 1997). It has 
been shown that the poly(A) tail and the 5´-cap structure function synergistically to 
promote translation initiation (Gallie, 1991). The cap structure is bound by the 
eukaryotic translation initiation factor 4E (eIF4E), which also interacts with eIF4G. eIF4G 
in turn interacts with PABPC, leading to a circularized structure of the mRNA, the so-
called closed loop conformation (see Figure 2), in which both ends of the mRNA end up 
in close proximity (Le et al., 1997). The simultaneous interaction of eIF4G with eIF4E and 
PABPC1 likely explains the synergetic effect between the cap and the poly(A) tail in 
translation initiation.  
 
 
 
  
 
 
Figure 2: Closed-loop conformation of the mRNA. eIF4G bridges the interaction between the PABPC 
bound to the poly(A) tail of the mRNA and the eIF4E protein bound to the mRNA cap structure (adapted 
from Braun et al., 2013). 
 
Because the 5´-cap structure and the poly(A) tail are stabilizing elements, an 
mRNA that is selected for degradation first needs to be deadenylated and decapped. 
These processes are described in the next two chapters. 
 
 
 
2 Introduction  10 
 
2.2 mRNA degradation in eukaryotes 
 
The decay of the mRNA body can be either initiated from the ends of the target RNA or 
through endonucleolytic cleavage as in specialized mRNA decay pathways. 
However, eukaryotic bulk mRNA degradation normally begins with the 
shortening or removal of the poly(A) tail, a process known as deadenylation. So far, 
three major independent deadenylase enzymes have been identified: the CCR4-NOT 
complex, the PAN2-PAN3 complex (both complexes are described in detail below) and 
the poly(A) specific ribonuclease, referred as PARN. In addition, numerous other 
deadenylases are known that exist in the mammalian genome (Astrom et al., 1991; 
Astrom et al., 1992; Korner and Wahle, 1997). Upon deadenylation, the mRNA target 
can either be degraded in the 3´-5´ direction through a multi-protein complex referred as 
the exosome complex, or the mRNA is first decapped and then degraded in the 5´-3´ 
direction. In the latter case, the mRNA is decapped by the decapping protein 2 (DCP2), 
and decapping is assisted by several co-activators, like DCP1, the enhancer of decapping 
3 (EDC3), the metazoan-specific enhancer of decapping 4 (EDC4), the DEAD box 
helicase 6 (DDX6, also known as RCK, Ge-1 or Me31B), Pat1 and the Lsm1-7 complex. 
DDX6 and Pat1 also act as translational repressors in addition to their roles as 
decapping activators (see below) (Chu and Rana, 2006). Once the mRNA is decapped, 
the uncapped 5´-end of the mRNA target exposes a 5´-phosphate, which is recognized as 
a substrate for the cytoplasmic 5´-3´ exonuclease XRN1. Moreover, it has been shown 
recently that XRN1 is actively recruited by the decapping complex to mRNA targets 
(Braun et al., 2012), thus adding another layer of regulation to the decapping machinery. 
Several factors involved in specialized decay pathways have been identified that 
promote or catalyze endonucleolytic cleavage. One well-established example is the 
evolutionarily conserved nonsense-mediated decay (NMD) pathway, a quality control 
mechanism which degrades aberrant mRNAs that possess a premature translation 
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termination codon or PTC (Schweingruber et al., 2013). In Drosophila melanogaster the 
first step of NMD decay is endonucleolytic cleavage close to the site of the PTC, 
resulting in short-lived decay intermediates that are rapidly digested by XRN1 and the 
exosome (Gatfield and Izaurralde, 2004). NMD can also be initiated by endonucleolytic 
cleavage in human cells (Eberle et al., 2009; Huntzinger et al., 2008). The conserved core 
of this multi-subunit machinery is formed by the three up-frameshift (UPF) proteins 
UPF1, UPF2 and UPF3 (Conti and Izaurralde, 2005). In multicellular organisms, 
additional factors such as the SMG proteins (SMG1, SMG5, SMG6 and SMG7) are 
required for NMD. The SMG proteins (suppressor with morphogenetic effect on 
genitalia) were first discovered in Caenorhabditis elegans (Cali et al., 1999; Hodgkin et al., 
1989). Out of them, only SMG6 has been shown to be an endonuclease capable to 
catalyze cleavage of the mRNA target (Eberle et al., 2009; Huntzinger et al., 2008). 
Another noteworthy pathway that depends on endonucleolytic cleavage is the 
siRNA (small-interfering RNA) pathway. In this pathway, the siRNA duplex is loaded 
into an mRNP particle referred as RNA-induced silencing complex (RISC). The small 
RNA duplex is unwound and the so-called guide strand remains associated with the 
RISC complex. As a result, the single-stranded RNA hybridizes with its mRNA target 
through perfect base complementarity and endonucleolytic cleavage of the mRNA 
occurs. This cleavage step is performed by an RNAse H-like domain, termed PIWI 
domain present in Argonaute protein (see chapter 2.4.1). Post-transcriptional gene 
silencing (PTGS) mechanisms mediated by small RNAs are explained in detail in 
chapter 2.4.  
Despite this variety of different mRNA decay pathways, the first and rate-
limiting step in bulk mRNA degradation is the shortening of the poly(A) tail, and 
deadenylation is the most efficient step in controlling mRNA decay (Decker and Parker, 
1993). 
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2.2.1 mRNA deadenylation 
 
Nearly all general cytoplasmic mRNA decay pathways in eukaryotes are initiated by the 
consecutive action of two deadenylase complexes, namely the PAN2-PAN3 [poly(A) 
specific ribonuclease] complex and the CCR4-NOT (Carbon catabolite repressor protein 
4 – Negative regulator of transcription) complex (Boeck et al., 1996; Chen and Shyu, 
2011; Miller and Reese, 2012; Tucker et al., 2001; Wahle and Winkler, 2013). These 
deadenylase complexes are highly conserved throughout evolution; however, no 
homologue of the PAN2-PAN3 complex has yet been identified in plants. 
Polyadenylated mRNAs are degraded in a 3´-5´ direction via hydrolysis of the C-
terminal adenylate residue and as a consequence, 5´-AMP is released. Monitoring 
mRNA deadenylation and decay kinetics using a Tet-off promoter-driven 
transcriptional pulse-chase approach revealed that mammalian deadenylation consists 
of a biphasic distribution (Chen and Shyu, 2011; Yamashita et al., 2005). In a first phase 
of deadenylation, mRNAs are degraded in a distributive manner by the PAN2-PAN3 
complex leading to a highly homologues length of their poly(A) tails with 
approximately 110 nucleotides (depending on the species). Importantly, in this first 
phase no degradation of the mRNA body can be observed. In addition, this phase is not 
essential for deadenylation, as mRNA deadenylation can be carried out solely by the 
CCR4-NOT complex in PAN2-PAN3-depleted cells (Tucker et al., 2001; Yamashita et al., 
2005). In contrast, the second phase of deadenylation is characterized by the processive 
action of the CCR4-NOT complex. The lengths of the poly(A) tail of the mRNAs 
becomes highly heterogeneous (between 20 and 100 nucleotides) in this phase, and 
decay of the mRNA body occurs (Yamashita et al., 2005). The composition and function 
of the different subunits of the PAN2-PAN3 complex and the CCR4-NOT complex are 
described in detail in the following to sub-chapters. 
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2.2.2 The PAN2-PAN3 complex  
 
PAN2 is the catalytic subunit of the PAN2-PAN3 complex that was originally 
discovered in yeast in 1992, and identified in 2004 in mammals (Lowell et al., 1992; Sachs 
and Deardorff, 1992; Uchida et al., 2004). PAN2 belongs to the DEDD (Asp-Glu-Asp-
Asp) class of 3´-5´ exonucleases (Moser et al., 1997). The acidic residues coordinate 
divalent metal ions that are essential for the catalytic activity of the protein. PAN2 
consists of an N-terminal WD40 domain, a ubiquitin-specific protease domain that is 
predicted to be inactive in its middle region (Quesada et al., 2004), and the 
aforementioned C-terminal exonuclease domain [see Figure 3 and (Moser et al., 1997)]. 
The activity of PAN2 strictly depends on its interaction with the adaptor protein PAN3.  
PAN3 binds directly to PABPC through an N-terminal PAM2 (PABPC-interacting 
motif 2) binding motif (see Figure 3), as a result of which PAN2 is recruited to mRNA 
targets. Consequently, PAN2 is inactive in the absence of its co-activator. PAN3 consists 
of a pseudokinase domain as well as a highly conserved C-terminal domain of unknown 
tertiary structure (see Figure 3). Importantly, the C-terminal domain has been shown to 
be critical for PAN2 binding (Mangus et al., 2004). Although it has been reported that 
PAN3 possesses the ability to self-interact, the stoichiometry of the complex has not yet 
been elucidated (Mangus et al., 2004).  
Recent reports unveiled a direct link between deadenylation and the miRNA-
mediated gene silencing pathways through direct interactions between the GW182 (or 
TNRC6 proteins in vertebrates) protein family members (see below) and the 
deadenylase complex subunits PAN3 and NOT1 (Braun et al., 2011; Chekulaeva et al., 
2011; Fabian et al., 2011). In the case of PAN3, both folded domains (pseudokinase and 
C-terminal domain) are necessary for the interaction with GW182, whereas the N-
terminal unstructured part of the protein is dispensable (Braun et al., 2011).  
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Figure 3: Domain organization of the PAN2 and PAN3 proteins. Globular domains in PAN2 and PAN3 
are highlighted in purple and green, respectively. The unstructured N-terminal PAM-2 (PABP-interacting 
motif 2) motif present in PAN3 is also shown in green (adapted from Christie et al., 2013).  
 
2.2.3 The CCR4-NOT complex  
 
The CCR4-NOT complex is the major deadenylase complex in eukaryotic organisms and 
was originally described in 1993 as a negative regulator of transcription (Cade and 
Errede, 1994; Collart and Struhl, 1993; Collart and Struhl, 1994). Over the years, many 
functions have been attributed to the CCR4-NOT complex, including transcriptional 
regulation, RNA export, mRNA decay and quality control, translational repression and 
protein degradation induced by ubiquitylation (Collart and Panasenko, 2012; Miller and 
Reese, 2012; Wiederhold and Passmore, 2010). Although it is fascinating that so many 
functions are covered solely by this multi-subunit complex, in this thesis I will focus on 
the role of the CCR4-NOT complex in mRNA deadenylation.  
The complex is formed out of at least five conserved core subunits; these can be 
divided into two modules, a catalytic module and the NOT-module. The catalytic 
module contains one DEDD type exonuclease, either CAF1 or POP2 and one EEP 
(endonuclease-exonuclease-phosphatase homology domain) type deadenylase subunit, 
either CCR4a or CCR4b (Bartlam and Yamamoto, 2010; Doidge et al., 2012; Wahle and 
Winkler, 2013). The NOT-module consists of at least NOT1, NOT2 and NOT3 or NOT5, 
a yeast paralogue of NOT3. Within the complex, the large subunit NOT1 serves as a 
modular scaffold. Additional described subunits of the complex are the ubiquitin ligase 
NOT4, the armadillo-repeat containing protein NOT9 (or CAF40 or RCD-1), and the 
2 Introduction  15 
 
species-specific subunits NOT10, NOT11 and CAF130. Interestingly, NOT4 is part of the 
core CCR4-NOT complex in yeast but not in the human counterpart (Lau et al., 2009). 
NOT4 possesses a conserved RRM (RNA-recognition motif) domain in its C-terminus 
which provides potential RNA-binding capacity. Nucleic acid binding capacity has also 
been attributed to CNOT9, a highly conserved protein which is supposed to be involved 
in the regulation of cell division (Garces et al., 2007).  
As mentioned above, the scaffold protein NOT1 features multiple binding sites 
for different sub-complexes along the entire protein. NOT1 is predicted to be almost 
completely ΅-helical with the exception of several linker regions between the domains. 
Except for a domain of unknown function (DUF) 3819, all domains have either been 
shown or are predicted to consist of primarily short ΅-helices that pack into HEAT-like 
repeats (Basquin et al., 2012; Petit et al., 2012). Recent studies have demonstrated that 
the binding site for the NOT10-NOT11 sub-complex resides in the N-terminus of NOT1, 
the CAF1-CCR4 catalytic subunits as well as the NOT9 subunit bind to the middle 
region, as do the NOT2 and NOT3/5 proteins to the C-terminus (Bawankar et al., 2013; 
Mauxion et al., 2013). The assembly of the sub-complexes is summarized in Figure 4. 
The CNOT1 scaffold protein has also been shown to bind to the translational repressor 
and decapping activator DDX6 in yeast (Maillet and Collart, 2002). 
A detailed structural model for the molecular basis between the interaction of the 
MIF4G domain (a special case of HEAT repeats) in the middle region of NOT1 and the 
catalytic module of the yeast and human CCR4-NOT complex has been obtained by two 
recently published crystal structures (Basquin et al., 2012; Petit et al., 2012).  
Furthermore, many RNA-binding proteins (RBPs) interact with the CCR4-NOT 
complex and here in particular with the NOT proteins, thereby recruiting the 
deadenylase complex to specific mRNA targets. For example, the RNA binding protein 
tristetraprolin (TTP) has been proven to bind to the 3´-UTR of mRNAs and to the NOT1 
scaffold (Lykke-Andersen and Wagner, 2005; Sandler et al., 2011). The latter interaction 
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was lately determined at an atomic resolution by a co-crystal structure between a 
HEAT-repeat like domain of NOT1 in its N-terminus bound to a tristetraprolin peptide 
(Fabian et al., 2013). This mechanism, which is known as ARE-mediated decay, is 
described in the following chapter. 
 
 
Figure 4: Domain organization of different subunits of the CCR4-NOT complex. Folded domains are 
colored; predicted unstructured regions are shown in gray. Dashed lines indicate known interaction 
between certain domains (adapted from Bawankar et al. 2013). 
 
2.3 Destabilizing sequence elements and their binding partners 
 
The half-life of an mRNA can vary from several minutes to more than 24 hours in 
mammals [(Sharova et al., 2009) and Figure 1] and is determined not only by the 
protecting structures such as the cap structure and the length of the poly(A) tail but, 
rather, by an complex interplay between those stabilizing structures and the presence of 
destabilizing sequence elements predominantly in the 3´-UTR of an mRNA. 
Tristetraprolin is a very well-known example that binds to certain destabilizing 
sequence elements, so-called AU-rich elements (AREs). AUUUA is a typical sequence 
motif that defines an ARE, which resides within a Uridine-rich sequence context in the 
3´-UTR of an mRNA. These motifs are found in approximately 9% of all cellular mRNAs 
(Chen et al., 2001) and serve as binding platforms for proteins such as TTP which in turn 
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can then interact with the deadenylase machinery and thereby induce rapid mRNA 
decay. Thus, AREs are typically found in mRNAs that require fast mRNA turnover, 
such as  the tumor necrosis factor ΅ mRN“ (Sandler and Stoecklin, 2008).  
Another remarkable example of destabilizing elements present mainly in the 3´-
UTR of target mRNAs are miRNA binding sites. These binding sites are used by small 
non-coding RNAs such as miRNAs (but also siRNAs and piRNAs; see below) to guide 
the miRISC to the 3´-UTR of target mRNAs. The miRISC complex can then induce 
translational repression and/or mRNA degradation. More than 1500 miRNA precursors 
have been identified being encoded in the mammalian genome, although the biological 
relevance of many of those potential miRNAs needs yet to be determined (Ameres and 
Zamore, 2013). It has been proposed that miRNAs regulate the gene expression for up to 
30% of all human genes (Filipowicz et al., 2008).  
 
2.4 Small RNA-mediated gene silencing mechanisms 
 
RNA interference or RNAi was first described in the early 1990s by Jorgensen and co-
workers in petunia when trying to deepen the flowers´ purple (Napoli et al., 1990). This 
work demonstrated that the transgenic introduction of the chalcone synthase gene, 
which is the key enzyme for flavonoid, flavone and anthocyanin synthesis, 
unexpectedly resulted in a block of anthocyanin biosynthesis, thereby leading to a 
partial or total loss of the flowers´ color in a wild-type pigmented background. 
Approximately one decade after this initial discovery, work by several groups (Elbashir 
et al., 2001; Fire et al., 1998; Hamilton and Baulcombe, 1999) identified a number of 
related and highly conserved pathways from plants to animals that completely 
revolutionized our understanding of gene expression and gene regulation in metazoans. 
Central to all gene silencing pathways are small non-coding RNAs, roughly ~20-
30 nucleotides long (miRNA, siRNA, piRNA), that interact with a member of the 
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Argonaute protein family to direct the resulting ribonucleoprotein complex (RNA-
induced silencing complex or RISC) to specific gene targets through perfect or partial 
base complementarity. The small double-stranded RNA associates with the Argonaute 
(AGO) first, whereupon the duplex is unwound and the so-called passenger strand is 
then removed. In contrast, the guide strand remains associated with the protein (Guo 
and Lu, 2010). In the case of perfect complementarity between the guide RNA and the 
target strand, endonucleolytic cleavage of the target RNA can occur if the Argonaute 
protein harbors catalytic activity. This process is known as slicing and only a subset of 
Argonautes possesses all the catalytic residues and loop elements that are required for 
this process. Slicing is the predominant process of exogenous and endogenous small-
interfering RNAs (siRNAs) and plant microRNAs (miRNAs).  
In sharp contrast, animal miRNAs are usually only complementary to their 
targets within nucleotides 2-7 of the guide RNA, a region known as seed sequence. 
Downstream of the seed sequence, animal miRNAs often exhibit mismatches and bulges 
which prevent the cleavage of target RNAs (Liu et al., 2004; Tolia and Joshua-Tor, 2007). 
In this case, even catalytically active AGOs cannot cleave the target but instead facilitate 
the recruitment of the CCR4-NOT and PAN2-PAN3 deadenylation complexes through 
the interaction with a bridging factor termed GW182 (or TNRC6 proteins in human; see 
Figure 5). This interaction has been shown to be direct and is mediated via conserved 
tryptophan-rich motifs present in the silencing domain (see Figure 7). Thus GW182 
proteins provide a link between miRNA target recognition by the RISC complex and 
subsequent target degradation by the major cytoplasmic deadenylase complexes (Braun 
et al., 2011; Chekulaeva et al., 2011; Fabian et al., 2011). Furthermore GW182 proteins 
have been shown to trigger also translational repression that precedes target 
degradation, but this mechanism is not yet well understood (Bazzini et al., 2012; 
Bethune et al., 2012; Djuranovic et al., 2012; Zekri et al., 2009). Argonaute proteins as 
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well as GW182 protein family members are described in more detail in the following 
two sub-chapters. 
 
 
 
 
 
 
 
 
 
Figure 5: GW182/TNRC6 proteins recruit the two major deadenylases to miRNA targets. Recruitment is 
achieved by interactions with the NOT1 subunit of the CCR4-NOT deadenylase complex and with the 
PAN3 subunit of the PAN2-PAN3 deadenylase complex (copied from Braun et al. 2013). 
 
2.4.1 The Argonaute proteins 
 
Argonaute proteins (AGOs) were first described in 1998 being important for the 
regulation of plant development in Arabidopsis thaliana (Bohmert et al., 1998; Moussian et 
al., 1998). The unusual morphological appearance of plant AGO1 mutants reminded the 
authors of a small squid, which prompted them to term these mutants after the famous 
warriors from Greek mythology that were sailing on the ship Argo (Bohmert et al., 
1998). 
Argonaute proteins have been conserved from bacteria to humans throughout 
evolution. Although only a few studies have been published regarding the function of 
Argonaute proteins in bacteria and archaea (Makarova et al., 2009; Olovnikov et al., 
2013; Shabalina and Koonin, 2008), their eukaryotic counterparts have diverse but very 
well-studied functions. Eukaryotic AGOs can act either in the cytosol together with 
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siRNAs and miRNAs to regulate post-transcriptional gene regulation or in the germ line 
together with piRNAs (PIWI-interacting RNAs) to control retrotransposons and other 
mobile genetic elements (Grivna et al., 2006; Lau et al., 2006). AGOs can also act in the 
nucleus and induce heterochromatin formation, to regulate gene expression at the level 
of transcriptional repression (He et al., 2009; Irvine et al., 2006). Moreover the number of 
AGOs differs strongly between different species. While the number of AGOs is low in 
prokaryotes, about 10 AGOs are found in Arabidopsis thaliana, more than two dozen 
AGOs are present in C. elegans genomes and only 4 cytosolic AGOs exist in humans 
(Pratt and MacRae, 2009; Tolia and Joshua-Tor, 2007).  
Despite the fact that bacteria and archaea have evolved a different nucleic acid-
based immune system (termed CRISPR system) that does not rely on Argonaute 
proteins, the first full-length structure was determined from the hyperthermophilic 
archaea Pyrococcus furiosus (Song et al., 2004). In the  years since then, a number of full-
length structures in complex with guide and target RNAs has been solved from various 
species namely Archaeoglobus fulgidus, Aquifex aeolicus and Thermus thermophilus (Ma et 
al., 2005; Parker et al., 2005; Wang et al., 2008a; Wang et al., 2008b; Yuan et al., 2005). 
These structures revealed a four domain protein consisting of a bilobal architecture with 
the N-terminal lobe containing the N-terminal (or simply N) and the PAZ domains, and 
a C-terminal lobe composed of the MID and the PIWI domains (see Figure 6).  
The N-terminal domain is the least conserved part of the protein and has been 
shown to play an important role in the unwinding step of the RNA duplex (Kwak and 
Tomari, 2012). Furthermore the N-terminal domain has been identified to be an 
important binding platform for RISC-interacting proteins (Phetrungnapha et al., 2013). 
The region between the N-terminal domain and the PAZ domain has been proven to act 
as a hinge, and it was suggested that this motion could be beneficial for RISC loading 
and mRNA target binding (Ming et al., 2007; Song et al., 2004). 
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Figure 6: Crystal structure of the Thermus thermophilus Argonaute in complex with a 5´-phosphorylated 
guide DNA strand (PDB code 3DLH). The N-terminal domain and the PAZ domain are colored in cyan 
and purple respectively. The MID and the PIWI domain are shown in green and in yellow. 
 
The structure and function of the isolated PAZ domain of eukaryotic AGOs was 
determined even before the first full-length prokaryotic structure was available. Several 
structural studies demonstrated simultaneously that the PAZ domain recognizes the 3´-
end overhang of the guide RNA (Lingel et al., 2003; Ma et al., 2004; Song et al., 2003; Yan 
et al., 2003).  
Studies on the 5´-end recognition revealed that the 5´-monophosphate of the 
guide RNA, which is generated during small RNA maturation, is required for the 
assembly of the small RNA into RISC (Chiu and Rana, 2002; Tomari et al., 2004). The 
domain responsible for 5´-end recognition in AGOs is termed the MID domain. Two 
independent structural studies characterized the binding pocket and hence how guide 
RNA-binding is achieved in prokaryotic AGOs. These studies also proposed a 
mechanism how distance-based measurement for target cleavage through the PIWI 
domain is achieved (the target is always cleaved opposite of nucleotide 10 and 11 of the 
guide strand) (Ma et al., 2005; Parker et al., 2005).  
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The PIWI domain has been shown to be the catalytic engine of the Argonaute 
protein and responsible for the endonucleolytic cleavage of the target RNA. Crystal 
structures revealed an unexpected homology to the RNase H family of enzymes (Parker 
et al., 2004; Song et al., 2004). Proteins belonging to the class of RNase H enzymes 
catalyze the hydrolysis of phosphodiester bonds in their respective DNA or RNA 
substrates. Thus the structural homology to RNase H, together with the conservation of 
critical aspartate residues important for catalysis, identified the PIWI domain being 
responsible for the slicer activity of the RNA-induced silencing complex. In addition the 
PIWI domain is also a binding partner for several AGO-interacting proteins (Friend et 
al., 2012). Nevertheless, the most well-characterized AGO-binding partners required for 
miRNA-mediated silencing of partially complementary targets are GW182 proteins, 
which are described in detail in the following section. 
 
2.4.2 The GW182 protein family  
 
In 2002, Eystathioy and colleagues discovered the GW182 protein (approx. 182 kDa in 
size with several glycine-tryptophan repeats) using sera from a patient with a motor and 
sensory polyneurophaty (Eystathioy et al., 2002). Three paralogues with overlapping 
function have been characterized in humans and vertebrates as well as various 
invertebrates (Trinucleotide repeat-containing gene 6 proteins; TNRC6A/B/C), whereas 
in insects only one paralogue is known so far (Ding and Han, 2007; Eulalio et al., 2009). 
The domain architecture of the three human paralogues, TNRC6A, TNRC6B and 
TNRC6C, is shown in Figure 7. Subsequent studies revealed an essential role for GW182 
protein family members in the miRNA-mediated gene silencing pathway (Ding et al., 
2005; Jakymiw et al., 2005; Liu et al., 2005; Rehwinkel et al., 2005). It was demonstrated 
that GW182 proteins physically bind to a certain subset of Argonaute proteins and, 
more precisely, only to those proteins that are part of the miRISC (Ding et al., 2005; Liu 
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et al., 2005). Shortly afterwards, the N-terminal domain of GW182 was identified as 
being necessary and sufficient for binding the PIWI domain, with tryptophan residues 
located in the N-term being crucial for this interaction (El-Shami et al., 2007; Eulalio et 
al., 2009; Till and Ladurner, 2007; Till et al., 2007). Consequently, the N-terminal domain 
of GW182 proteins was called the AGO-binding domain or ABD (see Figure 7). 
Interestingly, some Argonaute proteins (e.g. Hs AGO2) can participate in both, the 
siRNA pathway where cleavage of the target RNA occurs and in the miRNA pathway, 
in which GW182 proteins are essential binding partners to mediate silencing. Like 
mentioned before, one major difference between siRNAs and miRNA in animals is that 
miRNAs are only partially complementary to their RNA targets (Braun et al., 2013; 
Fabian and Sonenberg, 2012; Huntzinger and Izaurralde, 2011). As a consequence, the 
targeted mRNA is not cleaved by the Argonaute protein. Nevertheless, how GW182 
proteins can sense on a molecular basis whether the AGO protein is loaded with a 
miRNA (and thereby be a binding partner) or a siRNA has not yet been determined.  
Recently it has been reported that GW182 proteins also directly associate with the 
two major cytosolic deadenylases PAN2-PAN3 and CCR4-NOT (Braun et al., 2011; 
Chekulaeva et al., 2011; Fabian et al., 2011) and hence being important for the 
recruitment of the major cytosolic deadenylases to miRNA targets. The binding to both 
deadenylase complexes is also mediated through tryptophan residues, but these 
tryptophan residues are present in the C-terminal silencing domain (SD) of GW182 
proteins (Chekulaeva et al., 2011). Motifs critical for the binding to the CCR4-NOT 
complex have been identified and termed CIM motifs (CCR4-NOT interacting motifs) 
(Fabian et al., 2011).   
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Figure 7: Domain organization of the human TNRC6C as well as the Drosophila melanogaster GW182 
proteins (modified from Huntzinger et al. 2013). ABD, AGO-binding domain; UBA, ubiquitin associated-
like domain; QQQ, region rich in glutamine; CIM-1 and CIM-2, CCR4-interacting motif 1 and 2; MID, 
middle region; PAM2, PABP-interacting motif 2; RRM, RNA recognition motif. Vertical red lines indicate 
the positions of GW-repeats crucial for AGO-binding. Vertical blue lines indicate the position of 
tryptophans important for NOT1 and PAN3 binding.  
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3 Motivation and aims 
 
3.1 Structural and mechanistic insights into the cytoplasmic PAN2-PAN3 and CCR4-
NOT deadenylase complexes 
 
As mentioned in the introduction (see section 2.2), the PAN2-PAN3 and the CCR4-NOT 
complexes are the two major cytoplasmic deadenylase complexes in mammalian cells. 
These complexes commonly feature active deadenylase subunits bound to non-catalytic 
subunits that are essential for efficient deadenylation in vivo. The non-catalytic subunits 
often act as scaffold proteins that are likely required to stabilize the deadenylase 
subunits, i.e. the PAN3 and NOT1 subunits (Wahle and Winkler, 2013). Second, these 
non-catalytic subunits associate with RNA binding proteins and other pathway-specific 
proteins to recruit the deadenylases to certain mRNA targets.  
As an example, the PAN3 adaptor protein interacts with PABPC1 through its 
PAM2 motif to guide the PAN2 deadenylase to mRNA targets (Mangus et al., 2004). The 
NANOS protein family is another well-known RNA-binding protein that has been 
shown to directly interact with the CNOT1 scaffold to promote deadenylation of specific 
mRNA targets particularly in the germline (Suzuki et al., 2010; Suzuki et al., 2012). 
Furthermore, the GW182/TNRC6 proteins associate with PAN3 and NOT1 to promote 
translational repression and mRNA decay of miRNA targets (Braun et al., 2011; 
Chekulaeva et al., 2011; Fabian et al., 2011; Huntzinger et al., 2013). However, the 
mechanism of how translational repression is induced by the CCR4-NOT complex 
remained enigmatic so far, although Meijer et al. recently proposed that eIF4A2 is 
recruited to mRNA targets through the CNOT1 MIF4G domain thereby imposing 
translational repression (Meijer et al., 2013). Interestingly the CNOT1 MIF4G domain 
has been shown in yeast to interact directly with another DEAD-box helicase protein, 
namely the translational repressor DDX6 (Maillet and Collart, 2002). 
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During my PhD I was aiming to elucidate how these two major cytoplasmic 
deadenylase complexes assemble on an atomic level, how they are recruited to miRNA 
targets, and, in the case of CCR4-NOT, induce translational repression. When I started 
these projects, structural data on the non-catalytic subunits of the PAN2-PAN3 and the 
CCR4-NOT complexes were not available, despite their importance for general mRNA 
degradation and the miRNA pathway.  
The PAN3 adaptor protein consists of an N-terminal unstructured region that 
contains a PAM2 motif essential for PABPC1 binding, followed by a central domain 
predicted to adopt a pseudokinase fold and a highly conserved C-terminal domain of 
unknown three-dimensional structure. Self-interaction of the PAN3 protein, described 
earlier, could be attributed to the pseudokinase and the C-terminal domains. 
Additionally it was demonstrated that the C-terminal domain was sufficient to mediate 
binding to the PAN2 catalytic subunit (Mangus et al., 2004). 
The CCR4-NOT complex consists of two conserved modules: a catalytic module 
that contains two deadenylases (CCR4a or CCR4b and CAF1 or POP2) and a NOT-
module, minimally formed by the C-termini of NOT1, NOT2 and NOT3 (see section 
2.2.3; Figure 4) (Bawankar et al., 2013). The C-terminus of NOT1 is highly conserved and 
defines the so-called NOT1 superfamily homology (SH) domain. The C-termini of NOT2 
and NOT3 are highly related to each other and comprise the NOT-box domain (Zwartjes 
et al., 2004). Due to the lack of sequence homology to known structural folds it was not 
possible to predict the fold of the individual domains of NOT1, NOT2 and NOT3 and 
hence their assembly in the complex. 
Finally it was shown that W-residues present in the C-terminal silencing domain 
of GW182 proteins (see Figure 7; blue bars) mediate the recruitment of deadenylation 
complexes to miRNA targets. Thus we sought to identify tryptophan binding pockets 
present in PAN3 and NOT1 to gain structural and mechanistic insights into this 
interaction.  
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3.2 How do eukaryotic Argonautes fulfill their function in small-RNA mediated gene 
silencing pathways? 
 
By January 2009, the starting date of my PhD thesis, work from several groups had 
provided structural and mechanistic insights into the three-dimensional architecture of 
full-length prokaryotic AGOs, clarifying how these molecules bind nucleic acids (Ma et 
al., 2005; Parker et al., 2005; Song et al., 2004; Wang et al., 2008a; Wang et al., 2008b). 
Structural information on eukaryotic Argonaute proteins however, was limited to the 
isolated PAZ domain at that time (Lingel et al., 2003; Song et al., 2003; Yan et al., 2003).  
Consequently, no structural information was available for the MID and the PIWI 
domains of eukaryotic AGOs, despite their importance in RNA binding and catalysis. 
Moreover, several independent studies focused on the fold of the MID domain and its 
role in miRNA-mediated gene silencing (Djuranovic et al., 2010; Kinch and Grishin, 
2009; Kiriakidou et al., 2007). Based on the observation that human AGO2 binds to 
m7GTP Sepharose beads it was proposed that certain eukaryotic AGO MID domains (in 
particular those AGOs which participate in the miRNA pathway) can bind the 5´-cap 
structure of target mRNAs to repress translation. Two different modes of cap-structure 
binding had been proposed: Early on, Kiriakidou and colleagues hypothesized that the 
MID domains of eukaryotic AGOs adopt an eIF4E-like fold, thus allowing the MID 
domain to sandwich the mRNA cap structure between two highly conserved 
phenylalanine residues in a mode similar to that observed in eIF4E (Marcotrigiano et al., 
1997). In contrast, Djuranovic and co-workers identified a second, miRNA-dependent 
binding site located near the guide RNA binding pocket, which can bind nucleotides 
such as the 5´-cap structure. In this newly identified potential binding pocket, an 
aspartate residue was hypothesized to be central for allosteric control. To discriminate 
among the proposed models it was absolutely necessary to obtain structural information 
on the MID and PIWI domains at atomic resolution. 
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Furthermore, although the domain composition is conserved between 
prokaryotic and eukaryotic counterparts, the sequence conservation is low (less than 
20%) and the eukaryotic proteins exhibit numerous insertions in their sequences. 
Therefore, it remained to be elucidated, whether guide RNA binding in eukaryotic 
AGOs resembles the mode of DNA binding observed in prokaryotic proteins and 
whether the aforementioned insertions are important for nucleic acid binding or the 
recruitment of eukaryotic specific binding partners like the GW182 proteins.  
In essence, structural and functional analyses on the MID and the PIWI domains were 
crucial for improving our knowledge of eukaryotic Argonaute biology, especially since 
the PAZ domain was the only determined domain of eukaryotic Argonautes at that 
time.  
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4 Results and discussion 
 
My PhD work was aimed at providing a detailed molecular understanding of general 
and specific posttranscriptional gene regulation mechanisms. To this end, I solved the 
crystal structures of protein subunits or domains required for the assembly of the two 
major deadenylase complexes PAN2-PAN3 and CCR4-NOT, as well as of a key player 
in silencing pathways, the Argonaute protein QDE-2 from Neurospora crassa. During this 
work evidence emerged, that these two processes are directly interlinked in such a way, 
that AGOs acting in the miRNA silencing pathway, recruit the general deadenylase 
complexes to miRNA-targets through a bridging factor termed GW182. The assembly of 
this complex triggers translational repression and mRNA degradation. In the following 
two chapters I will summarize the results I obtained during my PhD, starting with the 
deadenylase complexes. 
 
4.1 The structure of the PAN3 pseudokinase and its interaction with GW182 proteins 
 
All experimental data and detailed descriptions about the experimental procedures can 
be found in the attached manuscript (Christie et al., 2013). 
Sequence analysis as well as secondary and tertiary structure prediction tools like 
PSIPRED (Buchan et al., 2013) and HHPRED (Soding et al., 2005) demonstrated that the 
PAN3 adaptor protein can be divided into three distinct regions: An N-terminal 
unstructured region (N-term) which mediates binding to PABC1 through a PAM2 motif, 
a central pseudokinase domain (PK), which is predicted to be inactive and a C-terminal 
conserved domain (C-term), which has been shown to be necessary and sufficient to 
mediate binding to the catalytic subunit PAN2 (Mangus et al., 2004) (see Figure 3). Due 
to the lack of sequence homology to known structural folds however, the structure of 
the C-terminal conserved domain remained obscure. In addition, it was known that 
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PAN3 can self-interact, however the stoichiometry of this self-interaction was not 
defined.  
By utilizing structure prediction tools I designed protein fragments of Nc PAN3 
suitable for protein expression and ultimately for protein crystallization. I optimized the 
purification conditions for several constructs from different species and demonstrated 
by thermal shift assays (Lucet et al., 2013) that PAN3 proteins are stabilized upon ATP-
binding. Interestingly, human PAN3 protein fragments could only be purified when 
nucleotides were supplemented during the purification process. Furthermore crystals of 
PAN3 were only obtained in the presence of nonhydrolyzable ATP analogues and 
MgCl2 in the protein solution (ATP-·-S in the case of Nc Pan3 and AMPPNP for Dm 
PAN3).   
In a shared project, we solved the crystal structures of the folded domains of the 
wild-type and a mutant version of Nc PAN3, as well as Dm PAN3 at 3.3, 2.85 and 3.6 Å 
resolution, respectively (Christie et al., 2013). Using a Nc PAN3 protein fragment I 
obtained the first crystals of a PAN3 protein and enhanced the crystal quality by using 
different optimization methods like microseeding. Thereby I improved the resolution of 
the wild-type protein to 3.3 Å from initially only poorly diffracting crystals (less than 4.5 
Å). I determined initial phases by the single-wavelength anomalous diffraction (SAD) 
method (Rice et al., 2000) using a selenomethionine substituted version of the protein. 
Phase determination was sufficient to build an initial model that was then used to solve 
and refine the structural model of the Dm PAN3 protein that had been crystallized by 
my colleague Tara Christie. In a bid to improve the resolution of our structural models, I 
designed and crystallized a mutant version of Nc PAN3 that indeed diffracted X-rays up 
to 2.85 Å and thus strengthened the conclusions that we made from the models. 
To determine the stoichiometry of PAN3 oligomers in solution, we performed 
size exclusion chromatography runs coupled to multiangle static laser-light scattering 
(MALLS) (Folta-Stogniew and Williams, 1999). These experiments indicated a molecular 
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weight of approximately 100 kDa for the Nc, Dm and Hs PAN3 proteins, in contrast to 
the expected size of roughly 50 kDa for a monomeric PAN3. This indicates that PAN3 
forms dimers in solution, and that dimer formation is conserved throughout evolution. 
In contrast, the PK and the C-term domains of Dm PAN3 in isolation behaved like 
monomers in solution, showing that dimer formation only occurs, when the protein 
fragment contains both folded domains.  
PAN3 not only forms dimers in solution, but also crystallizes as a homodimer. 
This homodimerization is mainly mediated via a central coiled coil domain that links 
the N-terminal pseudokinase domain (PK) to the C-terminal knob (CK) domain (see 
Figure 8). The central left-handed coiled coil domain is asymmetric due to a kink in only 
one ΅-helix of the coiled coil domain. The N-terminal pseudokinase domain displays, as 
expected, a canonical bilobal kinase domain fold (Bryant et al., 1974). Nevertheless the 
PK domain of PAN3 exhibits numerous substitutions in almost all conserved motifs that 
are crucial for kinase activity, i.e. the catalytic VAIK and HRD motifs. Another striking 
difference between PAN3 and canonical kinase domains is the lack of an activation loop, 
which usually bridges the DFG motif and the APE motif (Hanks et al., 1988). Therefore I 
tested whether PAN3 retained the ability to hydrolyze ATP in vitro. As expected, I could 
not detect any intrinsic ATPase activity, even after a prolonged incubation time of 20 
hours. 
 
 
 
 
 
 
 
Figure 8: Crystal structure of the Dm PAN3 pseudokinase dimer in complex with AMPPNP (adapted 
from Christie et al. 2013). The PAN3 monomers are colored in cyan and purple respectively. 
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The CK domain adopts a compact fold consisting of ř ΅-helices ǻhelix ΅Ř, ΅ř and ΅ŚǼ 
with a Ά-hairpin inserted between helix ΅ř and ΅Ś. Comparison of the CK domain to all 
deposited structures in the PDB database using the DALI-server revealed that the CK 
domain adopts a rather unique structural fold. With the structure in hand, we next 
analyzed the surface conservation of the CK domain to identify highly conserved and 
surface-exposed residues that could mediate PAN2 binding. Coimmunoprecipitation 
assays performed by my colleague Eric Huntzinger helped us to identify a number of 
surface-exposed residues involved in PAN2 binding (see Figure 5 C and D in Christie et 
al., 2013).  
Notably, crystal packing interactions within the Dm PAN3 crystal lattice unveiled 
the presence of a tryptophan-binding pocket at the base of the coiled coil domain (a 
neighboring symmetry mate in the crystal inserts a W-residue into this pocket). This 
pocket is highly symmetrical and formed by both monomers. It is lined by several 
hydrophobic residues including M651, G655 and F658. Importantly proline 652 in each 
monomer serves as a stacking partner for the bound tryptophan residue (W707). 
Consequently, this hydrophobic pocket is formed upon Dm PAN3 dimerization (see 
Figure 9). Again, mutagenesis of residues lining this W-binding pocket or mutants that 
abolish Dm PAN3 homodimerization efficiently abolish TNRC6C binding in vitro and in 
vivo, thus validating the importance of this W-binding pocket for TNRC6 binding and 
hence for the recruitment to miRNA targets (see Figure 6 D and E in Christie et al., 
2013). By sequence comparisons using Jalview (Waterhouse et al., 2009), I could show 
that the presence of the tryptophan-binding pocket correlates well with the presence of 
TNRC6/GW182 proteins in higher eukaryotes. 
 
4 Results and discussion  33 
 
 
 
 
 
 
 
 
Figure 9: Close-up view of the W-binding pocket (adapted from Christie et al. 2013). The two monomers 
forming a dimer are shown in cyan (Monomer A) and purple (Monomer B) respectively. A neighboring 
symmetry mate (gray) inserts an exposed W-residue (black) in a hydrophobic pocket at the base of the 
coiled coil domain. Selected residues forming the W-binding pocket are shown as sticks.  
 
In summary, these structures provides a detailed understanding of the assembly of the 
PAN2-PAN3 complex, the self-dimerization of PAN3 and most importantly, the 
recruitment of the complex to miRNA targets through GW182/TNRC6 proteins. 
 
4.2 The CCR4-NOT complex 
 
To gain functional and structural insights into the mechanisms of deadenylation and 
translational repression carried out by the CCR-NOT complex, I determined several sub-
complexes of the CCR4-NOT complex in two collaborative projects.  
In a first project, we initially solved the structures of the NOT-box domains of the 
human CNOT2 and CNOT3 proteins in isolation (both at 2.4 Å resolution), as well as the 
superfamily homology domain (SHD) of NOT1 from Chaetomium thermophilum (at 3.2 Å 
resolution). The highly conserved NOT-box domain is shared by NOT2 and NOT3 and 
located at their respective C-termini. Similarly, the C-terminus of NOT1 is highly 
conserved and defines the superfamily homology domain. In a previous study from the 
lab, it was demonstrated that the C-termini of NOT1, NOT2 and NOT3 form a complex, 
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the so called NOT-module (Bawankar et al., 2013). Next we also determined the 
structure of the assembled NOT-module core at 3.2 Å resolution. 
In an independent second project, we investigated the structural basis of the 
interaction between TNRC6/GW182 proteins and the CCR4-NOT complex and thus how 
the deadenylases are recruited to miRNA targets. We showed that a DUF3819 domain 
(domain of unknown function 3819) in CNOT1 is the binding site for the highly 
conserved subunit CNOT9 and that the binary complex consisting of CNOT1 and 
CNOT9 provides a major binding site for GW182 proteins. We determined the structure 
of this sub-complex at 1.65 Å resolution without and at 2.05 Å resolution in complex 
with tryptophan (free L-tryptophan was supplemented to the crystallization condition).  
Next we structurally addressed the question, how the CCR4-NOT complex could 
achieve its repressive activity on translation. As described previously (see section 3.1), it 
was known that NOT1 can bind the translational repressor and decapping activator 
DDX6 (Maillet and Collart, 2002) in yeast and in fly embryonic extract (Temme et al., 
2010). We determined the domain in CNOT1 responsible for binding to the DDX6 RecA-
C domain and solved this sub-complex at 1.75 Å resolution. This complex links 
decapping to deadenylation through direct interactions.  
 
4.2.1 The crystal structure of the human NOT-module core (CNOT1/2/3) 
 
All experimental data and detailed descriptions about the experimental procedures can 
be found in the attached manuscript (Boland et al., 2013). 
Again, by using secondary structure prediction and sequence alignment tools I 
designed all constructs used for crystallization purposes in this study and designed 
specific mutants for functional studies that abrogate NOT-module formation. I 
optimized the protein purification procedure and determined the optimal protein buffer 
conditions for crystallization by using thermal shifts assays (Lucet et al., 2013). In a first 
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attempt we crystallized the individual domains of the C-terminus of NOT1 from 
Chaetomium thermophilum and the human NOT-box domains of CNOT2 and CNOT3. I 
worked on all critical steps during the structure determination process like data 
collection, phase determination and structure refinement. Notably, all the isolated 
domains were solved by experimental phasing which paved the way to ultimately solve 
the structure of the ternary CNOT1/2/3 complex by molecular replacement. 
The C-term of CNOT1 consists of two tightly interacting subdomains that are 
arranged as two perpendicular stacks of HEAT-like repeats. The N-terminal subdomain 
comprises six ΅-hairpin repeats, the C-terminal subdomain consists of four HEAT-like 
repeats. These subdomains are connected by a long surface-attached linker. 
Next we showed by multi-angle laser light scattering and size exclusion 
chromatography that a protein fragment encompassing the CNOT3 NOT-box domain 
dimerizes in solution. CNOT3 also forms dimers in the crystal environment. The NOT-
box domain contains three ΅-helices followed by a five-stranded half-open Ά-barrel, 
similar to the SH3-type domain. In contrast to the SH3-fold, the NOT-box of CNOT3 
homodimerizes via its tightly packed N-terminal ΅-helix bundle. The interface exhibits a 
two-fold symmetry and is mainly composed of hydrophobic residues (see Figure 11).  
In contrast, CNOT2 crystallizes as a domain-swapped dimer in which the N-
terminal helices adopt an open conformation. CNOT2 packs as a dimer of dimers in the 
crystal leading to a fairly symmetrical homotetramer. The formation of dimers and 
tetramers can also be observed in solution measured by MALLS experiments. To 
discriminate between these two different binding modes, in the context of the assembled 
NOT-module, we crystallized a ternary complex additionally containing CNOT1.  
In a bid of crystallizing a ternary complex, I designed crystallization constructs 
compatible for co-expression in Escherichia coli cells (Diebold et al., 2011). In the context 
of the ternary complex, N-terminal sequences upstream of the NOT-box domains were 
included in the expression constructs of CNOT2 and CNOT3 because these regions were 
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shown to be crucial for complex assembly (Bawankar et al., 2013). Importantly, these 
upstream sequences were predicted to be devoid of any secondary structure element. I 
optimized the purification process of the ternary complex and used the purified 
complex for biochemical characterization. I identified a stable NOT-module core by 
performing limited proteolysis experiments with various proteases. Notably, solely the 
CNOT1 scaffold protein was degraded in these experiments. In contrast, the CNOT2 
and CNOT3 remained intact despite the presence of the N-terminal upstream sequences 
that were predicted to be unstructured. In a collaborative effort with my colleagues, the 
structure could be solved at 3.2 Å resolution. 
The heterotrimeric complex consisting of CNOT1, CNOT2 and CNOT3 displays a 
1:1:1 stoichiometry and is organized into a symmetrical lobe containing the NOT-boxes 
of CNOT2 and CNOT3 and an asymmetrical lobe containing the CNOT1 scaffold 
protein (see Figure 10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Crystal structure of the minimal NOT-module core showing CNOT1, CNOT2 and CNOT3 in 
gray, purple and green respectively (adapted from Boland et al. 2013).  
 
The structures of CNOT1 and CNOT2 in the complex are virtually identical to the 
isolated domains, whereas CNOT2 displays a closed conformation of the N-terminal ΅-
helices when crystallized as a ternary complex. As a consequence, CNOT2 and CNOT3 
form a highly symmetrical heterodimer, similar to the CNOT3 homodimer. Importantly, 
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the heterodimerization interface shows a higher degree of complementarity regarding 
the side chain interactions than the homodimerization interface does, which explains in 
part why heterodimerization is favored in solution (see Figure 11). 
 
 
 
 
 
 
 
Figure 11: Comparison between the CNOT3-CNOT3 homodimer interface and the CNOT2-CNOT3 
heterodimer interface (adapted from Boland et al. 2013). The CNOT3 and CNOT2 monomers are shown in 
green and in purple, respectively. Selected side chains forming the hydrophobic interfaces are shown in 
lime green and purple for CNOT3 and CNOT2, respectively. 
 
The N-terminal sequences upstream of the NOT-box domains wrap around the 
respective opposed NOT-box domain like clamps and lock themselves back through 
side chain interactions. The heterodimer is bound onto the NOT1 surface by further N-
terminal sequences, each of which consists of an N-terminal helix, followed by a region 
entirely devoid of any secondary structure. Those N-terminal helices insert into lateral 
grooves on the NOT1 surface (see Figure 10). The adjacent unstructured regions mold 
onto surface grooves on the NOT1 surface thereby tethering the symmetric lobe onto the 
asymmetric lobe. Lastly, the C-terminal tail of CNOT2 clamps the N-terminal residues of 
CNOT3 onto the CNOT1 surface, thereby preventing dissociation of CNOT3. This mode 
of assembly of the CCR4-NOT complex, mediated by intrinsically disordered regions 
(IDRs) could not have been detected without determining the crystal structure of the 
minimal NOT-module core.   
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Mutagenesis studies done by my colleague Dyugu Kuzuoğlu-Öztürk surprisingly 
revealed that substitutions of only two or three surface residues on CNOT1 that directly 
contact the IDRs of CNOT2 or CNOT3, are sufficient to prevent binding. Similarly, 
deletion mutants of the IDRs of CNOT2 and of CNOT3 prevent binding to CNOT1 and 
the respective opposed NOT-box protein.  
In summary, the NOT-module core structure was solved in a two step approach 
and the importance of the NOT-module for correct complex assembly and function was 
demonstrated in functional assays, i.e. complementation assays (see Figures 6 and 7 in 
Boland et al., 2013). 
 
4.2.2 Recruitment of the CCR4-NOT complex by GW182 proteins  
 
All experimental data and detailed descriptions about the experimental procedures can 
be found in the attached manuscript (Chen, 2014). 
Initial domain mapping experiments done by coimmunoprecipitation assays, revealed 
that GW182/TNRC6 proteins mainly interact with the DUF3819 domain present in the 
MID region of CNOT1 (see Figure 4). This domain of CNOT1 was also shown to 
mediate binding to the subunit CAF40/CNOT9 and we therefore termed it CN9BD. To 
gain structural insights into this dual function of the CNOT1 CN9BD domain, we 
crystallized a complex containing the CN9BD domain and CNOT9 in both the absence 
and the presence of free L-tryptophan in the crystallization condition. The crystals 
allowed us to determine the structures at 1.65 Å without and at 2.05 Å with bound 
tryptophan. 
Similarly to the described PAN3 and NOT-module projects before, I initiated and 
established the project in the lab. I designed all, and generated most constructs used in 
this project for protein expression and crystallization of the CN9BD, as well as 
constructs of CNOT9 suitable for co-expression with the CN9BD. In a crucial experiment 
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I showed that the CN9BD in isolation is unstable but gets highly stabilized when bound 
to the conserved ARM domain of the core subunit CNOT9. I established the conditions 
for complex purification and purified in an collaborative effort several different 
complexes which I set up for crystallization trials and used for in vitro pull-down assays. 
Furthermore, I worked on all critical steps during the structure determination process 
including crystal optimization as well as data collection, structure solution and 
refinement. 
The crystal structure of the highly conserved CNOT9 subunit was described in 
2007 (Garces et al., 2007) and used as a molecular replacement model to determine the 
structure of the CN9BD-CNOT9 complex. The CNOT9 subunit in isolation is virtually 
identical to CNOT9 in complex with CNOT1, as is indicated by a low root mean square 
deviation (r.m.s.d.). Six imperfect Armadillo (ARM) repeats are formed by ŗŝ ΅-helices 
that are arranged in a clockwise spiraling manner. The CNş”D domain consists of ŝ ΅-
helices in which helices ΅Ř–΅Ś are arranged as an antiparallel, rod-shaped bundle of 
three kinked ΅-helices (see Figure 12). 
 
 
 
 
 
 
 
 
 
Figure 12: Overview of the CNOT1-CNOT9 binary complex showing CNOT9 in cyan and CNOT1 helices 
΅Ř, ΅ř and ΅Ś in green, yellow and purple, respectively (adapted from Chen et al. 2014). The W-binding 
pockets present in CNOT9 are not shown. 
 
CNOT9 forms homodimers in solution. This homodimerization interface largely 
overlaps with the heterodimerization interface with CNOT1. The interface between 
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CNOT1 and CNOT9 is larger than the homodimerization interface (3170 Å2 vs 2005 Å2) 
and hence likely to be favored. The interaction between the CNOT1 CN9BD and CNOT9 
ARM domains is mainly mediated via hydrophobic interactions and assisted by only a 
few hydrogen bonds. To validate that the interface observed in the crystal environment 
also forms in solution, we designed CN9BD and CNOT9 mutants and performed in vitro 
pull-downs as well as coimmunoprecipitation experiments in human and fly cells. These 
experiments revealed that single point mutations reduced but did not abrogate the 
interaction between CN9BD and CNOT9. To disrupt binding of the CNOT9 to CNOT1 it 
was necessary to introduce four point mutations in CNOT9. Conversely, to disrupt 
binding of CNOT1 to CNOT9, it was necessary to introduce five specific point 
mutations. These results are consistent with a rather extensive and high affinity 
interaction, as observed in the crystal structure.  
However the most important observation was the presence of tryptophan residues 
inserted into tandem tryptophan pockets located on the convex surface of the horseshoe 
like ARM-domain of CNOT9 (see Figure 13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Close up view of the tandem tryptophan binding pockets identified in CNOT9. Selected side 
chains surrounding the tryptophan residues (yellow) are shown as sticks colored in purple. Tryptophan 2 
(W2) is only present when L-tryptophan is supplemented in the crystallization condition (A). Tryptophan 
1 (B) is presumably part of a disordered C-terminal tail from a neighboring symmetry mate within the 
crystal lattice (adapted from Chen et al. 2014).   
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To elucidate whether these W-binding pockets are important for binding to 
GW182/TNRC6 proteins I performed in vitro pulldown asssays. The results have been 
confirmed in cells as well. I mutated residues either lining W-binding pocket 1 or pocket 
2 or I combined those mutations. The pulldowns showed that mutation in either one of 
the two pockets reduced but did not completely abolish TNRC6 binding (see Figure 14 
lanes 8 and 9), whereas combining those mutations efficiently abrogated binding (see 
Figure 14 lanes 10-12). Importantly, a complex containing a mutated version of CNOT9 
bound to the CN9BD of CNOT1 did not interact with TNRC6A in vitro, indicating that 
tandem W-binding pockets in CNOT9 represent the major binding pockets for W-rich 
proteins (see Chen et al., 2014 Figure S1B). 
 
 
 
 
 
 
Figure 14: In vitro pull-down analysis between the silencing domain (SD) of TNRC6A and the ARM 
domain of CNOT9, using either wildtype or mutated pocket mutants of CNOT9. Pocket 1 (P1), pocket 2 
(P2) and a combination of various mutations in pocket 1 and pocket 2 (P1+2) (Chen et al. 2014). 
 
4.2.3 A complex comprising CNOT1 and the translational repressor and decapping 
activator DDX6 links deadenylation to decapping 
 
In a second part of this project, we tested a hypothesis previously proposed (Meijer et 
al., 2013) – namely, that the central MIF4G domain of CNOT1 interacts with eIF4A2 in 
an eIF4G-eIF4A1-like manner to interfere with translation. To this aim, 
coimmunoprecipitation experiments in human HEK293 cells were performed by my 
colleagues. In these experiments, we included another helicase, termed DDX6, as a 
positive control, because this helicase was previously described as an interaction partner 
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to the N-terminal half of NOT1 in yeast (Maillet and Collart, 2002). In contrast to Meijer 
and co-workers, we did not observe binding of DDX6 to CNOT1, but we clearly 
detected binding of DDX6 to the CNOT1 MIF4G domain. In a subsequent step, we 
determined the crystal structure of the CNOT1 MIF4G domain in complex with the 
RecA-C domain of DDX6.  
The protein complex was co-expressed in E.coli star cells using two previously 
described plasmids (Petit et al., 2012; Tritschler et al., 2009). Although the crystals tend 
to grow in clusters, I mechanistically separated a few single plates which finally led to a 
1.75 Å data set. We used the previously determined crystal structures of the DDX6 
RecA-C domain and the CNOT1 MIF4G domain as molecular replacement models.  
Similarly to the CNOT1-CNOT9 complex, I contributed to every step during structure 
determination, including phase determination by molecular replacement and 
refinement, as well as I analyzed the structure and designed binding mutants. 
In sharp contrast to the CN9BD-CNOT9 complex, the interface between the 
CNOT1 MIF4G domain and the RecA-C domain of DDX6 is rather small (approximately 
640 Å) and is dominated by polar interactions (see Figure 15). This might explain why 
DDX6 is not purified as a constitutive component of the CCR4-NOT complex in diverse 
studies (Bai et al., 1999; Gavin et al., 2002; Liu et al., 1998; Morel et al., 2003), although 
Me31b (the Drosophila melanogaster orthologue of DDX6) was found to 
coimmunoprecipitate with NOT1 using a monoclonal NOT1 antibody in Drosophila 
embryo extract (Temme et al., 2010). The yeast orthologue DHH1 was also described as 
interaction partner of NOT1 (Maillet and Collart, 2002).  
Two structural interface elements present in DDX6 are of particular interest. 
Firstly, a highly conserved Arginine residue (R375) in DDX6 serves as an ȃanchorȄ 
residue by inserting deeply into a highly conserved patch of CNOT1, thus forming 
multiple interactions, incuding stacking interactions and hydrogen bonds (see Figure 
15A). Secondly, loop L3 of DDX6 forms several hydrogen bonds to distinct side chains 
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of CNOT1, thereby providing specificity to this interaction (see Figure 15B). Hence we 
termed this loop L3 the specificity loop.      
 
 
 
Figure 15: Close up-views showing the hydrophilic interface between the RecA-C domain of Hs DDX6 
shown in yelloworange and human CNOT1 MIF4G domain in green. Selected residues are shown as 
sticks in orange and dark green for DDX6 and CNOT1, respectively. A highly conserved Arginine residue 
(R375) from DDX6 inserts into a conserved patch in CNOT1 (A). Specific site chain recognitions between 
Loop L3 from DDX6 and the first two HEAT repeats of CNOT1 (B) (Chen et al., 2014). 
 
Next, we identified key residues important for complex formation and validated those 
by pulldowns or coimmunoprecipitation experiments.  
In summary, in this project we showed that a binary complex consisting of the CNOT1 
CN9BD and the CNOT9 ARM domains, assist the recruitment of the CCR4-NOT 
complex to miRNA targets through tandem W-binding pockets located in the highly 
conserved subunit CNOT9. In a second part we showed that the CNOT1 MIF4G domain 
and DDX6 form a complex thereby linking translational repression and decapping to 
deadenylation. 
 
4.3 Structure and ligand binding of a eukaryotic Argonaute protein 
 
To address the questions raised in section 3.2 on the fold and the biology of eukaryotic 
AGOs, I determined the crystal structures of both, the MID domain in isolation (Boland 
et al., 2010; Faehnle and Joshua-Tor, 2010) as well as the first MID-PIWI lobe (Boland et 
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al., 2011) of the eukaryotic AGO QDE-2 from the filamentous fungus Neurospora crassa. 
Experimental data and detailed descriptions about the experimental procedures can be 
found in the attached manuscripts (Boland et al., 2011; Boland et al., 2010). 
In this chapter, two related projects are summarized. In both projects I conducted 
all in vitro experiments, including construct design, protein purification and 
crystallization as well as RNA binding assays.  
The structure of the MID domain in isolation revealed, that the Nc QDE-2 MID 
domain adopts a Rossmann-like fold and thus ruled out the possibility that eukaryotic 
AGO MID domains adopt an eIF4E-like fold to sequester the mRNA cap structure 
between two conserved phenylalanine residues. Additionally, the structure of the 
human AGO2 MID domain was published simultaneously to the Nc MID domain 
(Faehnle and Joshua-Tor, 2010; Frank et al., 2010), confirming that MID domains in 
eukaryotic AGOs adopt a Rossmann-like fold. The QDE-2 MID domain superposes very 
well onto the previously determined MID domains of prokaryotic Argonaute proteins, 
with an r.m.s.d. value of 2.6 Å between the Nc MID and the Af MID domain, despite 
poor sequence conservation (9 %).  
The 5´-guide RNA binding pocket however, is lined by several conserved 
residues mediating RNA binding. Among those highly conserved residues, Tyrosine 595 
in Nc QDE-2 serves as a stacking platform for the 5´-terminal nucleotide of the guide 
RNA, which shows a strong bias towards uridine (Ghildiyal et al., 2008; Ghildiyal et al., 
2010; Hu et al., 2009; Lau et al., 2001). The invariant K599 and K638 residues as well as 
the poorly conserved K634 coordinate a sulfate ion (S1) stemming from the 
crystallization condition (see Figure 16A). By superposing the Af MID-PIWI domains in 
complex with guide-RNA (Parker et al., 2005) (see figure 16 B) onto the Nc MID domain, 
the 5´-uridine base is positioned very well into the positively charged binding pocket 
(Figure 16 C). Importantly the 5´-phosphate of the guide RNA superposes almost 
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perfectly onto the sulfate ion S1. This model further validates Y595 as a stacking partner 
for the 5´-uridine base of the guide RNA.  
  
 
 
 
Figure 16: Comparison of the MID domain shown in lime from Neurospora crassa (A) and Archaeoglobus 
fulgidus bound to RNA, shown in gray (B). Modeling of an RNA substrate onto the Nc QDE-2 MID 
domain (C). 
 
Surprisingly, the structure of the Nc QDE-2 MID domain revealed a second bound 
sulfate ion. This second binding site is located in close proximity to the first ligand 
binding site (distance between the two sulfate ions is ~6.3 Å), sharing two highly 
conserved lysine residues (K599 and K638) in common. As a result, these two lysines 
coordinate both sulfate ions simultaneously. Moreover, the proposed aspartate residue 
(D603 in QDE-2) implicated in allosteric control in a subset of eukaryotic AGOs 
(Djuranovic et al., 2010), is distant less than 7 Å from the second sulfate ion (S2). Thus, 
this second sulfate could indeed represent a second ligand that is bound in close 
proximity to the 5´-nucleotide binding site. Both binding pockets are not independent of 
each other, since the lysine residues K599 and K638 participate in binding of both 
ligands and might therefore provide an explanation for the allosteric effects observed by 
Djuranovic and co-workers. However whether this second ligand binding site would be 
accessible in the context of a full-length eukaryotic Argonaute remained still obscure. In 
fact evidence from the prokaryotic structures would occlude such a model since the very 
C-terminal tail of the AGO is deeply inserted into the MID-PIWI interface and would 
therefore not allow binding of a second ligand in this conformation. 
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In a second project I crystallized the first MID-PIWI lobe of a eukaryotic Argonaute 
protein. Despite numerous attempts to optimize the crystal quality and an extensive 
crystal screening process, the resolution of the obtained data sets from the wild-type 
protein fragment was restricted to 3.65 Å. In a two step approach, I then first determined 
and refined the crystal structure of the wild-type protein at low resolution and 
subsequently designed a deletion mutant of an internal loop element that was 
disordered in the crystal lattice. This deletion mutant crystallized in a different space 
group and I obtained crystals that diffracted X-rays to 1.85 Å resolution.  
Three main conclusion could be drawn from this structure: First, not only the 
individual MID and PIWI domains superpose well with the previously determined 
archeal and eubacterial structures, but also the relative orientation of these two domains 
with respect to each other is highly conserved. Notably the C-terminal residues of the 
protein are deeply inserted into the MID-PIWI interface, reminiscent of the prokaryotic 
AGOs. 
Second, by modeling a double-stranded nucleic acid substrate stemming from a 
Tt AGO-nucleic acid complex (Wang et al., 2009) (PDB ID code 3HJF) onto the Nc QDE-2 
MID-PIWI lobe, I was able to identify a number of eukaryotic loops and their potential 
contribution to nucleic acid-binding. Briefly, I was able to show that loop L1 of the Nc 
QDE-2 MID-PIWI lobe is flexible and can adopt different conformations, probably 
depending on the bound nucleic acid substrate. In cases where the downstream duplex 
is formed, loop L2 is likely to fix the phosphodiester backbone of the target strand as 
well as nucleotide 14 from the guide strand, thereby supporting the positioning of the 
target strand onto the catalytic site. Loop L4 is disordered but based on the prokaryotic 
structures, this loop likely helps to orient and fix nucleotides 2-5 of the guide RNA, a 
region known as seed sequence. Finally, a striking feature of eukaryotic AGOs is a C-
terminal insertion that in the case of QDE-2 folds into two tightly packed helices (see 
Figure 17). This insertion is also predicted to be helical in the human AGO proteins. By 
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superposing the full-length Tt AGO onto the QDE-2 MID-PIWI lobe, loop L1 and the C-
terminal insertion of Nc QDE-2 end up in close proximity to the PAZ domain of the Tt 
AGO, but only when a miRNA is bound. This suggests, that loop Lŗ and the ΅-helical 
insertion establish conformation-dependent interaction with the PAZ domain in 
eukaryotic AGOs and thus these elements might act as sensors for the functional state of 
the AGO.  
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Crystal structure of the Nc QDE-2 MID-PIWI lobe. A double stranded nucleic acid from Tt 
AGO (PDB code 3HJF) is modeled onto the Nc QDE-2 MID-PIWI lobe (A). Bases that are recognized by 
RNA binding loops (red) are labeled in blue, green and cyan (B).   
 
Third, as in prokaryotic AGOs, the 5´-guide RNA binding pockets forms at the 
MID-PIWI interface and is completed by its C-terminal tail. Consequently, the C-
terminal residues are deeply inserted into the MID-PIWI interface thereby displacing the 
second sulfate ion (S2), observed in the crystal structure of the isolated MID domain. I 
was able to identify eukaryotic-specific residues important for the formation of the MID-
PIWI interface. Among those are R895 and H899 in the PIWI domain and D603 in the 
MID domain. D603 forms hydrogen bonds to R895 and H899. RNA binding studies 
demonstrated that mutations in any of these residues leads to the destabilization of the 
MID-PIWI interface, thereby reducing or abolishing RNA binding without having to 
invoke allosteric regulation (see Figure 18).    
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Figure 18: RNA binding studies using a gel filtration based assay (Muller et al., 2006). Free QDE-2 MID-
PIWI protein is shown as blue solid line, free RNA as dashed red line and a mixture is shown as red solid 
line. A shift of RNA upon mixing with the QDE-2 protein from low to high molecular weight 
demonstrates complex formation. RNA binding is clearly shown in a 1:1 stoichiometry for the wild-type 
protein fragment (A), whereas single point mutants show a reduced nucleic acid binding affinity (B and 
C).  
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5 Conclusions 
 
In summary, this thesis can be divided into two distinct but interlinked parts. In a 
chronological order, I was first working on the structure and function of eukaryotic 
Argonaute proteins. My research provided, for the first time, structural insights how 
guide RNA binding is achieved by eukaryotic Argonaute proteins. In particular, I 
showed how the AGO MID domain specifically recognizes the 5´-end of the guide RNA 
(Boland et al., 2010).  
Furthermore, I also determined the crystal structure of the first MID-PIWI lobe of 
a eukaryotic Argonaute protein (Boland et al., 2011). This structure led to the 
identification of several eukaryote-specific loops present in the PIWI domain (i.e. the 
catalytic domain) which are important for guide RNA binding. I showed that guide 
RNA binding is achieved by a composite binding pocket that forms at the MID-PIWI 
interface and that the integrity of this pocket is crucial for guide RNA binding (Boland et 
al., 2011). These results challenged a previously published model on allosteric control of 
eukaryotic AGOs and explained the long-range effects on guide RNA binding observed 
upon mutation of a critical aspartate residue in the MID-PIWI interface.  
The crystal structure of the human AGO MID domain (Frank et al., 2010), 
published at around the same time as the Nc QDE-2 MID domain (Boland et al., 2010), 
confirmed the results and identified a so-called nucleotide specificity loop, which 
explains the observed bias for uridine at the 5´-position of the guide RNA. 
Lately, several crystal structures of the full-length human AGO1 and AGO2 
proteins were published that confirmed and extended our conclusions drawn from the 
Neurospora crassa QDE-2 MID-PIWI lobe (Elkayam et al., 2012; Faehnle et al., 2013; Kuhn 
and Joshua-Tor, 2013; Nakanishi et al., 2013; Schirle and MacRae, 2012). The crystal 
structure of human AGO1 revealed that loop L2 is indeed, like predicted in our study, 
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important for precisely positioning the RNA duplex onto the catalytic site and hence for 
the slicer activity of the protein.  
Most importantly, Schirle & MacRae identified two possible GW interaction sites 
located in the PIWI domain by co-crystallizing free L-tryptophan, thereby uncovering 
molecular details of the interaction between GW182/TNRC6 proteins and human AGO2. 
Very recent work by Pfaff and co-workers (Pfaff et al., 2013), deepened our 
understanding in the GW182-Argonaute protein interactions by using a peptide 
scanning approach as well as NMR studies, to identify motifs present in TNRC6B crucial 
for Argonaute binding. The study led to the identification of two tryptophan residues 
present in TNRC6B (W623 and W634), being mainly required for AGO2 binding. It was 
proposed that selection for the correct tryptophan residues for binding to AGO2 is 
mediated by nonspecific interactions of the flanking regions, in particular of W623. 
However, to fully understand the details of this interaction between GW182/TNRC6 
proteins and AGO proteins in molecular terms, crystal structures of binary complexes of 
human AGO2 in complex with GW182 peptides will be indispensable.    
 Finally, the crystal structure of the Nc MID-PIWI lobe revealed the presence of a 
eukaryote-specific ΅-helical insertion located right above the RNA binding groove. This 
C-terminal insertion is disordered in the human AGO2 crystal structures; however, 
given its location, this insertion might serve to discriminate between a bound single 
stranded substrate and a guide-target duplex. Furthermore this insertion could provide 
a binding platform for eukaryote-specific binding partners of AGO proteins. Future 
structural studies on RISC complexes with different binding partners will be critical to 
expand our knowledge on the mechanisms of RNAi.  
 
 In the second half of my PhD thesis, I was working on the structure and the 
assembly of the two major cytoplasmic deadenylase complexes, namely the PAN2-
PAN3 complex and the CCR4-NOT complex. The structure of the PAN3 adaptor protein 
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(Christie et al., 2013) uncovered the molecular basis for the described self-dimerization, 
which is mediated by an unpredicted, central coiled coil domain that links the N-
terminal pseudokinase domain (PK) to a C-terminal knob (CK) domain. The CK domain 
has been identified to mediate binding to the catalytic subunit PAN2 and this 
knowledge was further deepened in our study, through specific point mutations that 
abolish PAN2 interaction.  
The fact that PAN3 homodimerizes in solution and in the crystal environment 
and that dimerization is conserved throughout evolution is intriguing and immediately 
suggests that homodimerization is important for PAN3 function. Indeed dimerization is 
crucial for binding to GW182/TNRC6 proteins, a protein partner only present in higher 
eukaryotes. In contrast, PAN2 binding does not require dimerization and the isolated 
CK domain is sufficient for the interaction (see Christie et al., 2013 Figure S4 C-F). This 
result indicates that one PAN3 homodimer could potentially interact with two PAN2 
proteins simultaneously. However, the crystal structures of Nc and Dm PAN3 also 
revealed that homodimerization is mediated by an asymmetric coiled coil domain, with 
only one helix being kinked. As a consequence the two C-terminal CK domains are 
posed into asymmetric structural environments with likely consequences on PAN2 
binding affinity. Therefore it might be well possible that one PAN3 homodimer binds 
only one PAN2 molecule. Future structural studies on the entire PAN2-PAN3 complex 
will reveal the stoichiometry of the PAN2-PAN3 complex. 
 The pseudokinase domain of PAN3 adopts a typical bilobal kinase domain fold, 
although many structural motifs present in canonical kinases are absent in PAN3, which 
explains the loss of enzymatic activity (see Christie et al., 2013 Figure S4A).  Importantly, 
PAN3 proteins however are still capable of binding nucleotides, in a Mg2+-dependent 
manner (see Christie et al., 2013 Table S2). This suggests that PAN3 could possibly act as 
an ATP sensor and, for example, couple deadenylation to the energetic state of the cell 
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In collaborations, I was also able to obtain structural insights into the assembly of 
the CCR4-NOT complex by determining the structures of several sub-complexes. These 
are the NOT-module core formed by the C-termini of CNOT1, CNOT2 and CNOT3 
(Boland et al., 2013), the CNOT1 CN9BD in complex with CNOT9 (Chen, 2014) and the 
CNOT1 MIF4G domain in complex with DDX6 (Chen, 2014).  
The structure of the NOT-module core revealed that intrinsically disordered 
regions (IDRs) present in CNOT2 and CNOT3 are absolutely essential for mediating the 
assembly of the NOT-module core, which is formed by the C-termini of CNOT1, 
CNOT2 and CNOT3. Interestingly these IDRs remain largely devoid of any secondary 
structure, even upon binding to the respective protein partner.  
The structure of the minimal NOT-module is of particular relevance because 
many RNA-associated proteins (including GW182, NANOS and CUP) interact with the 
C-terminal regions of CNOT1, CNOT2 and CNOT3, to recruit the CCR4-NOT complex 
to certain mRNA targets (see chapter 4.2). Future structural studies on the NOT-module 
components in complex with RNA-binding proteins will unveil the molecular details of 
these interactions.  
 To address the question how the CCR4-NOT complex is recruited to miRNA 
targets, we solved the structure of a binary complex containing the CNOT1 CN9BD and 
the CNOT9 ARM domain. Surprisingly, the structure led to the identification of tandem 
tryptophan binding pockets located in CNOT9. I have validated these tandem W-
binding pockets as interaction sites for W-rich proteins in vitro. Interestingly the spatial 
arrangement of the two tryptophan binding pockets is reminiscent of the tryptophan 
binding pockets identified in the human AGO2 (Schirle and MacRae, 2012). In both 
proteins the distance between the tandem tryptophan binding pockets is roughly 20-25 
Å, a distance that can be spanned by an extended 8-10 amino acid long peptide. This 
distance is a typical spacer distance between two tryptophan residues in GW182/TNRC6 
proteins.  
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This observation raises the question, why tryptophan residues in the N-terminus 
of GW182 proteins mainly interact with AGOs, whereas tryptophan residues present in 
the silencing domain (a C-termianl region of GW182 proteins; see Figure 7) mainly 
interact with the two cytosolic deadenylases. The potential contribution of residues 
flanking the tryptophan residue is nicely demonstrated by the structure of Dm PAN3 
bound to a TWS-containing peptide (stemming from a neighboring symmetry mate) 
(Christie et al., 2013). The flanking threonine and serine residues stabilize the peptide in 
a bent conformation, thereby exposing the tryptophan residue. A peptide scanning 
approach (Pfaff et al., 2013) identified a subset of W-motifs present in TNRC6B and 
allowed analysis of the flanking residues. It was found that the contact with AGOs is 
mainly mediated by the tryptophan residues and that small or hydrophilic residues are 
tolerated as flanking residues whereas bulky side-chains are not. Clearly, as for the 
AGO-GW182 interaction, future studies co-crystallizing tryptophan rich peptides will 
provide molecular insights into the specificity of the interaction between AGOs and the 
deadenylases with GW182/TNRC6 proteins.  
Finally, the structure of the CNOT1 MIF4G in complex witht the DDX6 RecA-C 
domain addressed the question of the repressive action on translation by the CCR4-NOT 
complex. A recent model by Meijer and co-workers (Meijer et al., 2013) proposed that 
the described repressive activity of the CCR4-NOT complex on translation is mediated 
through a direct interaction of the CNOT1 MIF4G domain with eIF4A2, reminiscent to 
the interaction of eIF4G with eIF4A. It was proposed that the CNOT1 MIF4G domain 
competes with eIF4G for eIF4A2 binding, however without demonstrating a direct 
interaction between CNOT1 and eIF4A2. We refute this hypothesis and demonstrate 
that the MIF4G domain of CNOT1 does not bind eIF4A2 but instead binds another 
helicase protein, namely the translational repressor DDX6. Additionally, the 
translational repressor DDX6 has been demonstrated to directly interact with EDC3 and 
PAT, two components of the decapping machinery as well as with Sde6, a translational 
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repressor. Therefore our data complete a pathway of direct physical interactions 
between deadenylation, translational repression and decapping. Future structural 
studies will reveal how translational repression is achieved mechanistically on an 
atomic level.  
In Figure 19 this work is graphically summarized. 
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Highlights presented in this thesis: 
 The MID domain reveals sRNA 5´-
end recognition by eukaryotic AGOs.  The MID-PIWI interface is crucial 
for guide RNA binding.  PAN3 dimerizes via a central coiled 
coil domain that harbors a W-binding 
pocket, required for RNA targeting.  The assembly of the minimal NOT-
module is orchestrated by IDRs.   CNOT9 binds the CNOT1 DUF3819 
domain and harbors tandem W-binding 
pockets, required for RNA targeting.  DDX6 binds the CNOT1 MIF4G 
domain, thereby providing a molecular link 
between decapping and deadenylation. 
 
 
 
 
Figure 19: Structural summary of the work presented in this doctoral thesis. An Argonaute protein recruits through the bridging factor 
GW182/TNRC6 the two deadenylases PAN2-PAN3 and CCR4-NOT to the mRNA target. The CCR4-NOT complex in turn binds the translational 
repressor and decapping activator DDX6, thus linking deadenylation and decapping through direct interactions.  
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6 Author´s contributions to publication 
6.1 Crystal structure and ligand binding of the Nc QDE-2 MID domain 
Boland A, Tritschler F, Heimstädt S, Izaurralde E, Weichenrieder O (2010) Crystal 
structure and ligand binding of the MID domain of a eukaryotic Argonaute protein. 
EMBO Reports 2010 Jul; 11(7): 522-7. 
 
A. Boland designed the constructs, expressed and purified the Nc QDE-2 MID domain 
as wild-type and selenomethionine substituted versions. He optimized the crystals, 
collected the diffraction data and contributed to the writing of the manuscript.  
 
6.2 Crystal structure and ligand binding of the Nc QDE-2 MID-PIWI domains 
Boland A, Huntzinger E, Schmidt S, Izaurralde E, Weichenrieder O (2011) Crystal 
structure of the MID-PIWI lobe of a eukaryotic Argonaute protein. PNAS 2011 Jun; 
108(26): 10466-71. 
 
A. Boland designed all constructs including RNA-binding mutants, expressed and 
purified all native Nc QDE-2 MID-PIWI proteins (wild-type and mutant versions) as 
well as a selenomethionine substituted version. He optimized the crystals, collected the 
diffraction data, phased the structure experimentally, refined all structures and 
contributed to the writing of the manuscript. He also performed biochemical assays like 
guide-RNA binding studies.  
 
6.2 A direct interaction between DCP1 and XRN1 links decapping to degradation   
Braun JE, Truffault V, Boland A, Huntzinger E, Chang CT, Haas G, Weichenrieder O, 
Izaurralde E (2012) A direct interaction between DCP1 and XRN1 couples mRNA 
decapping to 5´ exonucleolytic degradation. NSMB 2012 Dec; 19(12): 1324-31. 
 
A. Boland contributed to the purification of the proteins and set up crystallization trials. 
Furthermore he contributed to the completion of the manuscript including design of 
mutants, writing of the manuscript and the preparation of structural figures.    
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6.3 Crystal structure of the PAN3 adaptor protein 
Christie M*, Boland A*, Huntzinger E, Schmidt S, Izaurralde E, Weichenrieder O (2011) 
Structure of the PAN3 pseudokinase reveals the basis for interactions with the PAN2 
deadenylase and the GW182 proteins. Mol Cell. 2013 Aug 8;51(3):360-73.  
 
A. Boland initiated the project, designed all Nc PAN3 constructs including a mutated 
version, expressed and prepared native proteins (different wild-type fragments and the 
mutant) and selenomethionine substituted protein. He characterized the protein 
biochemically by using thermal shift assays to demonstrate nucleotide binding and 
performed the ATPase assay. He obtained and optimized the first PAN3 crystals, 
collected diffraction data sets, phased the structure experimentally, prepared figures 
and contributed to the writing of the manuscript. 
 
6.4 Crystal structure of the human NOT-module core and its individual domains 
Boland A*, Chen Y*, Raisch T*, Jonas S*, Kuzuoğlu-Öztürk D, Wohlbold L, 
Weichenrieder O, Izaurralde E (2013) Structure and assembly of the NOT-module of the 
human CCR4-NOT complex. NSMB 2013 Nov; 20(11): 1289-97. 
 
A. Boland established the project in the lab. He designed all constructs used for 
crystallization including the isolated domains of Ct NOT1, Hs CNOT2 and Hs CNOT3. 
He also designed the constructs used for the expression of a ternary complex (excluding 
the Hs CNOT1 construct). He contributed to the purification, crystallization and 
structure determination (data collection, experimental phasing and refinement) of all 
isolated domains.  
Furthermore, he expressed and optimized the purification procedure for the ternary 
complex and identified a minimal version of the Hs CNOT1 C-term. He contributed to 
the interpretation of data and to the writing of the manuscript. 
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6.5 Crystal structures of CNOT1-DDX6 and CNOT1-CNOT9 complexes 
Chen Y*, Boland A*, Kuzuoğlu-Öztürk D, Bawankar P, Chang CT, Loh B, 
Weichenrieder O, Izaurralde E (2013) A DDX6-CNOT1 complex and W-binding pockets 
in CNOT9 reveal direct links between miRNA target recognition and silencing. Mol 
Cell. 2014 Jun 5;54(5):737-50. 
 
A. Boland initiated the project and designed several Hs CNOT1 DUF3819 constructs. He 
established the expression and purification of the binary CNOT1-CNOT9 complex and 
purified several complexes. He contributed to data collection and phased the structure 
using MR. He further designed binding mutants of CNOT1 that abrogated CNOT9 
binding and mutants of CNOT9 that abolished CNOT1 or TNRC6 binding. He 
performed in vitro pull-down assays validating the importance of the indentified W-
binding pockets with purified proteins or protein complexes. Finally, he also 
contributed to the structure determination process of the CNOT1-DDX6 complex 
including crystal freezing, data collection and structure solution by MR. Again he 
designed binding mutants, prepared figures and contributed to the writing of the 
manuscript. 
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Å     Ångström (1 Å = 0,1 nm = 10-10 m) 
Ά-Me     Ά-Mercaptoethanol 
Af     Archaeoglobus fulgidus 
AGO     Argonaute 
ARE     AU-rich elements 
AMP     adenosine monophosphate 
AMPPNP    “denosine ś′-ǻΆ,·-imido)triphosphate 
ATP     adenosine triphosphate 
“TP·S     Adenosine-5'-(·-thio)-triphosphate  
ASU     molecules per asymmetric unit 
CAF     CCR4-associated factor  
CCR4     Carbon catabolite repressor protein 4 
Ct     Chaetomium thermophilum 
CRISPR    clustered regularly interspaced short palindromic repeats 
C-term     C-terminal 
cDNA     complementary DNA 
DALI     Distance-matrix ALIgnment 
Dm     Drosophila melanogaster 
DCP1     decapping protein 1 
DCP2     decapping protein 2 
DDX6     DEAD box polypeptide 6 
DEAD box    Asp-Glu-Ala-Asp box 
DEDD     Asp-Glu-Asp-Asp 
Dhh1     DExD/H-box helicase 1 
DNA     deoxyribonucleic acid 
DTT     dithiothreitol 
DUF     domain of unknown function 
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E. coli     Escherichia coli 
EDC3     enhancer of decapping 3 
EDC4     enhancer of decapping 4 
EDTA     ethylenediaminetetraacetic acid 
EEP     endonuclease-exonuclease-phosphatase homology domain 
eIF     eukaryotic translation initiation factor 
FOM     figure of merit 
GST     glutathione-S-transferase 
GW-repeat    Gly-Trp-repeat 
GW182    Gly-Trp repeat containing protein of 182 kDa size 
HEAT     Huntingtin, ef3, protein phosphates 2A, TOR1 
HEPES     4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Hs     Homo sapiens 
IDR     intrinsically disordered region 
LSm     Sm-like 
m7G     7-methyl-guanosine 
MAD     multiple-wavelength anomalous dispersion 
MALLS    multiangle laser-light scattering 
MBP     maltose binding protein 
Me31B     maternal expression at 31B 
MID     Middle 
miRISC    miRNA induced silencing complex 
miRNA    microRNA 
MR     molecular replacement 
mRNA     messenger ribonucleic acid 
mRNP     messenger ribonucleoprotein 
Mut     mutant 
Nc     Neurospora crassa 
Ni-NTA    nickel-nitrilotriacetate 
NMD     nonsense-mediated mRNA decay 
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N-term    N-terminal 
NOT     Negative regulator of transcription homolog 
nt     nucleotides 
ORF     open reading frame 
PABPC    cytoplasmic poly(A) binding protein 
PABPN    nuclear poly(A) binding protein 
PAM2     PABPC-interacting motif 2 
PAN     poly(A) specific ribonuclease subunit homolog 
PARN     poly(A) specific ribonuclease 
Pat1     protein associated with topoisomerase II 
PAZ     PIWI, Argonaute, Zwille/Pinhead 
PDB     Protein Data Bank 
piRNA     PIWI-interacting RNAs 
PIWI     P-element induced wimpy testis 
poly(A) tail    poly adenine tail 
POP2     Poly(A) ribonuclease POP2 
pre-mRNA    precursor mRNA 
PTC     premature termination codon 
PTGS     post-transcriptional gene silencing 
QDE-2     quelling deficient-2 
r.m.s.d.     root mean square deviation 
Rcryst / Rwork    crystallographic reliability factor 
Rfree     free crystallographic reliability factor 
RBP     RNA-binding protein 
RCD-1     required for cell differentiation protein 1 
RISC     RNA-induced silencing complex 
RNA     ribonucleic acid 
RNAi     RNA interference 
RNP     ribonucleoprotein (particle) 
RRM     RNA recognition motif 
8 Abbreviations  VI 
 
S-SAD     Sulphur-SAD 
Sc     Saccharomyces cerevisiae 
Sp     Schizosaccharomyces pombe 
SAD     single-wavelength anomalous dispersion 
SD     silencing domain of GW182 
SDS-PAGE    sodium dodecylsulfate polyacrylamide gel electrophoresis 
siRNA     small interfering RNA 
SMG     Suppressor of morphogenesis in genitalia 
TEV-protease    tobacco etch virus protease 
Tris     tris(hydroxymethyl)aminomethane 
TNRC6    Trinucleotide repeat-containing gene 6 protein 
Tt     Thermus thermophilus 
TTP     tristetraprolin 
UPF     up-frameshift proteins 
UTR     untranslated region 
WD     tryptophan-aspartate dipeptide 
WD40     domain of ~40 residues terminating with a WD dipeptide 
Xt     Xenopus tropicalis 
XRN1     exoribonuclease 1  
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9.1.3 Table of solved crystal structures 
 
List of crystal structures determined independently or in collaboration during this thesis  
Crystallized protein Method Space 
group 
Resolution 
in Å 
Rwork/Rfree 
in % 
PDB 
entry 
Nc MID SAD C2 2 21 2.20 19.4 / 22.3 2XDY 
Nc MID-PIWI SAD P63 2 2 3.65 23.4 / 25.2 2YHA 
Nc MID-PIWI ΔL MR P32 2 1 1.85 19.7 / 23.6 2YHB 
Nc PAN3 SAD P65 3.30 22.2 / 26.9 4BWP 
Nc PAN3 mutant MR P65 2.85 21.3 / 24.2 4BWX 
Hs CNOT3 SAD P21 21 21 2.40 22.3 / 25.7 4C0G 
Hs CNOT2 SAD P65 2 2 2.40 21.9 / 26.3 4C0F 
Ct  NOT1 SAD P21 3.20 21.9 / 25.9 4C0E 
Hs CNOT1/2/3 MR P21 21 2 3.20 22.6 / 27.3 4C0D 
Hs CNOT1/CNOT9 MR C1 2 1 1.65 16.0 / 17.5 N/A 
Hs CNOT1/CNOT9/W MR C1 2 1 2.05 16.8 / 20.5 N/A 
Hs CNOT1/DDX6 MR P21 21 21 1.75 16.0 / 19.8 N/A 
Nc QIP S-SAD Unpublished data 
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Crystal structure and ligand binding of the MID
domain of a eukaryotic Argonaute protein
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Argonaute (AGO) proteins are core components of RNA-induced
silencing complexes and have essential roles in RNA-mediated
gene silencing. They are characterized by a bilobal architecture,
consisting of one lobe containing the amino-terminal and PAZ
domains and another containing the MID and PIWI domains.
Except for the PAZ domain, structural information on eukaryotic
AGO domains is not yet available. In this study, we report the
crystal structure of the MID domain of the eukaryotic AGO
protein QDE-2 from Neurospora crassa. This domain adopts a
Rossmann-like fold and recognizes the 50-terminal nucleotide of
a guide RNA in a manner similar to its prokaryotic counterparts.
The 50-nucleotide-binding site shares common residues with a
second, adjacent ligand-binding site, suggesting a mechanism
for the cooperative binding of ligands to the MID domain of
eukaryotic AGOs.
Keywords: GW182; miRNAs; RNAi; silencing; siRNAs
EMBO reports (2010) 11, 522–527. doi:10.1038/embor.2010.81
INTRODUCTION
Proteins of the Argonaute (AGO) family have essential roles
in RNA-mediated gene silencing mechanisms throughout the
eukaryotic lineage. They associate with small non-coding RNAs to
form RNA–protein effector complexes called RNA-induced
silencing complexes (Tolia & Joshua-Tor, 2007; Jı´nek & Doudna,
2009). In RNA-induced silencing complexes, the small RNA
functions as a sequence-specific guide that directs AGOs to
fully or partially complementary target RNAs through base
pairing interactions. The target RNA is then silenced at the
transcriptional or post-transcriptional level (Tolia & Joshua-Tor,
2007; Jı´nek & Doudna, 2009).
Structural and biochemical studies showed that AGOs
consist of four domains: an amino-terminal domain; a PIWI/
Argonaute/Zwille (PAZ) domain that binds to the 30-end of guide
RNAs; the middle (MID) domain that provides a binding pocket
for the 50-phosphate of guide RNAs; and the P-element-induced
whimpy testes (PIWI) domain that adopts an RNaseH fold and
has endonucleolytic activity in some but not all AGOs (Parker
et al, 2004, 2005, 2009; Song et al, 2004; Ma et al, 2005; Yuan
et al, 2005; Wang et al, 2008a,b, 2009). Thus far, structural
information on full-length AGOs is only available for the homo-
logous proteins from archaea and eubacteria (Song et al, 2004;
Ma et al, 2005; Parker et al, 2005; Yuan et al, 2005; Wang et al,
2008a,b, 2009), which can use DNA instead of RNA as guide
molecules (Ma et al, 2005; Parker et al, 2005; Yuan et al, 2005;
Wang et al, 2008a,b, 2009).
The function of AGO, however, has only been studied in
eukaryotic systems; and, in the microRNA (miRNA) pathway, the
precise mechanism by which AGO proteins mediate translational
repression of target messenger RNAs (mRNAs) remains contro-
versial (Eulalio et al, 2008a). Understanding such silencing
mechanisms requires detailed structural information about the
domains of eukaryotic AGOs; however, so far, this level of
information is only available for the PAZ domain (Lingel et al,
2003; Song et al, 2003; Yan et al, 2003).
In this study, we focused on the structure of a eukaryotic
AGO MID domain, because it is thought to perform essential
and distinct functions in the miRNA pathway and because
a considerable amount of discussion has focused on the
MID domain fold (Kiriakidou et al, 2007; Kinch & Grishin,
2009; Djuranovic et al, 2010). Furthermore, it has been
proposed that certain eukaryotic AGO MID domains sequester
the mRNA 50-cap structure (m7GpppN) of target mRNAs, thereby
repressing translation. Initially, this idea was based on the
observation that the human AGO2 binds to m7GTP Sepharose
beads (Kiriakidou et al, 2007). Recent data by Djuranovic et al
(2010) supported this concept, indicating that, in addition to
the 50-phosphate-binding pocket for the guide RNA, Drosophila
melanogaster AGO1 has a second miRNA-dependent site that
can bind to nucleotides such as the 50-cap.
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Kiriakidou et al (2007) proposed that eukaryotic AGO MID
domains fold in a eukaryotic initiation factor 4E (eIF4E)-like
manner, sandwiching the m7GpppN cap between two phenyl-
alanine residues (Marcotrigiano et al, 1997). By contrast, Djuranovic
et al (2010) modelled the MID domain onto the Rossmann-like fold
of the archaeal and eubacterial homologues. This latter modelling
lead the authors to propose allosteric control of cap binding
by the presence of the guide RNA 50-nucleotide in a conserved
binding pocket corresponding to that observed in the prokaryotic
MID domains.
In this study, we present the crystal structure of the Neurospora
crassa quelling deficient 2 (QDE-2) MID domain (Fulci & Macino,
2007) as an example of a eukaryotic AGOMID domain. This structure
convincingly refutes the idea that eukaryotic MID domains adopt an
eIF4E-like fold and shows the guide RNA 50-phosphate-binding site is
conserved. Furthermore, we describe a second, previously unreported
ligand-binding site that allows a simple mechanistic explanation for
the allosteric effects reported by Djuranovic et al (2010).
RESULTS
Structure of a eukaryotic AGO MID domain
The 2.2 A˚ structure of the N. crassa AGO MID domain (Nc QDE-2
MID; residues Lys 514–Gly 640) was solved by experimental
phasing using a selenomethionine-substituted protein and was
refined with excellent stereochemistry (supplementary Table S1
online). The protein adopts a Rossmann-like fold with a central
four-stranded parallel b-sheet sandwiched between a-helices in
a babababaa topology (Fig 1A–D). The structure superimposes
well with the structures of previously determined archaeal and
eubacterial AGO MID domains, despite the low sequence identity
(Fig 1C,D). Among the best-scoring structural relatives is the
AGO MID domain from Archaeoglobus fulgidus (Af; Protein Data
Bank (PDB) ID: 1w9h), showing an r.m.s.d. value of 2.6 A˚ and
a sequence identity of 9%. For comparison, the r.m.s.d./sequence
identity is 2.2 A˚/16% for Aquifex aeolicus (Aa; PDB ID: 1yvu),
2.7 A˚/12% for Pyrococcus furiosus (Pf ; PDB ID: 1u04) and 3.3 A˚/14%
for Thermus thermophilus (Tt ; PDB ID: 3ho1). By contrast, the
sequence identities for eukaryotic homologues are generally
greater than 20% (24% for Homo sapiens (Hs) AGO2, 26% for
D. melanogaster (Dm) AGO1; Fig 1D). The structure of the Nc
QDE-2 MID domain thus serves as a prototype for eukaryotic
AGO MID domains.
The Nc QDE-2 MID domain structure has no similarity to
eukaryotic eIF4E. Consequently, it is unlikely that eukaryotic
AGO MID domains sandwich the m7GpppG mRNA 50-cap
between two aromatic amino-acid side chains in an eIF4E-like
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β2 α2
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Fig 1 | Structure of the Neurospora crassa QDE-2 MID domain. (A) Ribbon representation of the MID domain showing the positions of two bound
sulphate ions (I and II) as sticks (red: oxygen; yellow: sulphur). Residues corresponding to those proposed by Kiriakidou et al (2007) to sandwich the
m7GpppN cap are shown as purple sticks. Secondary structure elements are labelled. (B) Ribbon representation of an Af MID domain in complex with
the 50-end of a guide RNA (sticks), generated from Protein Data Bank entry 2bgg (Parker et al, 2005). (C) Superposition of the Nc QDE-2 MID domain
onto the Af MID domain, illustrating the conservation of the Rossmann-like fold. (D) Structure-based sequence alignment of the Nc QDE-2 MID
domain with archaeal (Af, Pf) and eubacterial (Aa, Tt) homologues, as well as with eukaryotic MID domains involved in the miRNA pathway.
Positions involved in coordinating the two sulphate ions are shown in green. Positions proposed by Kiriakidou et al (2007) to bind the m7GpppN
cap are shown in purple. The position proposed by Djuranovic et al (2010) to effect allosteric regulation of miRNA binding is shown in pink.
Invariant or highly conserved positions are marked by an asterisk. Aa, Aquifex aeolicus; Af, Archaeoglobus fulgidus; MID, middle; miRNA, micro RNA;
Nc, Neurospora crassa; Pf, Pyrococcus furiosus; QDE-2, quelling deficient 2; Tt, Thermus thermophilus.
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manner. In our structure, the two residues (Ala 535 and Phe 570)
corresponding to those proposed to be important for cap
binding (Kiriakidou et al, 2007) lie more than 25 A˚ apart (Fig 1A,
purple). Earlier sequence analyses and homology modelling
reached similar conclusions (Kinch & Grishin, 2009; Djuranovic
et al, 2010). Furthermore, in previous studies, we showed that
double valine substitutions of these residues abolished the
silencing activity of Dm AGO1 and Hs AGO2 by preventing
the interaction with both miRNAs and the GW182 protein,
which is essential for miRNA-mediated silencing in animal cells
(Eulalio et al, 2008b).
The 50-phosphate-binding pocket is highly conserved
Several archaeal AGO proteins have been crystallized in complex
with a guide RNA/DNA (Ma et al, 2005; Parker et al, 2005; Yuan
et al, 2005; Wang et al, 2008a,b, 2009). The respective structures
reveal that the 50-terminal nucleotide of the guide molecule is not
available for base pairing with the RNA target but is strongly bent
and accommodated in a preformed pocket of the MID domain
(Fig 1B). In each case, the base stacks onto an aromatic or arginine
side chain (Fig 1D, red asterisk). Most importantly, the 50-terminal
phosphate (a hallmark of small interfering RNAs and miRNAs) is
coordinated precisely by several side-chain and main-chain
contacts to residues from helix a3, strand b4 and helix a4
(supplementary Fig S1A,B online; Parker et al, 2005; Wang et al,
2009). Furthermore, in the context of full-length proteins, the
carboxyl terminus of the PIWI domain contacts the 50-phosphate
through a metal ion (Parker et al, 2005; Wang et al, 2009).
When a binary complex containing the Af MID and PIWI
domains plus a guide RNA (PDB ID: 2bgg; Parker et al, 2005) is
superposed onto the Nc QDE-2 MID domain, the 50-terminal
uridine of the guide RNA is positioned favourably into its
positively charged binding pocket, with the base stacking on
the aromatic ring of Tyr 595 of the NcQDE-2 MID domain and the
50-phosphate being coordinated by the Tyr 595 hydroxyl group
(Fig 2A,B). Most importantly, the 50-phosphate superimposes almost
perfectly with a sulphate ion (ion I; from the crystallization
conditions) that is coordinated additionally by the invariant
lysines Lys 599 (helix a3) and Lys 638 (helix a4), as well as by
the main-chain nitrogen of Cys 612 (strand b4) and the poorly
conserved Lys 634 (helix a4; Fig 2A,B). Conversely, a super-
position of the Nc QDE-2 MID domain onto the structures of Af or
Tt MID domains places the sulphate ion (I) at the position of the
50-phosphate of the guide RNA or DNA, respectively; this
illustrates that the ligand-binding residues are conserved structu-
rally (supplementary Fig S1A,B online). We conclude that
eukaryotic AGO MID domains accommodate the 50-terminal
nucleotide of the guide RNA in a manner similar to their archaeal
and eubacterial counterparts.
A second ligand-binding pocket
The structure of the Nc QDE-2 MID domain contains a second
sulphate ion (II), only 6.3 A˚ from the first ion; this second ion is
also well coordinated (Fig 3A,B). This second ligand-binding
pocket is separated from the first 50-phosphate-binding pocket by
only two invariant lysines, Lys 599 and Lys 638, which thus
participate simultaneously in coordinating both sulphate ions
(Fig 3A,B). The second sulphate ion is coordinated further by the
main-chain and side-chain atoms from Thr 610 (strand b4), which
is invariantly a serine or threonine, and by the non-conserved
side-chain of His 609 (strand b4; Fig 3A,B). As a consequence, the
two sulphate-binding pockets are not independent of each other,
but are likely to display positive cooperativity (that is, a ligand
binding to either would orient the lysines favourably and
promote binding of a ligand to the other site).
The presence of two positively coupled ligand-binding sites
on the Nc AGO MID domain is particularly interesting in the
context of a recent report by Djuranovic et al (2010), indicating
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Fig 2 | Conservation of the guide RNA 50-nucleotide-binding pocket.
(A) Electrostatic potential mapped onto the molecular surface of the
Nc QDE-2 MID domain, with the two bound sulphates shown as yellow
sticks. Potentials are contoured from 10 (red) to þ 10 kT/e (blue).
The 50-RNA nucleotide from the superposition with the Af MID domain
in complex with a guide RNA (Fig 1B,C) is shown as grey sticks.
(B) Close-up of the RNA 50-end nucleotide-binding site. The
superimposed 50-uridine from the Af complex structure is shown as
sticks, together with the two sulphates and important side chains from
the Nc QDE-2 structure. The uridine base stacks on the aromatic
Tyr 595 ring, whereas the 50-phosphate superimposes with sulphate I.
Red: oxygen; blue: nitrogen; yellow: sulphur; violet: phosphorus.
Af, Archaeoglobus fulgidus; MID, middle; Nc, Neurospora crassa;
QDE-2, quelling deficient 2.
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that miRNA binding to the MID domain of Dm AGO1 might be
under allosteric control (Djuranovic et al, 2010). These authors
suggested that the MID domains of certain eukaryotic AGOs
(that is, those involved in miRNA-mediated gene regulation)
contain a second nucleotide-binding site in addition to the
50-phosphate-binding pocket, which gains affinity for m7GpppG
cap analogues (or eventually for other ligands) only in the
presence of the guide-strand RNA (and vice versa). It is thus
tempting to speculate that the second sulphate ion observed in
the context of the Nc QDE-2 MID domain could occupy such
a second ligand-binding site.
Ligand binding by the two sites is expected to be cooperative.
Accordingly, Dm AGO1b binding to miRNAs, m7GpppG cap
analogue and GW182 protein was abrogated by substituting the
invariant tyrosine residue in the first binding site (Dm AGO1b
residue Tyr 619, corresponding to NcQDE-2 Tyr 595) or swapping
the charge of an aspartic residue in the second ligand-binding
site (Dm AGO1b residue Asp 627, corresponding to Nc QDE-2
Asp 603; Djuranovic et al, 2010). The inhibitory effect of the
D627K substitution on miRNA binding is surprising because this
residue is distant from the miRNA-binding site (Djuranovic et al,
2010). The equivalent residue in the Nc QDE-2 MID domain
Asp 603 is located less than 7 A˚ away from the second sulphate
(Fig 3A,B). Consequently, the Asp 627 side chain of Dm AGO1b
could indeed participate in binding a ligand that superimposes
with the second sulphate.
DISCUSSION
The structure of the Nc QDE-2 MID domain suggests that AGO
proteins could be regulated by positive cooperativity of distinct
ligands. Indeed, the structure reveals two precisely coordinated
sulphate ions in adjacent binding pockets. Two highly conserved
lysines (Lys 599 and Lys 638) coordinate both sulphates simulta-
neously and are thus shared by both binding pockets. Clearly,
the first of the two sulphates on the Nc QDE-2 MID domain
occupies the binding pocket for the 50-terminal phosphate of the
miRNA/short interfering RNA. The second sulphate is coordinated
directly by three of the six most highly conserved side chains
in AGO MID domains (that is, T(S)610, Lys 599 and Lys 638;
Fig 1D). These residues are conserved not only in sequence
but also in their structural orientation in bacterial and archaeal
MID domains (supplementary Fig S1A,B online). Thus, the second
sulphate might mark an ancient second (allosteric) binding
site that has evolved different specificities in different AGO
homologues (for example, for the cap structure, GW182 or
other ligands).
We cannot predict what the ligand for the second binding site
might be for different AGOs, because the properties and
accessibility of this second binding site would depend on the
orientation and the nature of the side chains provided by the PIWI
domain. Indeed, in the current structures of the archaeal and
eubacterial proteins, the PIWI domain restricts access to the
second ligand-binding site. Nevertheless, the situation might be
different for the eukaryotic AGOs, as Djuranovic et al (2010)
observed an allosteric effect between the two binding sites using
protein constructs that contained the PIWI domain. For AGO
proteins involved in the miRNA pathway, the second ligand-
binding site was suggested to bind to the m7GpppN cap structure,
or residues from the GW182 protein (Djuranovic et al, 2010).
In agreement with this hypothesis, substituting residues in either of
the two binding pockets simultaneously abrogated Dm AGO1
binding to miRNAs, GW182 and m7GpppG cap analogue
(Djuranovic et al, 2010). However, other AGO proteins, such as
Nc QDE-2, might have evolved to be regulated by distinct ligands
or might no longer be regulated by a second ligand. Nevertheless,
for those AGO proteins that show ligand-dependent regulation,
the coupled participation of the invariant lysines, Lys 599 and
Lys 638, in both ligand-binding sites would be an attractive
and mechanistically simple explanation for the ligand-dependent
regulation of AGO protein function.
METHODS
Cloning, protein expression, purification and crystallization. The
sequence encoding the MID domain of Nc QDE-2 was
amplified by PCR from a pBluescript-SKþ plasmid containing
the genomic sequence of the qde-2 gene (provided by G. Macino)
and subsequently inserted into the NcoI and NotI sites of
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Fig 3 | Coupled coordination of the two sulphate ion ligands.
(A) Difference density for the sulphate ions. Difference density
((|Fo||Fc|)e(iac)) is contoured at 3.0 sigma values over the mean,
where |Fo| is the observed structure factor amplitudes and |Fc| and ac
are structure factor amplitudes and phases calculated from a model
prior to including the sulphates. (B) Potential hydrogen bonds of the
two sulphate ions (I and II) to side-chain and main-chain atoms of
the Nc QDE-2 MID domain. Relevant side chains and the main chain
of strand b4 are shown as sticks. Hydrogen bonds are shown as
dotted lines. Asp 603 (pink) corresponds to the aspartate proposed by
Djuranovic et al (2010) to effect allosteric regulation of miRNA binding.
Red: oxygen; blue: nitrogen; yellow: sulphur. MID, middle; miRNA,
micro RNA; Nc, Neurospora crassa; QDE-2, quelling deficient 2.
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the pETM60 vector (derived from pET24d; Novagen) using
the primer pairs: 50-CATGCCATGGCAGTCAAGGTCGCCAGA
CCTT-30 (forward) and 50-ATAAGAATGCGGCCGCTTAGATATTG
TGATTGGTGCCGC-30 (reverse).
The resulting NusA–6His–MID protein fusion was expressed
in the Escherichia coli BL21 Star (DE3) strain (Invitrogen) at 20 1C
overnight. Protein expression was induced with 1mM isopropyl b-
D-1-thiogalactopyranoside at an A600 of 0.6. The fusion protein
was purified first by a Ni2þ -affinity step. The removal of the NusA
and polyhistidine tags was done by proteolytic digestion using
tobacco etch virus protease at 4 1C overnight. The MID domain was
purified further by heparin affinity chromatography and subsequent
gel filtration (HiLoad 26/60 Superdex 75pg; GE Healthcare). Finally,
the QDE-2 MID domain was concentrated to 25mg per ml in
10mM HEPES (pH 7.2), 150mM NaCl and 1mM DTT.
Crystalline clusters of native and selenomethionine-substituted
QDE-2 MID domain were grown by hanging drop vapour
diffusion over a 500 ml reservoir at 18 1C. The protein solution
described above was mixed 1:1 with various solutions containing
16–30% polyethylene glycol 4000 and 150–250mM ammonium
sulphate. Crystals were optimized by microseeding and flash-
frozen in liquid nitrogen in the respective reservoir solution
supplemented with 10 or 15% glycerol for cryoprotection.
Data collection, structure solution and refinement. Diffraction
data were recorded on a PILATUS 6M detector (Broennimann
et al, 2006) at the beamline PXII of the Swiss Light Source at a
wavelength of 1.0 A˚ for the native data set and at the absorption
peak of the selenomethionine derivative at 0.9792 A˚. Diffraction
images were processed with XDS (Kabsch, 1993). The crystals
belong to space group C2221, with one molecule per asymmetric
unit and 52% solvent. The structure was solved from the
selenomethionine data by single anomalous dispersion. Auto-
SHARP (Vonrhein et al, 2007) was used to search for five selenium
sites per molecule. The assignment of the correct hand and solvent
flattening was done automatically. ARP/wARP (Cohen et al, 2008)
built a partial model comprising 99% of the backbone and 93%
of the side chains docked correctly. The model was completed
manually in COOT (Emsley & Cowtan, 2004) by using the native
data. Refinement was done using Phenix (Adams et al, 2010) and
COOT iteratively. The structure was validated with MOLPROBITY
(Davis et al, 2007) and WHATCHECK (Hooft et al, 1996).
Accession codes. The coordinates of the MID domain have been
deposited at the PDB with the accession code 2xdy.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Supplementary Fig 1 Structural conservation of ligand-binding residues. The two sulfate ions 
(I and II) from the Nc QDE-2 MID domain (Fig 2B, same view) superimposed onto the guide 
RNA 5’ nucleotide-binding pocket of AGO proteins from Archaeoglobus fulgidus (A) and 
Thermus thermophilus (B). Only the MID domains and the 5’ nucleotide of the co-crystallized 
nucleic acid substrates are shown. (Red: oxygen; blue: nitrogen; yellow: sulfur; violet: phos-
phorus). (A) Archaeoglobus fulgidus AGO MID domain (PDB-ID: 2BGG, Parker et al, 2005) 
together with the 5’ nucleotide of the guide RNA. (B) Thermus thermophilus AGO MID 
domain (PDB-ID: 3HVR, Wang et al, 2009) together with the 5’ nucleotide of the guide DNA.
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Table S1. Data collection, phasing and refinement statistics. 
 Native Selenomethionine substituted 
Data collection  
Space group C2221 C2221 
Unit cell (Å, °) 80.1, 91.39, 42.93 
90, 90, 90 
80.17, 91.52, 43.16 
90, 90, 90 
Molecules per asymmetric unit 1 1 
Resolution range (Å) a 60.238-2.2 (2.26-2.2) 60.302-2.2 (2.26-2.2) 
Unique reflections 8285 8259 
Completeness, (%) a 99.4 (100)  
I/σ(I) a 18.36 (2.94) 8.44 (1.90) 
Rmerge (%) 
a 4.7 (49.6) 7.9 (55.1) 
Average redundancy a 3.6 (3.6)  
Phasing Statistics  
Phasing power (anom.) 1.078 
Rcullis (anom.) 0.809 
 Mean FOM 0.29525 
Anomoulous Completeness (%) a 98.5 (96.1) 
Anomoulous average redundancy a 
 
1.8 (1.7) 
Structure refinement  
Resolution range (Å) a 60.238-2.2 (2.26-2.2) 
R-factor / R-free (%) 19.29 / 22.29 
Number of  
     protein atoms 989 
     sulfate ions 2 
     glycerol molecules 1 
     water molecules  52 
Ramachandran plot b  
     most favoured (%) 98.4 
     additional allowed (%) 1.6 
     outliers (%) 0 
RMSD bond lengths, (Å) 0.004 
RMSD bond angles, (°) 0.776 
 
 a Numbers in parentheses are for the highest-resolution shell 
 b Calculated using Molprobity 
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Argonaute proteins (AGOs) are essential effectors in RNA-
mediated gene silencing pathways. They are characterized by a
bilobal architecture, in which one lobe contains the N-terminal
and PAZ domains and the other contains the MID and PIWI do-
mains. Here, we present the first crystal structure of the MID-PIWI
lobe from a eukaryotic AGO, the Neurospora crassa QDE-2 protein.
Compared to prokaryotic AGOs, the domain orientation is con-
served, indicating a conserved mode of nucleic acid binding. The
PIWI domain shows an adaptable surface loop next to a eukar-
yote-specific α-helical insertion, which are both likely to contact
the PAZ domain in a conformation-dependent manner to sense the
functional state of the protein. The MID-PIWI interface is hydrophi-
lic and buries residues that were previously thought to participate
directly in the allosteric regulation of guide RNA binding. The inter-
face includes the binding pocket for the guide RNA 5′ end, and
residues from both domains contribute to binding. Accordingly,
micro-RNA (miRNA) binding is particularly sensitive to alteration in
the MID-PIWI interface in Drosophila melanogaster AGO1 in vivo.
The structure of the QDE-2 MID-PIWI lobe provides molecular and
mechanistic insight into eukaryotic AGOs and has significant impli-
cations for understanding the role of these proteins in silencing.
Proteins of the Argonaute (AGO) family play essential roles inRNA-mediated gene silencing mechanisms in eukaryotes
(1, 2). They are loaded with small noncoding RNAs to form the
core of RNA-induced silencing complexes, which repress the
expression of target genes at the transcriptional or posttran-
scriptional level (1, 2). The targets to be silenced are selected
through base-pairing interactions between the loaded small RNA
(also known as the guide RNA) and an mRNA target containing
partially or fully complementary sequences (1–3).
Thus far, structural information on full-length AGOs has been
available only for the homologous proteins from Archaea and
Eubacteria, which preferentially use DNA as a guide (4–10).
These studies revealed that AGOs consist of four domains: the
N-terminal domain; the PAZ domain, which binds the 3′ end
of guide RNAs/DNAs; the MID domain, which provides a bind-
ing pocket for the 5′ phosphate of guide RNAs/DNAs; and the
PIWI domain, which adopts an RNase H fold and has endonu-
cleolytic activity in some, but not all, AGOs (4–11).
For the eukaryotic AGO clade of Argonaute proteins, structural
information is available only for the isolated PAZ domains of
Drosophila melanogaster (Dm) AGO1 and AGO2, human AGO1
(12–16) and the MID domains of human AGO2 and Neurospora
crassa (Nc) QDE-2 (17, 18). Structural information is also avail-
able for PAZ domains of the PIWI clade of AGOs (19, 20). These
studies showed that the PAZ and MID domains of eukaryotic
AGOs adopt folds similar to the prokaryotic homologs and recog-
nize the 3′- and 5′-terminal nucleotides of the guide strand, respec-
tively, in a similarmanner to their prokaryotic counterparts (12–18).
Our previous structure of the isolated Nc QDE-2 MID domain
revealed that the 5′-nucleotide binding site shares residues with a
second, adjacent sulfate ion-binding site, suggesting that the 5′-
terminal nucleotide of the guideRNAand a second ligandmay bind
cooperatively to the MID domain of eukaryotic AGOs (17). These
findings supported the observation of Djuranovic et al. (21) that
the isolated MID domains of certain eukaryotic AGOs [i.e., those
involved in the micro-RNA (miRNA) pathway] contain a second,
allosteric nucleotide binding site with an affinity for m7GpppG
cap analogs. However, considering the structures of the prokaryotic
AGOs, it was unclear whether the putative second ligand-binding
site would be accessible in the presence of the PIWI domain.
To address this question and gain further molecular insight into
eukaryotic AGOs, we determined the crystal structure of the
entire MID-PIWI lobe of the Nc QDE-2 protein, tested its
RNA-binding properties in vitro, and analyzed its implications
in vivo in the context of the Dm AGO1 protein. The structure
provides a detailed, high-resolution view of the MID-PIWI inter-
face in a eukaryotic AGO protein and shows that the two domains
are oriented very similarly to their prokaryotic counterparts,
indicating a conserved mode of guide RNA/DNA strand recogni-
tion. However, despite these similarities, the PIWI-domain
exhibits eukaryote-specific structural features that might act as
sensors for the functional state of the protein. Finally, we show
that residues that have been implicated in allosteric regulation in
previous studies (21) are in fact involved in MID-PIWI interdo-
main interactions and contribute to guide RNA binding by
stabilizing the MID-PIWI interface.
Results
The Eukaryotic AGOMID-PIWI Lobe Adopts a Fold Highly Similar to the
Prokaryotic Homologs. The Neurospora crassa Argonaute protein
QDE-2 (Nc QDE-2) is a close sequence homolog of eukaryotic
AGOs that act in the small interfering RNA (siRNA) and miR-
NA pathways [e.g., sequence identities with Hs AGO2 and Dm
AGO1 are 30% and 29.7%, respectively (Fig. S1) (22, 23)]. We
obtained diffracting crystals of a QDE-2 fragment containing the
MID and PIWI domains (amino acids 506–938) and determined
the structure at 3.65 Å resolution (crystal form I; Table S1). The
structure revealed a disordered loop (loop L3, Fig. 1A, and
Fig. S1) including amino acids K786–A840 of the PIWI domain,
which we replaced with a Gly-Ser (GSG) linker to generate crys-
tals of a MID-PIWI ΔL3 protein that diffracted to 1.85 Å resolu-
tion. This structure (crystal form II) was refined to an Rwork of
19.6% (Rfree ¼ 23.6%), whereas crystal form I yielded an Rwork
of 23.3% (Rfree ¼ 25.2%) (Table S1).
This structure reveals the details of a eukaryotic AGO MID-
PIWI lobe. The individual MID and PIWI domains superimpose
well with the structures of previously determined archaeal and
eubacterial AGO MID and PIWI domains (Fig. 1A vs. 1B and
Author contributions: A.B., E.I., and O.W. designed research; A.B., E.H., and O.W.
performed research; A.B., E.H., S.S., E.I., and O.W. analyzed data; and A.B., E.I., and
O.W. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Freely available online through the PNAS open access option.
Data deposition: The accession codes and coordinates of the QDE-2 MID-PIWI lobe and
MID-PIWI ΔL3 have been deposited in the Protein Data Bank, www.pdb.org (PDB ID codes
2yhb and 2yha).
1To whom correspondence may be addressed. E-mail: elisa.izaurralde@tuebingen.mpg.de
or oliver.weichenrieder@tuebingen.mpg.de.
This article contains supporting information online at www.pnas.org/lookup/suppl/
doi:10.1073/pnas.1103946108/-/DCSupplemental.
10466–10471 ∣ PNAS ∣ June 28, 2011 ∣ vol. 108 ∣ no. 26 www.pnas.org/cgi/doi/10.1073/pnas.1103946108
Fig. S2 A and B). Importantly, the relative orientation of the
MID and PIWI domains is similar to the prokaryotic proteins,
with the C-terminal residues (labeled “C” in Fig. 1A) of the pro-
tein deeply inserted into the MID-PIWI interface. Therefore,
this structure can be superimposed over bacterial AGO-nucleic
acid complexes to identify structural features that are specific
to eukaryotes (Fig. 1 A–D).
The structure of the Nc QDE-2 MID-PIWI lobe serves as a
prototype for MID-PIWI domains from all the eukaryotic clades
of the Argonaute protein family, including the AGO, PIWI, and
WAGO clades (Fig. S1 and ref. 1). However, we limit our analysis
here to the AGO clade, which containsNcQDE-2 and eukaryotic
AGOs involved in the siRNA and miRNA pathways.
The PIWI Domain and the Interaction with Target mRNA. The PIWI
domain of Nc QDE-2 (residues H644–I938) adopts an RNase H
fold with a catalytically active DDD motif, which is less common
than the DDH motif present in most eukaryotic AGOs (Fig. S1).
A structure-based alignment (Fig. S1) identified a series of loops
on the putative nucleic acid-binding surface of the PIWI domain
[Fig. 1A, loops L1 (H667–P681), L2 (G746–Q751), L3 (K788–
A840), and L4 (F873–I882)]. Their significance is best under-
stood in the context of a double stranded nucleic acid substrate
that can be placed on the QDE-2 MID-PIWI lobe by the struc-
tural superposition with Thermus thermophilus AGO-nucleic acid
complex [Fig. 1 B and C; Protein Data Bank (PDB) ID code
3HJF; ref. 10]. In this particular model substrate, the 3′ end of
the guide DNA strand is not anchored in the PAZ domain.
Instead, nucleotides 2 to 15 of the guide DNA are base-paired
to an RNA target strand, forming a duplex extending beyond
the seed sequence (see Fig. 1D for a numbering of the respective
nucleotides), which is typical for siRNA targets but rather rare
for animal miRNA targets (3).
The scissile bond of the model target strand (between nucleo-
tides 10′ and 11′) fits nicely in the catalytic site (Fig. 2 A and B),
and loop L2 is perfectly positioned to probe the minor groove of
the duplex (base pair 13) with S748 (Fig. 2 C and D). Loop L2 is
highly conserved in all eukaryotic AGOs and likely fixes the phos-
phodiester backbone of the target strand (nucleotides 12′ and
13′) via E749 and nucleotide 14 from the guide strand via Q751
(Fig. 2 C and D) in cases where the downstream duplex is formed
(e.g., in the case of fully complementary targets).
Loop L3 is disordered in crystal form I and was deleted in crys-
tal form II. Judging from the prokaryotic AGO structures, the
central parts of this loop likely organize the missing lobe (contain-
ing the N-term and PAZ domains) of the AGO protein (Fig. S2B),
whereas the N-terminal residues of loop L3 [including the con-
served K786 (Fig. S1)] might assist loop L2 in fixing the backbone
of the target strand (nucleotides 10′ and 11′). Therefore, regard-
less of whether the downstream duplex is formed, all eukaryotic
AGO proteins are likely to bind the target strand between loops
L2 and L3 in a conserved way.
The most interesting feature in this context is loop L1, which
changes conformation between crystal form I (conformation I,
Fig. 1C) and crystal form II (conformation II, Fig. 1A and
Fig. S1) and is more variable in sequence and length than loop
L2. In conformation II, loop L1 clashes with the base-paired
guide strand at nucleotides 12–14 (Fig. 2D), whereas conforma-
tion I may recognize and stabilize nucleotides 13 and 14 in the
duplex via H667 (Fig. 2C). Consequently, this “switch loop” could
sense or control the formation of a downstream duplex, with
important consequences for subsequent steps in the siRNA and
miRNA pathways (e.g., recruitment of GW182 proteins). A
switch in loop L1 upon duplex formation has previously been de-
scribed for Tt AGO (10), indicating that this may indeed be an
important and conserved function in AGO proteins. In contrast
to the TtAGO structure, however, we do not observe a correlated
flip of the beta strand β6 (10).
Finally, loop L4 is disordered in this structure (note that in
Figs. 1 and 2 this loop is modeled as in prokaryotic structures).
Based on prokaryotic structures, loop L4 likely helps to fix
nucleotides 2 to 5 from the guide RNA seed region, even in the
absence of a target strand, ensuring it is held in a hybridization-
competent state for target seed recognition, as proposed for
the prokaryotic homologs (6, 24) and Caenorhabditis elegans
ALG1 (25).
The Eukaryotic PIWI Domains Contain a C-Terminal Insertion.A pecu-
liar feature of the eukaryotic AGO clade is a C-terminal insertion
Fig. 1. Structure of the Neurospora crassa QDE-2 MID-PIWI lobe. (A) Ribbon
representation of the QDE-2 MID-PIWI ΔL3 structure showing the position of
a bound sulfate ion (S1) as sticks (red, oxygen; yellow, sulfur). Disordered
portions of the polypeptide chains are indicated with dashed lines. Selected
loops and secondary structure elements are labeled. Loop L1 is shown in
conformation II. Loop L3 was deleted and replaced by a GSG linker. Loop
L4 is modeled based on prokaryotic structures [PDB ID code 1W9H (11)].
The eukaryotic-specific insertion is colored orange. (B) Ribbon representation
of the MID-PIWI lobe of Thermus thermophilus (Tt) AGO in complex with a
guide DNA-target RNA duplex, generated from PDB ID code 3HJF (10). (C, D)
Model for a nucleic acid bound to the QDE-2 MID-PIWI lobe, based on the
superposition with the Tt PIWI domain (PDB ID code 3HJF, as shown in panel
B). Specific bases of the guide DNA and target RNA strands are colored as
indicated in panel D. Loop L1 is shown in conformation I.
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(K901–G925) that, in QDE-2, folds into two closely packed
helices (Fig. 1 A and C; in orange). This eukaryote-specific α-he-
lical insertion is located right next to the switch loop L1, and also
shows a minor conformational difference between the two crystal
forms in the short turn connecting the helices. In contrast to loop
L1, however, the α-helical insertion does not change position be-
tween the two crystal forms, and there are no specific contacts to
loop L1 (Fig. 1 A vs. C). Judging from the superposition with a
closed conformation of TtAGO (PDB ID code 3DLH; ref. 8), the
α-helical insertion together with loop L1 is able to contact the
PAZ domain (Fig. 2E). The respective TtAGO structure contains
a guide strand with the 5′ and 3′-terminal nucleotides anchored in
their specific binding pockets in the MID and PAZ domains,
respectively. In contrast, in the superposition with an open
conformation of Tt AGO bound to a guide-target duplex, in
which the 3′-terminal nucleotide of the guide RNA is released
from the PAZ domain (PDB ID code 3HJF; ref. 10), the PAZ
domain moves away from loop L1 and the α-helical insertion
(Fig. 2F). These observations suggest that loop L1 and the
α-helical insertion establish conformation-dependent interac-
tions with the PAZ domain in eukaryotic AGOs. These structural
elements might, therefore, act as a sensor for the functional state
of the protein and play a regulatory role.
The Binding Pocket for the 5′ End of the Guide Strand Forms at
the MID-PIWI Interface. The structure of the MID domain
(V506–N643), with its Rossmann-like fold, remains highly similar
to the previously determined structure in isolation (17, 18).
Accordingly, we also find a sulfate ion (S1) in the binding pocket
of the guide RNA 5′ end, coordinated by the highly conserved
residues Y595, K599, and K638 (Figs. 1A and 3A). This sulfate
ion mimics and occupies the position of the 5′ phosphate that is
characteristic of siRNAs and miRNAs. Importantly, when we
superimpose the prokaryotic nucleic acid substrates, using the
PIWI domain as a reference, the 5′ phosphate of the guide strand
is at a distance of less than 2.5 Å from the sulfate, and the first
nucleotide stacks on Y595, as previously suggested (Fig. 3B and
refs. 5, 17, and 18). This confirms that the relative orientation
of the MID and PIWI domains and the geometry of substrate
binding are very similar between prokaryotes and eukaryotes,
validating the interpretations of the prokaryotic complexes in
this respect.
Indeed, as in prokaryotes, the binding pocket for the 5′ phos-
phate of the guide strand lies at the MID-PIWI interface and
is completed by the C-terminal carboxyl group of the protein
(labeled “C” in Figs. 1A and 3 A and B). Furthermore, R895
(PIWI), which is present in most eukaryotic proteins from the
AGO andWAGO clades, also participates in the 5′ binding pock-
et (Fig. 3 A and B). It forms hydrogen bonds to Y595 (MID) and
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Fig. 2. Details of the nucleic acid binding surface. (A) View of the QDE-2
PIWI domain bound to a model guide DNA-target RNA duplex color-coded
as in Fig. 1D. (B) Expanded view of the framed region in panel A showing the
catalytic site of Nc QDE-2 PIWI domain and the position of the backbone
phosphate linking the 10′-11′ bases of the target RNA relative to the catalytic
residues (D664, D745, and D890). For clarity, loop L1 is colored pink. (C, D)
Extended view of loops L1 and L2 in contact with the guide DNA-target
RNA duplex. Panel (C) shows loop L1 in conformation I whereas panel D
shows conformation II, in which loop L1 clashes with the duplex. (E, F) Rela-
tive orientation of eukaryotic AGO domains (ribbons), using bacterial AGO
structures as template (transparent surfaces). (E) Closed conformation in
the absence of a target strand, where the 3′ end of the guide strand is an-
chored in the PAZ domain [based on PDB ID code 3DLH (8)]. (F) Open con-
formation in the presence of a target strand, where the 3′ end of the
guide strand is released [based on PDB ID code 3HJF (10)]. Note that in
the closed conformation (E), the C-terminal insertion (C-term ins) and loop
L1 of the QDE-2 MID-PIWI lobe can contact the PAZ domain. In both panels,
loop L1 is shown in the conformation observed in crystal form I. However, in
the closed conformation (E) loop L1 could adopt conformation II or any other
similar conformation and still contact the PAZ domain.
Fig. 3. Details of the MID-PIWI interface. (A, B) Extended view of the guide
strand 5′-terminal nucleotide-binding pocket, without (A) andwith (B) bound
guide strand (DNA) model from the superposition of the TtMID-PIWI domain
in complex with a guide-target duplex (Fig. 1C). The guide strand is shown
as sticks colored according to the scheme in Fig. 1D. The 5′ base of the guide
strand stacks onto Y595, whereas the 5′ phosphate superimposes with sulfate
S1. Relevant side chains are shown as sticks. Hydrogen bonds are shown
as dotted lines (red forwaterw1). Thewatermolecule (w1) is shown in purple,
and amagnesium ion from the TtAGO structure (PDB ID codes 3DLHand 3HJF)
is shown in gray (red, oxygen; blue, nitrogen; yellow, sulfur and phosphorus).
(C, D) Comparison of QDE-2 MID domain structures in the context of the
MID-PIWI lobe (C) or in isolation (D). Loop LD603 (dark gray) changes conforma-
tion between the two structures. The structure of the isolated QDE-2 MID
domain contains two bound sulfate ions (S1 and S2). S1 marks the position
of the 5′ phosphate of the guide strand, whereas S2 marks the position of
a putative second ligand-binding site [PDB ID code 2xdy (17)]. In the structure
of the QDE-2 MID-PIWI lobe, the S2 binding site is occluded by the C-terminal
tail of the protein, and S2 is replaced by three water molecules (magenta).
Relevant side chains and secondary structure elements are labeled. D603
corresponds to the aspartate proposed by Djuranovic et al. (21) to mediate
allosteric regulation of miRNA binding. MID, pale green; PIWI, yellow.
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to an important water molecule (w1, purple sphere in Fig. 3 A
and B) that contacts both the C-terminal carboxyl group and
the bound sulfate. In the presence of the guide strand, the carbox-
yl group is also expected to coordinate a magnesium ion (Fig. 3B,
gray sphere, 3DLH and 3HJF, and refs. 8 and 10) and to bend the
guide RNA backbone between nucleotides 1 and 2 to a degree
similar to that observed in the prokaryotic complexes (5, 6, 8,
10). Consequently, whereas the phosphates of nucleotide 1 and
3 would be bridged by themagnesium ion, the ribose of nucleotide
2 would be contacted by the conserved N630 (MID), the phos-
phate of nucleotide 3 by K634 (MID), and the phosphate of
nucleotide 4 by Y887 (PIWI) (Fig. 3 A and B). This places
nucleotides 2–4 from the guide RNA seed region in a hybridiza-
tion-competent state (Fig. 3B), that is likely to be stabilized
further by presently disordered residues from loop L4 (see above).
Interestingly, in the PIWI clade of the AGO protein family, the
highly conserved residues N630 and K634 are replaced by lysine
and glutamine, respectively, and in the WAGO clade, the other-
wise invariant Y595 is a histidine. These clade-specific diagnostic
differences in the 5′ binding pocket are worth pointing out here
and deserve further structural investigation.
The Hydrophilic MID-PIWI Interface. A comparison of the QDE-2
MID domain in the presence (Fig. 3C) or absence (Fig. 3D
and ref. 16) of the PIWI domain revealed an interesting confor-
mational difference in a loop between residues D603 and V608
(termed loop LD603). This loop had previously been implicated in
the allosteric regulation of guide RNA binding, and mutational
analysis has suggested that an aspartate (D603 in Nc QDE-2)
could mediate this effect (21); this residue is conserved in a subset
of eukaryotic AGOs (Fig. S1). Furthermore, the isolated QDE-2
MID domain bound a second sulfate ion (S2) in a position that
would be ideal for an allosteric ligand (Fig. 3D) and could be con-
tacted by D603 if loop LD603 adopted the conformation observed
in the human AGO2 MID domain (18).
The structure of the Nc QDE-2 MID-PIWI lobe now reveals
that loop LD603 can indeed change into the conformation ob-
served for the human MID domain (Fig. 3C and Fig. S3A), which
creates space for the insertion of the C-terminal tail of the protein
into the MID-PIWI interface (Fig. 3C and Fig. S3A). As a result,
the tail displaces the sulfate ion (S2) and occludes the second
sulfate ion-binding site in the present structure, deeply burying
three water molecules (magenta spheres). These are coordinated
by residues K599, H609, V608 (main chain carbonyl), T610, K638
and D603 from the MID domain, and R895 and Y936 (main
chain carbonyl) from the PIWI domain, most of which are highly
conserved (Fig. 3C and Figs. S1 and S3B). Importantly, D603 is
now buried in the interface as well and directly contacts R895
from the PIWI domain, which is part of the 5′ guide RNA binding
pocket (Fig. 3 A and B and Fig. S3B). Furthermore, D603 also
contacts H899 from the PIWI domain, a residue that is conserved
only among animal AGOs implicated in the miRNA pathway
(Fig. 3 A and B and Fig. S3B).
The polar and hydrophilic character of the interface is con-
served within the eukaryotic AGO and WAGO clades and
explains why a mutation in D603 has long-range effects on guide
RNA binding (21) without having to invoke allosteric control.
Guide RNA Binding by QDE-2 Requires the MID-PIWI Interaction. To
investigate the contribution of the PIWI domain to 5′-nucleotide
binding in vitro, we used size exclusion chromatography. As a
substrate, we chose a 10-mer guide RNA mimic that started with
a 5′-phosphorylated uridine (23). We first showed that the MID
domain alone could not bind the substrate (Fig. 4A), whereas a
protein fragment containing the MID and PIWI domains readily
bound RNA, forming a 1∶1 protein–RNA complex (Fig. 4B).
This shows that the PIWI domain is indeed essential for guide
RNA binding. Remarkably, the PIWI domain does not contribute
to guide RNA binding only through residues that are part of the
5′-nucleotide binding pocket because the MID-PIWI ΔL3 pro-
tein from the high-resolution structure (crystal form II) exhibited
reduced RNA-binding affinity (Fig. 4C). Therefore, we used the
full-length MID-PIWI lobe for additional RNA-binding assays.
First, we showed that, in vitro, the guide RNA mimic binds
specifically to the 5′-terminal nucleotide binding pocket because
the substitution of the Y595 stacking platform with a leucine
abolished binding, as expected (Fig. 4D and ref. 5). We also found
guide RNA binding to be abolished by R895A (Fig. 4E), although
R895 contacts the 5′ phosphate only indirectly via water w1
(Fig. 3A). Hence, guide RNA binding seems very sensitive to
subtle alterations in the 5′ binding pocket. Additionally, the
R895A substitution may also affect guide RNA binding via a de-
stabilization of the MID-PIWI interface (Fig. 3A and Fig. S3B).
This hypothesis is supported by an even more distant H899A
mutation that also reduces RNA binding (Fig. 4F). Both R895
and H899 contact D603, located at the center of the interface
(Fig. 3A). However, an additional D603K mutant could not be
obtained in soluble form, indicating that the complete disruption
of the interface strongly destabilizes the protein. Finally, we pre-
pared a deletionmutant lacking the eukaryote-specific C-terminal
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insertion. This protein was soluble and bound the 10-mer 5′ guide
RNAmimic (Fig. 4G). This indicates that the interface, including
the very C-terminal end of the protein remains intact in this
mutant and that the C-terminal insertion is, therefore, not re-
quired to bind to this particular substrate. This result is not
surprising because prokaryotic AGOs bind guide nucleic acids
even though they lack the C-terminal insertion (Fig. S1).
The MID-PIWI Domain Interface Is Required for Dm AGO1 to Bind miR-
NAs and GW182. To exploit the crystal structure in a physiological
context and to gain additional functional insight into the miRNA
pathway, we generated analogous mutations in the context of
full-length, HA-tagged Dm AGO1 protein and tested them for
interactions with an endogenous miRNA (Bantam) and the
GW182 protein in D. melanogaster S2 cells. Previous studies have
shown that GW182 proteins interact directly with AGOs and
are essential for miRNA-mediated gene silencing in animal cells
(26). Using a complementation assay (27), we also tested Dm
AGO1 mutants for their ability to restore silencing in cells
depleted of endogenous AGO1 (Fig. S4A).
In contrast to previous mutational analyses of human AGO2
and Dm AGO1 (27, 28), we could design and interpret our
experiments in the context of the QDE-2 structure, which is
29.7% identical to Dm AGO1. Moreover, the hydrophilic MID-
PIWI interface (including residues R895, D603, H899) is particu-
larly well conserved in Dm AGO1 (Fig. S1). We generated three
classes of mutations: (i) mutations on the putative RNA-binding
interface, (ii) mutations in theMID-PIWI interface, and (iii) dele-
tions of either the eukaryote-specific C-terminal insertion or of
loop L1 (Table S2). A Dm AGO1 F2V2 mutant that is unable to
bind miRNAs and GW182 (27, 29) served as a negative control.
Dm AGO1 mutants targeting the 5′-phosphate binding pocket
were strongly impaired in miRNA binding. These include
substitutions of the following residues (corresponding QDE-2
residues in brackets, Table S2): Y653L (Y595), K657E (K599),
K690A (K634), and K694A (K638; Fig. 5 A and C). These mu-
tants were also impaired in complementation assays, as expected
(Fig. S4 A–C). Additionally, the replacement of loop L3 (Dm
AGO1) with a glycine-serine linker strongly impaired miRNA
binding (Fig. 5B; ΔLoop L3). This can be explained by a direct
binding defect, as shown for QDE-2 (Fig. 4C), although it is
possible that this deletion affects the function of the protein in a
more severe manner, given that L3 also contacts the N-term-PAZ
lobe (Fig. S2B). Accordingly, deleting loop L3 completely abol-
ished silencing activity in complementation assays (Fig. S4 A–C).
In contrast, mutations of residues in loop L2 that are predicted to
contact the RNA in a target-bound state [E798 (E749) and Q800
(Q751), Fig. 2C] had no effect on miRNA binding (Fig. 5C, lanes
15 and 16). These mutants were also active in complementation
assays (Fig. S4 A–C), indicating that the interaction of loop L2
with the target mRNA is dispensable, at least for partially com-
plementary targets that are not sliced.
Importantly, mutations in the MID-PIWI interface impaired
miRNA binding and silencing activity to different extents. These
include D661K (D603), R937A (R895) and H941A (H899;
Fig. 5 A and B; Fig. S4 A–C). These results show that the inter-
actions observed in the QDE-2 structure are indeed conserved in
Dm AGO1 and are crucial for miRNA binding. They also un-
cover a particular sensitivity of miRNA binding to the stability
of the MID-PIWI interface and to the relative orientation of
the two domains.
Unexpectedly, replacing the eukaryote-specific C-terminal in-
sertion with a glycine-serine linker (Fig. 5B, lane 16; Table S2)
also impaired miRNA binding and abolished silencing activity
(Fig. S4 A–C). This is intriguing because it is unlikely that this
insertion affects guide strand RNA binding directly and because
the corresponding deletion in the context of QDE-2 did not
affect the binding to a 10-mer guide RNA mimic in vitro
(Fig. 4G). Hence, these observations may reflect interesting
functional differences between AGOs that act in distinct path-
ways. Alternatively, the insertion may be important in an earlier
step, such as during structural arrangements accompanying the
loading of a full-length 21-mer miRNA with its 3′ end anchored
in the PAZ domain. Indeed, in the context of a full-length Dm
AGO1 protein the C-terminal insertion would be in a position
to contact the PAZ domain (Fig. 2E).
Finally, we also tested the effect of deleting loop L1, which
together with the C-terminal insertion contacts the PAZ domain.
We generated a deletion mutant that completely lacks loop L1
(ΔL1+His) and a mutant lacking only the most distal tip of this
loop (ΔL1) conserving residue H724 (H667). Histidine 667 may
contribute to miRNA binding by contacting the guide strand
downstream of the seed sequence (Fig. 2C). Thesemutants bound
miRNA and GW182 and were fully active in complementation
assays (Fig. S4 A–D). These results indicate that loop L1 is
dispensable at least for miRNA-mediated silencing and further
suggest that loop L1 and the C-terminal insertion play distinct
functional roles.
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Fig. 5. Mutational analysis of Dm AGO1. (A–C) Lysates from S2 cells expres-
sing HA-tagged versions of MBP, wild-type AGO1 or AGO1 mutants were
immunoprecipitated using a monoclonal anti-HA antibody. Inputs and immu-
noprecipitates were analyzed by Western blotting. Endogenous GW182 was
detected using anti-GW182 antibodies. The association between HA-AGO1
and endogenous Bantam miRNA was analyzed by northern blotting.
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Strikingly, we could not identify anymutation that disrupts bind-
ing to miRNAs without simultaneously affecting GW182 binding
(Fig. 5 A–C). This correlation is strict, but the converse is not
the case; there are mutations that reduce GW182 binding whereas
miRNA binding remains intact [R771A (K720) and F777A
(W726), as reported previously (Fig. 5B, lanes 17 and 18; Figs. S1
and S5 and ref. 27]. Consequently, miRNA binding may be re-
quired for GW182 binding, whereas GW182 binding might facili-
tate, but is not required, formiRNAbinding. Notably, these results
also exclude the possibility that the loss of miRNA binding after
mutating D661 (D603) or any other interface residue indirectly
results from a loss of GW182 binding. Clearly, an understanding
of the complex interplay between miRNA binding and the recruit-
ment of GW182 requires detailed structural information.
Conclusion
The structure of a MID-PIWI lobe from a eukaryotic AGO illus-
trates that the relative domain orientations are highly conserved
compared with the prokaryotic structures, indicating a conserved
mode of interaction with the RNA substrate. The interface of the
two domains is polar and hydrophilic, with D603 as a central
residue that is crucial for the stability of the MID-PIWI interac-
tion. This argues against the direct involvement of the analogous
residue in the allosteric regulation of human AGO2 or Dm
AGO1 and provides a simple explanation for why the D661K
(D603K) mutation abolished the small RNA binding activity
of Dm AGO1 in vivo. Interestingly, the more subtle H941A
(H899) mutation had a similar, although slightly weaker effect,
confirming that the MID-PIWI interface is conserved and quite
sensitive to alterations. Mutational analysis of the Dm AGO1
protein also showed that GW182 binding is lost in all instances
in which miRNA binding is lost, indicating that GW182 binding
depends on the presence of miRNA or an AGO conformation
that results from the presence of miRNA.
In conclusion, the hydrophilic MID-PIWI interface of Nc
QDE2 (comprising residues R895-D603-H899) is particularly
well conserved in AGOs from the animal miRNA pathway, and
its stability has direct consequences for substrate binding. This
raises the possibility that factors that influence the stability of
the interface might have evolved to regulate AGO function. The
interface itself may also be dynamic during the AGO reaction
cycle. This would fit with a flexible role for the AGO proteins,
where the adoption of guide and/or target specific conformations
(30–32) would channel them into distinct pathways (such as the
miRNA or siRNA pathway).
Materials and Methods
Detailed experimental procedures are given in SI Text. Briefly, the MID-PIWI
lobe of Nc QDE-2 (amino acids 506–938) was expressed from a pETM60 vector
(derived from pET24d; Novagen) in Escherichia coli BL21 Star (DE3) cells as a
NusA-6xHis-tagged fusionprotein. ItwaspurifiedbyaNi2þ-affinity step (HiTrap
ChelatingHPcolumn,GEHealthcare), followedbya removalof thepurification
tag and additional cation exchange (SP) chromatography and gel filtration
steps (HiLoad 26∕60 Superdex 75 pg; GE Healthcare). The proteins was concen-
trated to 20 mg∕mL in 10 mM Hepes (pH 7.2), 150 mM NaCl and 1 mM DTT.
The structure of the MID-PIWI lobe was solved by molecular replacement
using the MID domain (PDB ID code 2xdy; ref. 17) as a search model. The
resulting difference density allowed the placement of a copy of the
T. thermophilus PIWI domain [from PDB ID code 3DLB (8)] to start model
building and refinement. The structure of the MID-PIWI ΔL3 was solved
by molecular replacement using the low-resolution structure as a model.
For analytical size exclusion chromatography, proteins ormixtures of proteins
with RNA were injected onto the columns and UV absorption was detected
simultaneously at 230, 260, and 280 nm.
Mutants of D. melanogaster AGO1 were generated by site-directed
mutagenesis using the plasmid pAc5.1B-λN-HA-AGO1 as template and the
QuickChange Mutagenesis Kit from Stratagene. All Dm AGO1 mutants
and the equivalent QDE-2 mutants are described in Table S2. The interaction
of AGO1 with endogenous miRNAs and GW182 as well as the complementa-
tion assays were performed as described previously (27, 29).
ACKNOWLEDGMENTS.We thank G.Macino for providingN. crassaQDE-2 cDNA
and R. Büttner for excellent technical assistance. We thank the staff at the PX
beamlines of the Swiss Light Source for assistance with data collection. This
study was supported by the Max Planck Society, by grants from the Deutsche
Forschungsgemeinschaft (DFG, FOR855 and the Gottfried Wilhelm Leibniz
Program awarded to E.I.) and by the Sixth Framework Programme of the
European Commission, through the SIROCCO Integrated Project LSHG-CT-
2006-037900.
1. Tolia NH, Joshua-Tor L (2007) Slicer and the argonautes. Nat Chem Biol 3:36–43.
2. Jínek M, Doudna JA (2009) A three-dimensional view of the molecular machinery of
RNA interference. Nature 457:405–412.
3. Bartel PD (2009) MicroRNAs: Target recognition and regulatory functions. Cell
136:215–233.
4. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L (2004) Crystal structure of Argonaute and
its implications for RISC slicer activity. Science 305:1434–1437.
5. Ma JB, et al. (2005) Structural basis for 5′-end-specific recognition of guide RNA by the
A. fulgidus Piwi protein. Nature 434:666–670.
6. Parker JS, Roe SM, Barford D (2005) Structural insights into mRNA recognition from a
PIWI domain-siRNA guide complex. Nature 434:663–666.
7. Yuan YR, et al. (2005) Crystal structure of A. aeolicus argonaute, a site-specific
DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage.
Mol Cell 19:405–419.
8. Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ (2008) Structure of the guide-strand-
containing argonaute silencing complex. Nature 456:209–213.
9. Wang Y, et al. (2008) Structure of an argonaute silencing complex with a seed-contain-
ing guide DNA and target RNA duplex. Nature 456:921–926.
10. Wang Y, et al. (2009) Nucleation, propagation and cleavage of target RNAs in Ago
silencing complexes. Nature 461:754–761.
11. Parker JS, Roe SM, Barford D (2004) Crystal structure of a PIWI protein suggests
mechanisms for siRNA recognition and slicer activity. EMBO J 23:4727–4737.
12. Lingel A, Simon B, Izaurralde E, Sattler M (2003) Structure and nucleic-acid binding of
the Drosophila Argonaute 2 PAZ domain. Nature 426:465–469.
13. Lingel A, Simon B, Izaurralde E, Sattler M (2004) Nucleic acid 3′-end recognition by the
Argonaute2 PAZ domain. Nat Struct Mol Biol 11:576–577.
14. Song JJ, et al. (2003) The crystal structure of the Argonaute2 PAZ domain reveals an
RNA binding motif in RNAi effector complexes. Nat Struct Mol Biol 10:1026–1032.
15. Yan KS, et al. (2003) Structure and conserved RNA binding of the PAZ domain. Nature
426:468–474.
16. Ma JB, Ye K, Patel DJ (2004) Structural basis for overhang specific small interfering
RNA recognition by the PAZ domain. Nature 429:318–322.
17. Boland A, Tritschler F, Heimstädt S, Izaurralde E, Weichenrieder O (2010) Crystal
structure and ligand binding of the MID domain of a eukaryotic Argonaute protein.
EMBO Rep 11:522–527.
18. Frank F, Sonenberg N, Nagar B (2010) Structural basis for 5′-nucleotide base-specific
recognition of guide RNA by human AGO2. Nature 465:818–822.
19. Simon B, et al. (2011) Recognition of 2′-O-methylated 3′-end of piRNA by the PAZ
domain of a Piwi protein. Structure 19:172–180.
20. Tian Y, Simanshu DK, Ma JB, Patel DJ (2011) Structural basis for piRNA 2′-O-methylated
3′-end recognition by Piwi PAZ(Piwi/Argonaute/Zwille) domains. Proc Natl Acad Sci
USA 108:903–910.
21. Djuranovic S, et al. (2010) Allosteric regulation of Argonaute proteins by miRNAs. Nat
Struct Mol Biol 17:144–150.
22. Fulci V, Macino G (2007) Quelling: post-transcriptional gene silencing guided by
small RNAs in Neurospora crassa. Curr Opin Microbiol 10:199–203.
23. Lee HC, et al. (2010) Diverse pathways generate microRNA-like RNAs and Dicer-
independent small interfering RNAs in fungi. Mol Cell 38:803–814.
24. Parker JS, Parizotto EA, Wang M, Roe SM, Barford D (2009) Enhancement of the
seed-target recognition step in RNA silencing by a PIWI/MID domain protein.Mol Cell
33:204–214.
25. Lambert NJ, Gu SG, Zahler AM (2011) The conformation of microRNA seed regions in
native microRNPs is prearranged for presentation to mRNA targets. Nucleic Acids Res
10.1093/nar/gkr077.
26. Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: Contributions of
translational repression and mRNA decay. Nat Rev Genet 12:99–110.
27. Eulalio A, Helms S, Fritzsch C, Fauser M, Izaurralde E (2009) A C-terminal silencing
domain in GW182 is essential for miRNA function. RNA 15:1067–1077.
28. Till S, et al. (2007) A conserved motif in Argonaute-interacting proteins mediates
functional interactions through the Argonaute PIWI domain. Nat Struct Mol Biol
14:897–903.
29. Eulalio A, Huntzinger E, Izaurralde E (2008) GW182 interaction with Argonaute is
essential for miRNA-mediated translational repression and mRNA decay. Nat Struct
Mol Biol 15:346–353.
30. Chen HM, et al. (2010) 22-Nucleotide RNAs trigger secondary siRNA biogenesis in
plants. Proc Natl Acad Sci USA 107:15269–15274.
31. Cuperus JT, et al. (2010) Unique functionality of 22-nt miRNAs in triggering RDR6-
dependent siRNA biogenesis from target transcripts in Arabidopsis.Nat StructMol Biol
997–1003.
32. Noto T, et al. (2010) The Tetrahymena argonaute-binding protein Giw1p directs a
mature argonaute-siRNA complex to the nucleus. Cell 140:692–703.
Boland et al. PNAS ∣ June 28, 2011 ∣ vol. 108 ∣ no. 26 ∣ 10471
B
IO
C
H
E
M
IS
T
R
Y
Supporting Information
Boland et al. 10.1073/pnas.1103946108
SI Materials and Methods
Cloning, Expression, and Purification of the QDE-2 MID-PIWI Lobe. A
cDNA fragment encoding the MID and PIWI domains of Nc
QDE-2 (amino acids 506–938) was amplified by PCR from a
pBluescript-SK plasmid containing the genomic sequence of
the qde-2 gene (kindly provided by G. Macino) using the primer
pairs:
5′ATGCCATGGCAGTCAAGGTCGCCAGACCTT-3′ (for-
ward) and 5′- TAGCGGCCGCTTAGATATAGTACATGGAG-
TTCCTA -3′ (reverse). The cDNA was then cloned into the NcoI
and NotI sites of the pETM60 vector (derived from pET24d;
Novagen), downstream of a NusA-6xHis tag. The construct for
the expression of the QDE-2 MID-PIWI ΔL3 protein in which
residues 787–838 were replaced by a Gly-Ser-Gly linker was
obtained by site-directed mutagenesis.
The NusA-6xHis-tagged MID-PIWI lobe proteins were ex-
pressed in Escherichia coli BL21 Star (DE3) cells (Invitrogen)
at 20 °C overnight. Protein expression was induced with 0.5 mM
Isopropyl ß-D-1-thiogalactopyranoside at an A600 of 0.6. The fu-
sion proteins were first purified by a Ni2þ-affinity step (HiTrap
Chelating HP column, GE Healthcare). Removal of the NusA
and polyhistidine tags was done by proteolytic digestion with
tobacco etch virus protease at 4 °C overnight. The proteins were
further purified by cation exchange (SP) chromatography and sub-
sequent gel filtration (HiLoad 26∕60 Superdex 75 pg; GE Health-
care). Finally, the proteins were concentrated to 20 mg∕mL in
10 mM Hepes (pH 7.2), 150 mM NaCl and 1 mM DTT.
Crystallization. Crystals of native and selenomethionine-substi-
tuted QDE-2 MID-PIWI construct were grown by hanging drop
vapor diffusion over a 500 μL reservoir at 18 °C. The protein so-
lution described above was mixed 1∶1 with various reservoir solu-
tions containing 1.6–2.3 M ammonium sulfate as precipitant and
100–250 mM potassium format leading to a total droplet size of
3 μL. Crystals were optimized by hair-seeding and flash frozen in
liquid nitrogen in the respective reservoir solution supplemented
with 15 or 20% glycerol for cryoprotection.
Diffraction quality crystals of the QDE-2 MID-PIWI ΔL3
protein were grown by sitting drop vapor diffusion over a
50 μL reservoir at 22 °C after mixing 0.2 μL protein solution with
0.2 μL reservoir solution (2.3M ammonium sulphate and 200 mM
di-sodium tartrate). Crystals were cryoprotected in 2.3 M ammo-
nium sulfate and 200 mM di-sodium tartrate supplemented with
20% glycerol before flash-freezing in liquid nitrogen.
Data Collection, Structure Solution, and Refinement.Diffraction data
were recorded on a PILATUS 6M detector (1) at the beamline
PXII of the Swiss Light Source at a wavelength of 1.0 Å for the
native dataset and at the absorption peak of the selenomethio-
nine derivative at 0.9792 Å. Extensive screening of crystals from
the QDE-2 MID-PIWI protein led to a native dataset at 3.65 Å
resolution that was assembled from three 10° wedges collected
from different spots along the crystal due to severe radiation
damage. The best selenomethionine dataset extended to 4.35 Å
resolution. Diffraction images were processed with XDS (2).
The structure was solved by molecular replacement in PHA-
SER (3), using the MID domain [Protein Data Bank (PDB)
ID code 2xdy (4)] as a search model. A copy of the Thermus ther-
mophilus PIWI domain [from PDB ID code 3DLB (5)] could
be placed in the resulting difference density and was rigid-body
refined and trimmed in COOT (6). Aided by the high solvent con-
tent (79%) of this crystal form, we could build (COOT) and
refine a model of QDE-2 MID-PIWI using PHENIX (7).
Because loop L3 was disordered in this crystal form, we deleted
the relevant sequence in the QDE-2 MID-PIWI ΔL3 construct.
The resulting crystals diffracted X-rays to 1.85 Å resolution, and
the structure was solved by molecular replacement (PHASER)
using the low-resolution structure as a model. The QDE-2
MID-PIWI ΔL3 model was (re-)built automatically with ARP/
wARP (8) and finished manually in COOT, alternating with
rounds of refinement (PHENIX). Finally, the high-resolution
QDE-2 MID-PIWI ΔL3 model was used for a last cycle of model
adjustment and refinement of the low-resolution QDE-2 MID-
PIWI model, and proper sequence assignment was confirmed
by the calculation of anomalous difference Fourier maps from
the selenomethionine dataset, with peaks corresponding to the
methionine positions. Stereochemical properties were analyzed
with MOLPROBITY (9) andWHATCHECK (10), and structure
figures were generated in PYMOL.
Analytical Size Exclusion Chromatography. Proteins were prepared
and analyzed in the same buffer, as described for crystallization
(10 mM Hepes (pH 7.2), 150 mM NaCl, 1 mM DTT). Proteins
or mixtures of proteins with RNA were injected either onto a
Superdex 75 10∕300 (MID domain) or onto a Superdex 200
10∕300 GL (MID-PIWI) analytical gel filtration column (GE
Healthcare, 18 °C, preequilibrated) as part of an ÄKTA Purifier-
10 at a flow rate of 0.5 mL∕min. UV absorption was detected
simultaneously at 230 nm, 260 nm and 280 nm. Protein and
nucleic acid concentrations were estimated from the theoretical
molar extinction coefficients at 280 nm and 260 nm, respectively.
The relative contributions of protein and nucleic acid to the total
absorption at each wavelength were calculated assuming constant
ratios of the extinction coefficient at 230 nm to the extinction
coefficient at 280 nm for each substance (11). The protein mu-
tants tested are described in Table S2.
Coimmunoprecipitation and Complementation Assays in S2 Cells.
Mutants of Drosophila melanogaster AGO1 were designed based
on the structure of the Nc QDE-2 MID-PIWI lobe with the goal
to avoid general folding defects. Mutants were generated by
site-directed mutagenesis using the plasmid pAc5.1B-λN-HA-
AGO1 small interfering RNA (siRNA)-resistant as template and
the QuickChange Mutagenesis Kit from Stratagene. All Dm
AGO1 mutants and the equivalent QDE-2 mutants are described
in Table S2. Transfections of S2 cells were performed in 6-well
plates, using Effectene transfection reagent (Qiagen). The inter-
action of AGO1 with endogenous micro-RNAs (miRNAs) and
GW182 was tested as described previously (12). Wild-type AGO1
or AGO1 mutants were immunoprecipitated using a monoclonal
antiHA antibody (Covance Research Products; catalog number
MMS-101P). Inputs (1.5%) and immunoprecipitates (30%) were
analyzed by Western blotting using a polyclonal antiHA antibody
(SIGMA; catalog number T6199). Antibodies to D. melanogaster
GW182 were described before (13). All Western blot experiments
were developed with the ECLWestern Blotting Detection System
(GE Healthcare) as recommended by the manufacturer.
Complementation assays were carried out as described before
(12, 14) except that transfections were performed in 24-well
plates. The following siRNAs were used: control GFP siRNA
(5′-GCGACGUAAACGGCCACAAGUUCUU) and AGO1 si-
RNA1 (5′- CGAAGGAGAUCAAGGGUUUUU) at a final con-
centration of 75 nM. The transfection mixtures contained 20 ng of
F-Luc-Par-6 reporter plasmid, 80 ng of the Renilla transfection
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control, and 20 ng of a plasmid expressing miR-1 primary tran-
script or the corresponding vector without insert. When indi-
cated, 10 ng of plasmid expressing siRNA-resistant forms of
wild-type or mutant Dm AGO1 were included. A plasmid
expressing Maltose binding protein (MBP) served as a negative
control.
1. Broennimann C, et al. (2006) The PILATUS 1M detector. J Synchrotron Radiat
13:120–130.
2. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66(Pt 2):125–132.
3. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr
40(Pt 4):658–674.
4. Boland A, Tritschler F, Heimstädt S, Izaurralde E, Weichenrieder O (2010) Crystal
structure and ligand binding of the MID domain of a eukaryotic Argonaute protein.
EMBO Rep 11:522–527.
5. Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ (2008) Structure of the guide-strand
containing argonaute silencing complex. Nature 456:2093–213.
6. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta
Crystallogr D Biol Crystallogr 60:2126–2132.
7. Adams PD, et al. (2010) PHENIX: A comprehensive Phython-based system for macro-
molecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):213–221.
8. Cohen SX, et al. (2008) ARP/wARP and molecular replacement: The next generation.
Acta Crystallogr D Biol Crystallogr 64:49–60.
9. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for
proteins and nucleic acids. Nucleic Acids Res 35:W375–W383.
10. Hooft RW, Vriend G, Sander C, Abola EE (1996) Errors in protein structures. Nature
381:272.
11. Müller M, Weigand JE, Weichenrieder O, Suess B (2006) Thermodynamic characteriza-
tion of an engineered tetracycline-binding riboswitch.Nucleic Acids Res 34:2607–2617.
12. Eulalio A, Huntzinger E, Izaurralde E (2008) GW182 interaction with Argonaute is
essential for miRNA-mediated translational repression and mRNA decay. Nat Struct
Mol Biol 15:346–353.
13. Behm-Ansmant I, et al. (2006) mRNA degradation by miRNAs and GW182 requires
both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev
20:1885–1898
14. Eulalio A, Helms S, Fritzsch C, Fauser M, Izaurralde I (2009) A C-terminal silencing
domain in GW182 is essential for miRNA function. RNA 15:1067–1077.
Boland et al. www.pnas.org/cgi/doi/10.1073/pnas.1103946108 2 of 8
Fig. S1. Structure-based sequence alignment of the Nc QDE-2 MID and PIWI domains with archaeal and eubacterial homologs (IV), as well as with eukaryotic
MID-PIWI domains of AGOs from the Argonaute-like clade (I), the WAGO clade (II), and the PIWI-like clade (III). The MID-PIWI domain boundary is indicated
with a vertical black line. Residues lining the 5′ binding pocket are shaded green, and residues involved in interdomain interactions are shaded orange. Clade-
specific differences are highlighted in pale green. Loop L1 and L2 are shaded yellow. Residues in the unstructured loops L3 and L4 are indicated in gray. The
catalytic residues (DDD) are shaded cyan. The C-terminal conserved hydrophobic residues are shaded brown. The eukaryotic insertion includes α-helices 12 and
13. Mutations that abolish GW182 binding but not miRNA binding (14), are shaded magenta. Residues potentially involved in RNA binding are boxed in red.
Residues mutated in the QDE-2 MID-PIWI domain are marked with a red asterisk, and residues mutated in Dm AGO1 are labeled with a black asterisk. AGO,
Argonaute; Af, Archaeoglobus fulgidus; At, Arabidopsis thaliana; Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Hs, Homo sapiens; Nc, Neuro-
spora crassa; PIWI, P-element-induced wimpy testis; RDE-1, RNA interference deficient 1; QDE-2, quelling-defective 2; Sp, Schizosaccharomyces pombe; Tt,
Thermus thermophilus.
UniProt accession numbers: Nc QDE2 (Q9P8T1), Hs AGO2 (Q9UKV8), Dm AGO1 (Q32KD4), Dm AGO2 (Q9VUQ5), Ce RDE1 (Q9XU82), At AGO1 (O04379), At
AGO4 (Q9ZVD5), Sp AGO1 (O74957), Ce GCC7 (Q21770), Ce Q27GU1 (Q27GU1), Ce YQ53 (Q09249), Hs HIWI (Q96J94), Hs HILI (Q8TC59), Hs HIWI2 (Q7Z3Z4), Af
PIWI (O28951), Tt AGO (Q746M7).
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Fig. S2. (A) Structural superposition of a Tt AGO-nucleic acid complex (as shown in Fig. 1C) onto the QDE-2 MID-PIWI lobe (using the PIWI domains as
reference). The guide DNA-target RNA duplex was removed. (B) Ribbon representation of the Tt AGO-nucleic acid complex. The N-terminal and PAZ domains
are shown in gray, and the MID-PIWI lobe in brown. Loop L3, which is highlighted in dark brown, contacts the N-terminal domain as well as the PAZ-MID
domain linker. Guide strand: dark blue; target strand: light blue [PDB ID code 3HJF (1)].
1 Wang Y, et al. (2009) Nucleation, propagation, and cleavage of target RNAs in Ago silencing complexes. Nature 461:754–761.
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Fig. S3. Structural superposition of the isolated QDE-2 MID domain (gray) onto the QDE-2 MID-PIWI lobe (green). (A) Loop LD603 changes conformation
between the two structures. The structure of the isolated QDE-2 MID domain contains two bound sulfate ions (S1 and S2). S1 marks the position of the
5′ phosphate of the guide strand and is also present in the structure of the QDE-2 MID-PIWI lobe. S2 marks the position of a putative second ligand-binding
site in the isolated MID domain [PDB ID code 2xdy (4)]. In the structure of the MID-PIWI lobe, three well-coordinated water molecules (magenta spheres)
replace S2 and superimpose almost perfectly with three oxygens of S2. (B) Extended view of residues coordinating the water molecules including water w1.
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Fig. S4. Complementation assay in S2 cells. (A–C) S2 cells were transfected with the indicated siRNAs plus a mixture of three plasmids: one expressing the FLuc-
Par-6 reporter; another expressing miR-1 primary transcript (black bars) or the corresponding empty vector (gray bar); and a third expressing Renilla luciferase
(RLuc). Plasmids encoding siRNA-resistant versions of wild-type or mutant HA-AGO1 proteins were included in the transfection mixtures, as indicated. HA-MBP
served as a negative control. Firefly luciferase activities were normalized to those of the Renilla luciferase transfection control and set to 100 in cells transfected
with the empty vector (i.e., in the absence of the miR-1). Panel (A) shows normalized Firefly luciferase activities in the absence or presence of miR-1 in control
cells (i.e., cells treated with GFP siRNA and transfected with HA-MBP). Panel (B) shows the relative fold derepression for each condition. Mean values standard
deviations from three independent experiments are shown. (C) Western blot showing that all proteins were expressed at similar levels. (D) Lysates from S2 cells
expressing HA-tagged versions of MBP, wild-type AGO1 or the indicated AGO1 mutants were immunoprecipitated using a monoclonal antiHA antibody and
analyzed as described in Fig. 5 A–C.
Boland et al. www.pnas.org/cgi/doi/10.1073/pnas.1103946108 6 of 8
C-term ins
PIWI
MID
S1
C
R720
W726
α3
α1
α5
α11
α10
α6
Fig. S5. DmAGO1 residues that impair GW182 binding without compromising miRNA binding. Ribbon representation of theNcQDE-2MID-PIWI lobe rotated
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Table S1. Data collection and refinement statistics
Data set MID-PIWI MID-PIWI ΔLOOP
(Crystal form I) (Crystal form II)
Data collection*
Space group P6322 P3221
Unit cell
dimensions (a/b/c), Å 218.9∕218.9∕76.7 63.1∕63.1∕170.5
angles (α/β/γ), ° 90∕90∕120 90∕90∕120
Resolution range, Å 54.7–3.65 54.6–1.85
(3.75–3.65) (1.94–1.85)
Rsym, % 11.0 (53.6) 5.6 (66.5)
Completeness, % 96.1 (97.1) 99.8 (100)
Mean I∕σðIÞ 9.1 (2.2) 15.3 (2.4)
Number of unique reflections 12,017 34,431
Multiplicity 3.2 5.1
Refinement
Data range, Å 54.7–3.65 54.6–1.85
Rcryst, % 23.3 19.6
Rfree, % 25.2 23.6
Number of atoms
per asymmetric unit
all atoms 2,891 3,066
protein 2,880 2,841
ligand/ion 6∕5 6∕5
water 0 225
Average B-factor, Å2
all atoms 99.8 36.8
protein 99.8 36.5
ligand/ion 107.5 48.2
water — 40.0
Ramachandran plot
favored regions, % 97.0 97.5
disallowed regions, % 0.0 0.0
Rmsd from ideal geometry
bond lengths, Å 0.015 0.015
bond angles, ° 1.24 1.45
*Values in parentheses are for highest-resolution shell.
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Table S2. Overview of Dm AGO1 mutants used in this study and equivalent residues in QDE-2
Dm AGO1 Nc QDE-2 equivalent residues Predicted function
Y653L Y595L 5′ binding pocket / guide RNA binding
K657E K599 5′ binding pocket / guide RNA binding
K690A K634 5′ binding pocket / guide RNA binding
K694A K638 5′ binding pocket / guide RNA binding
R937A R895A MID-PIWI interface and 5′ binding pocket
D661ED661K D603 MID-PIWI interface
H941AH941QH941K H899A MID-PIWI interface
E798A, Q800AE798Q, Q800E E749, Q751 target strand binding
ΔL3 (835–886) ΔL3 (787–838) RNA binding, contacts the N-term-PAZ lobe
ΔC-term insertion(942–971) ΔC-term insertion(900–925) predicted to contact the N-term-PAZ lobe
ΔL1 (726–733) ΔL1 (669–681) predicted to contact the N-term-PAZ lobe
ΔL1+His724 (724–733) ΔL1+His667 (667–681) predicted to contact the N-term-PAZ lobe
and the guide-target RNA duplex
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Molecular Cell
Article
Structure of the PAN3 Pseudokinase
Reveals the Basis for Interactions with the
PAN2 Deadenylase and the GW182 Proteins
Mary Christie,1,2 Andreas Boland,1,2 Eric Huntzinger,1 Oliver Weichenrieder,1,* and Elisa Izaurralde1,*
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tu¨bingen, Germany
2These authors contributed equally to this work
*Correspondence: oliver.weichenrieder@tuebingen.mpg.de (O.W.), elisa.izaurralde@tuebingen.mpg.de (E.I.)
http://dx.doi.org/10.1016/j.molcel.2013.07.011
SUMMARY
The PAN2-PAN3 deadenylase complex functions
in general and miRNA-mediated mRNA degradation
and is specifically recruited to miRNA targets by
GW182/TNRC6 proteins. We describe the PAN3
adaptor protein crystal structure that, unexpectedly,
forms intertwined and asymmetric homodimers.
Dimerization is mediated by a coiled coil that links
an N-terminal pseudokinase to a C-terminal knob
domain. The PAN3 pseudokinase binds ATP, and
this function is required for mRNA degradation
in vivo. We further identified conserved surfaces
required for mRNA degradation, including the bind-
ing surface for the PAN2 deadenylase on the knob
domain. The most remarkable structural feature is
the presence of a tryptophan-binding pocket at the
dimer interface, which mediates binding to TNRC6C
in human cells. Together, our data reveal the struc-
tural basis for the interaction of PAN3 with PAN2
and the recruitment of the PAN2-PAN3 complex to
miRNA targets by TNRC6 proteins.
INTRODUCTION
Shortening of mRNA poly(A) tails by deadenylation is a common
mechanism for regulating the translation and stability of mRNAs
(Weill et al., 2012). Deadenylation represses translation and can
initiate irreversible mRNA degradation. Indeed, eukaryotic bulk
mRNA degradation begins with the removal of the mRNA poly(A)
tail; deadenylated mRNAs are then decapped and degraded by
the 50-to-30 exonuclease XRN1. Alternatively, following deadeny-
lation mRNAs can be degraded from the 30 end by the exosome
(Wahle and Winkler, 2013).
Current models suggest that mRNAs are deadenylated by the
consecutive but redundant action of two cytoplasmic deadeny-
lase complexes: PAN2-PAN3 and CCR4-NOT (Tucker et al.,
2001; Yamashita et al., 2005). Poly(A) tails are first trimmed to
approximately 50–110 nt by the distributive activity of the
PAN2-PAN3 complex, after which the shortened mRNA tails
are rapidly degraded by the CCR4-NOT complex (Tucker et al.,
2001; Yamashita et al., 2005). Although the PAN2-PAN3 com-
plex can associate with the CCR4-NOT complex (Zheng et al.,
2008), the molecular details and mechanism for the consecutive
action of these complexes are unclear.
The PAN2-PAN3 and CCR4-NOT complexes commonly
feature catalytically active deadenylases in association with non-
catalytic subunits that are required for efficient deadenylation
in vivo and likely confer additional regulatory functions. However,
the precise role of the noncatalytic subunits in mRNA deadeny-
lation is not completely understood. One possible function is the
stabilization of the catalytic subunits (Wahle and Winkler, 2013).
A second possibility is the recruitment of the catalytic subunits to
specific mRNA targets (Wahle and Winkler, 2013; Weill et al.,
2012). One example is the N-terminal PAM2 motif (PABP-inter-
acting motif 2) of PAN3, which interacts with the cytoplasmic
poly(A) binding protein (PABP) bound to the poly(A) tails of
mRNAs. This interaction enables PAN3 to recruit the PAN2
deadenylase to polyadenylated mRNAs to initiate their deadeny-
lation (Mangus et al., 2004; Siddiqui et al., 2007; Uchida et al.,
2004). Accordingly, PAN2 is inactive in the absence of PAN3,
and the activity of the PAN2-PAN3 complex is stimulated by
PABP (Boeck et al., 1996; Brown et al., 1996; Lowell et al.,
1992; Uchida et al., 2004; Zheng et al., 2008).
In addition to the interaction between PAN3 and PABP, which
plays a role in general mRNA deadenylation, other examples of
RNA-associated proteins that recruit the PAN2-PAN3 complex
to specific mRNA targets to expedite their degradation have
been described. For example, PAN3 cooperates with the Dun1
kinase to regulate the expression of RAD5 mRNA (Hammet
et al., 2002). Furthermore, proteins of the GW182 family (known
as TNRC6A–C in humans), which are required for miRNA-medi-
ated gene silencing in animals, interact directly with PAN3,
thereby recruiting the PAN2-PAN3 complex to miRNA targets
(Braun et al., 2011; Chekulaeva et al., 2011; Fabian et al., 2011).
Despite the importance of deadenylation in posttranscriptional
mRNA regulation, structural information is available for only a
few subunits or domains of the CCR4-NOT complex (Wahle
and Winkler, 2013). However, no structural information has
been obtained for the PAN2-PAN3 complex. To gain better
insight into the molecular mechanism of mRNA deadenylation,
we determined the crystal structures of the folded domains of
the PAN3 protein from Neurospora crassa (Nc) and Drosophila
melanogaster (Dm). The crystal structures reveal that PAN3
homodimerizes through an unexpected coiled coil (CC) that
360 Molecular Cell 51, 360–373, August 8, 2013 ª2013 Elsevier Inc.
connects an N-terminal pseudokinase (PK) domain with a C-ter-
minal knob domain (CK). Remarkably, the PAN3 PK domain has
retained its ATP binding capacity, and this function is required for
mRNA degradation in vivo. We used mutational and functional
studies to identify key features of the Dm and Hs PAN3 protein.
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Figure 1. PAN3 Dimerizes and Interacts
with PAN2
(A) Schematic representation of Hs, Dm, Nc, and
Sc PAN3 showing the positions of the N-term
region and the pseudokinase (PK) and C-term
domains. The N-term contains a PAM2 motif. The
C-term domain contains a coiled coil (CC) and a
conserved C-terminal knob (CK) domain.
(B and C) Interaction between GFP-Dm PAN3
(full-length or fragments) and HA-Dm PAN2 or
PAN3 in S2 cells. GFP-tagged firefly luciferase
(F-Luc) served as a negative control.
(D and E) The interaction of V5-tagged Hs PAN3
(full-length or fragments) with HA-tagged Hs PAN2
and PAN3 proteins in human cells. V5-tagged
maltose binding protein (MBP) served as a nega-
tive control.
(F) MALLS analysis of Dm PAN3 and Nc PAN3
protein fragments. The molecular weights of the
proteins insolutionare indicated.SeealsoTableS1.
These studies revealed the PAN2 binding
surface on PAN3, a W-binding pocket
required for the interaction with TNRC6
proteins and additional conserved sur-
face residues required for mRNA degra-
dation. Collectively, our data provide a
structural foundation for understanding
the role of PAN3 in recruiting PAN2 to
mRNA targets to initiate deadenylation.
RESULTS
PAN3 Dimerizes and Interacts with
PAN2
PAN3 proteins contain three prominent
regions: an unstructured N-terminal re-
gion (N-term), a central PK domain, and
a highly conserved C-terminal domain
(C-term) that is unique to the PAN3
protein family (Figure 1A). While the N-ter-
minal region of PAN3 contains a well-
characterized PAM2 motif (Mangus
et al., 2004; Siddiqui et al., 2007), studies
of the roles of the PK and C-term domains
have primarily been restricted to the
yeast protein. In particular, yeast two-
hybrid assays have demonstrated that a
C-terminal fragment of Saccharomyces
cerevisiae (Sc) PAN3 (560–679) is
required for Sc PAN2 binding, while
both the PK and C-term domains mediate
self-interaction (Mangus et al., 2004).
However, the stoichiometry and significance of PAN3 oligo-
merization are still unknown.
To investigate whether these interactions are also conserved
in Dm and human (Hs) PAN3 proteins, we performed coimmu-
noprecipitation assays using various PAN3 fragments in Dm
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Schneider (S2) and human HEK293 cells. We observed that a
green fluorescent protein (GFP)-taggedDm PAN3 fragment con-
taining the PK and C-term domains (PK+C) displayed the binding
properties of the full-length protein and interacted with HA (influ-
enza hemagglutinin)-tagged Dm PAN2 and PAN3 (Figures 1B
and 1C, lane 8 versus lane 7). Therefore, the PAN3 N-term is
not required for these interactions. Further analyses demon-
strated that the PAN3 C-term domain was sufficient for PAN2
binding (Figure 1B, lane 10), whereas both the PK and C-term
domains were required for PAN3 self-interaction (Figure 1C,
lane 8). Similarly, Hs PAN3 interacted with PAN2 via the
C-term domain, which in isolation exhibited a higher affinity for
PAN2 when compared to the PK+C fragment (Figure 1D, lane
10 versus lane 8). This differential binding was confirmed in
independent experiments (data not shown) and suggests
that the PK domain may negatively regulate the ability of
the C-term domain to bind PAN2. By contrast, Hs PAN3
self-interaction required both the PK and C-term domains (Fig-
ure 1E, lane 8).
To determine the stoichiometry of PAN3 oligomers, we em-
ployed multiangle static laser-light scattering (MALLS) coupled
with size-exclusion chromatography andmeasured the apparent
molecular weight of the protein in solution. We found that the pu-
rifiedDmPAN3PK+C fragmentwas dimeric in solution (Figure 1F
and see Table S1 online; molecular mass of 100 kDa compared
to the expected value of 51 kDa for the monomeric protein). The
corresponding Nc and Hs PAN3 fragments were also dimeric in
solution (Figure 1F and Table S1). By contrast, the isolated Dm
PAN3 PK and C-term domains were monomeric in solution
(Figure 1F and Table S1). Thus, the PK+C fragment mediates
PAN3 homodimerization, and this function is conserved from
yeast to humans.
PAN3 Proteins Have Retained the Ability to Bind ATP
Given the importance of the PK and C-term domains in the
assembly of the PAN2-PAN3 complex, we sought to determine
the structure of a PAN3 fragment encompassing these domains.
We initially expressed the corresponding fragments of the Nc,
Dm, and Hs PAN3 proteins in E. coli. As protein kinases typically
bind adenosine nucleotides (Taylor and Kornev, 2011), we exam-
ined the ATP-binding ability of the PAN3 proteins. Thermal-
shift assays indicated that the Nc, Dm, and Hs PAN3 protein
fragments were stabilized by the addition of ATP in a
Mg2+-dependent manner, while stabilization by AMP and ADP
was independent of Mg2+ (Figure S1A and Table S2). By
contrast, PAN3 proteins were not stabilized by GTP (Table S2).
Consequently, protein crystallization experiments routinely
included nonhydrolyzable ATP analogs and MgCl2 in the protein
solution.
Structure Determination of the Nc and Dm PK
and C-Terminal Domains
Crystals of Nc PAN3 (residues 234–656, wild-type or mutant)
and Dm PAN3 (residues 349–790) were obtained in the
presence of nonhydrolyzable ATP analogs (ATP-g-S and
AMP-PNP for the Nc and Dm proteins, respectively) and
MgCl2. However, no crystals were obtained for the human pro-
tein in diverse conditions. Experimental phases for Nc PAN3
selenomethionine-substituted crystals were obtained using the
single-wavelength anomalous dispersion (SAD) method. The
structure of Nc PAN3 was refined at 3.3 A˚ resolution (Table 1)
and was then used as a molecular replacement model to phase
the structure of Dm PAN3 and mutant Nc PAN3 (Nc PAN3M),
which were refined at 3.6 A˚ and 2.85 A˚ resolution, respectively
(Table 1). The Nc PAN3M protein and other Dm and Hs PAN3
mutants were generated after the refinement of the wild-type
proteins in order to promote alternative crystal packing arrange-
ments (see Table S3 for a description of Nc PAN3M). Higher-
resolution data were obtained only for the Nc PAN3M protein,
although it crystallized in the same crystal form as wild-type
Nc PAN3 (Table 1). Importantly, Nc PAN3M retains the ability
Table 1. Data Collection and Refinement Statistics
Data Set Dm PAN3 Nc PAN3 Nc PAN3M Nc PAN3
(SeMet)
Space group P4322 P65 P65 P65
Unit cell
Dimensions
(a, b, c ) (A˚)
102.2, 102.2,
264.7
89.5, 89.5,
228.8
90.3, 90.3,
230.6
88.6, 88.6,
228.7
Angles
(a , b , g ) ()
90, 90, 90 90, 90,
120
90, 90,
120
90, 90,
120
Data Collectiona
Wavelength 0.99999 1.00001 0.99998 0.97927
Resolution
range (A˚)
49–3.6 46–3.3 46–2.85 46–4.0
Rsym, % 10.8 (89.1) 5.5 (76.8) 7.9 (72.6) 9.5 (78.6)
Completeness, % 99.8 (99.9) 99.9 (99.8) 99.9 (99.7) 99.9 (100)
Mean I/s(I) 14.5 (2.1) 19.9 (3.0) 13.9 (2.2) 11.1 (2.7)
Unique
reflections
17,015
(2,447)
15,611
(2,292)
24,793
(3,621)
8,626
(1,263)
Multiplicity 6.4 (6.6) 7.9 (7.7) 4.4 (4.4) 7.8 (7.6)
Refinement
Rcryst, % 22.0 25.2 21.1
Rfree, % 26.9 29.4 24.2
Number of atoms
All atoms 6,125 6,407 6,524
Protein 6,071 6,345 6,460
Ligand 54 62 62/2
Average B factor (A˚2)
All atoms 136 119 89
Protein 136 119 89
Ligand 119 85 102/87
Ramachandran plot
Favored
regions, %
96.1 96.6 96.4
Disallowed
regions, %
0.0 0.1 0.1
Rmsd from ideal geometry
Bond lengths (A˚) 0.010 0.008 0.010
Bond angles () 1.47 1.52 1.40
aValues in parentheses are for highest-resolution shell.
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to bind ATP and has similar melting temperatures compared to
the wild-type protein (Table S4).
The Nc and Dm PAN3 crystals contain one homodimer per
asymmetric unit (Figure 2). Most residueswere visible in the elec-
tron density, with the exception of two surface loops in both the
Nc andDm structures (Nc PAN3 residues 368–377 and 558–567,
Dm PAN3 residues 488–513 in both monomers, and 700–710 in
monomer B) and an N-terminal extension in the Dm PK domain
(residues 349–378; aN and L1, see below, Figure 3A). Further-
more, clear density for ATP-g-S was visible in the Nc PAN3
structures (Figure 3D). In the Dm PAN3 crystals, clear density
for AMP-PN was observed (Figure S2A), suggesting that the
g-phosphate of the AMP-PNP analog was hydrolyzed, most
likely due to the length of time (1 week) required for the Dm
PAN3 crystals to grow.
PAN3 Forms Intertwined Dimers
PAN3 forms dimers in solution and in the crystal environment
(Figures 1F and 2). Each PAN3 monomer consists of three struc-
tural domains: the PK domain at the base of the assembly, a
C-terminal knob (CK) domain, and a long central a-helix (a1)
that connects these two globular domains (Figures 2A and 2B).
The interactions responsible for dimerization are predominantly
foundwithin the longcentrala1helix,which interactswith thecor-
responding central a1 helix of the second monomer to form an
asymmetric left-handed parallel coiled coil (Figure 2). The asym-
metry is caused by a kink in only one chain of the PAN3 dimer
(Figure 2 and Figure S3). As a result of the dimerization via the
intertwined coiled coil, the CK domain of monomer A is posi-
tioned close to the PKdomain ofmonomerB (Figures 2A and 2B).
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Figure 2. The Structure of PAN3 Homo-
dimers
(A) Cartoon representation of the overall structure
of the Dm PAN3 dimer. Chains A and B are shown
in blue andmagenta, respectively. The positions of
the nucleotide binding sites are marked by AMP-
PN shown in stick representation. Secondary
structure elements are indicated. The two views
are related by a rotation of 90 around the hori-
zontal axis.
(B) Structure ofNc PAN3M in the same orientations
as in (A). Chains A and B are shown in gray and
cyan, respectively. The positions of the nucleotide
binding sites are marked by ATP-g-S shown in
stick representation. See also Figures S1–S3 and
Table S2.
Comparison of the wild-type Nc and
Dm PAN3 structures indicates that the
homodimers superpose well with RMSD
values of 1.87 A˚ for monomer A and
2.94 A˚ for monomer B (Figure 2 and Fig-
ure S2D). The kink angle of the a1 helix
is smaller in the Nc PAN3 protein (ca.
17) compared to Dm PAN3 (ca. 22), ex-
plaining the higher rmsd values obtained
for the superposition of the B monomers
(Figure S3). Comparison of the wild-type
and mutant Nc PAN3 structures reveals high structural similarity
(Figure S2E, rmsd values of 0.85 A˚ and 1.0 A˚ for monomers A and
B, respectively).
One clear difference between the Dm and Nc PAN3 structures
is the presence of an additional N-terminal helix preceding the
Nc PK domain (helix aN, Figure 2A versus Figure 2B), which is
arranged almost perpendicular to the central coiled-coil helices.
Secondary structure prediction identified an analogous helix in
the Dm PAN3 and Hs PAN3 sequences, although this region is
less conserved among orthologs (Figure 3A). The similarity
between the Nc and Dm PAN3 structures, together with the
conservation of critical structural residues, indicates that the
fold observed in these structures is likely to be common to all
PAN3 family proteins.
The PAN3 Pseudokinase Domain Adopts a Divergent
Kinase Fold
The PK domain of PAN3 exhibits the canonical bilobal protein
kinase fold, with a smaller N-terminal lobe (N-lobe) and a larger
C-terminal lobe (C-lobe) (Figures 3A and 3B). The N-lobe (Dm
residues 383–479 and Nc residues 263–359) comprises a five-
stranded antiparallel b sheet (b1–b5) and a flanking a helix (helix
aC) (Figures 3A and 3B). The C-lobe (Dm residues 480–655 and
Nc residues 360–514) is composed predominantly of a helices
(Figures 3A and 3B, denoted as aD–aI). Despite retaining the
general structural characteristics of protein kinases, analysis of
PAN3 amino acid sequences demonstrates that the PK domain
has substitutions in all the conserved motifs that are critical for
kinase activity, such as in the catalytic VAIK and HRD motifs
and in the Mg2+ binding DFG motif (Figure 3A).
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A B
C D
Figure 3. The PAN3 Pseudokinase Domain Binds ATP
(A) Structure-based sequence alignment of PAN3 orthologs and human WNK1. Secondary structure elements as determined from the Nc and Dm PAN3
structures are shown above the alignment. Conserved kinase motifs are shown below the WNK1 sequence and are as described for the canonical PKA kinase
(Taylor and Kornev, 2011). Residues conserved in all aligned sequences are shown with a purple background, and residues with >70% similarity are in red. Nc
PAN3M residues that form hydrogen bonds with the ATP-g-S molecule are shown in green background, and residues that line the W-binding pocket have a
magenta background. Residues mutated in the M7, M8, M9, andM10mutants are marked by asterisks. Residues that line the nucleotide-binding pocket that are
substituted in the M3 mutant are marked by red squares. The species abbreviations are as follows: Dm (Drosophila melanogaster), Hs (Homo sapiens), Ce
(Caenorhabditis elegans), Nc (Neurospora crassa), and Sc (Sacchromyces cerevisiae).
(B) Cartoon representation of Nc PAN3M PK domain with bound ATP-g-S and Mg2+ in the nucleotide-binding pocket (shown in stick and sphere representation,
respectively).
(C) Superimposition of WNK1 kinase domain (gray) onto the PK domain of Nc PAN3M (cyan). WNK1 catalytic, activation, and glycine-rich loops are highlighted in
orange, red, and yellow, respectively.
(D) Close-up view of theNc PAN3M nucleotide binding site, with the simulated annealing Fo Fc omit map contoured at 3s shown in graymesh. The ATP-g-S and
Mg2+ molecules are overlaid, shown in stick and sphere representation, respectively. See also Figures S1 and S2 and Tables S1, S2, and S4.
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Structural superposition ofNc and Dm PAN3 PK domains with
all structures deposited into the Protein Data Bank (PDB) using
the DALI server indicates that theWNK1 (with no Lys [K] 1) kinase
is most similar in structure to the PAN3 PK domain (lowest Z
score of 21.6 and 21.2 for Dm PAN3 and Nc PAN3, respectively;
Figures 3A and 3C). As observed in the structure ofWNK1 kinase
(Min et al., 2004), the structure of PAN3N-lobe exhibits an almost
closed b-barrel appearance due to extensions at the N terminus
(L1) and the loop L6 (Figures 3A and 3B).
The most striking structural difference between the PAN3 PK
domain and canonical kinases is the lack of the activation
loop, which normally bridges the DFG motif and the APE motif
(Figures 3A and 3C). The conformation of this loop is typically
regulated by phosphorylation and provides a platform for pep-
tide substrates to bind and access the catalytic site of the kinase
(Huse and Kuriyan, 2002; Taylor and Kornev, 2011). Sequence
comparison shows that the activation loop and the APE motif
are missing in all PAN3 orthologs (Figure 3A).
Furthermore, the substrate-binding groove, typically located
between the aDand aGhelices of canonical kinases, is disrupted
in PAN3. This is due to a shift of the aG helix to a position closer
to the N terminus of the aH helix (Figures 3B and 3C), a confor-
mational change that likely results from a deletion in the L14
loop (Figure 3A), as observed in most PAN3 protein sequences.
The positioning of the aC helix is critical for the catalytic activ-
ity of protein kinases, and in the active state it adopts a closed
conformation (Huse and Kuriyan, 2002; Taylor and Kornev,
2011). In PAN3, the aC helix is displaced away from the N-lobe
of the protein. This conformation is reminiscent of the open
conformation of kinase domain structures in the inactive state
(Huse and Kuriyan, 2002; Taylor and Kornev, 2011). Lastly, the
central aF helix of PAN3 is notably longer than that of typical
kinase domains (Figures 3A–3C). Given these differences from
the structure of canonical kinases, it is highly unlikely that
PAN3 is an active kinase or participates in protein phosphoryla-
tion in a canonical manner.
The PAN3 Nucleotide-Binding Site
It is remarkable that the PAN3 PK domain binds ATP despite
adopting a divergent kinase fold and lacking several key catalytic
residues (Figure 3A and Table S2). Similar to other kinases, the
ATP-binding site is located in the cleft between the N- and
C-lobes of the kinase fold (Figure 3B). However, the ATP-binding
pocket is wider than that of typical kinases, allowing the nucleo-
tide to bind in a position that would clash with the L7 loop in
canonical kinases (Figure 3D). Due to the higher resolution of
the Nc PAN3M structure, which has no substitutions within the
nucleotide-binding site (Table S3), we focus our discussion of
the PAN3 ATP-binding mode for the Nc protein.
In catalytically active kinases, the invariant Lys residue in
the VAIK motif coordinates the a- and b-phosphate groups of
the ATP molecule to position the nucleotide correctly within the
active site for catalysis (Huse and Kuriyan, 2002; Taylor and Kor-
nev, 2011). This interaction is further stabilized by an ionic inter-
action between the Lys residue and a highly conserved Glu in the
aC helix of protein kinases in the active conformation (Huse and
Kuriyan, 2002; Taylor and Kornev, 2011). In PAN3, the conserved
Glu and Lys residues have been substituted with a hydrophobic
residue and Arg, respectively (Figure 3A). Nonetheless, R302 in
Nc PAN3 interacts with the a-phosphate of ATP-g-S in a manner
similar to the analogous Lys100Arg substitution in the VAIKmotif
of the STRADa PK (Figure 3D; Zeqiraj et al., 2009). The ATP bind-
ing scaffold is further degraded by substitutions in the Gly-rich
loop (Figures 3A and 3C), which is typically responsible for inter-
acting with the phosphate moieties of adenosine nucleotides.
Simulated annealing omit maps for Nc PAN3M with the nucle-
otide and Mg2+ coordinates removed reveal clear difference
density within the ATP-binding pocket (Figure 3D) that can be
well described by a Mg2+-coordinated ATP-g-S molecule. In
this model, an Asp residue (D271) adjacent to the Gly rich loop
is positioned close to the Mg2+ ion, potentially replacing the
substitutedMg2+ binding residues of the DFGmotif and catalytic
loop (Figure 3D and Figures S2B and S2C). Thus, the PAN3 PK
domains appear to have adopted a noncanonical mechanism
for binding adenosine nucleotides.
To test whether it is possible to generate a soluble Dm
PAN3 dimer that does not bind ATP for functional studies, we
substituted two hydrophobic residues that line the ATP-binding
pocket (C421 and I555 in Dm PAN3, Figure S2A) with Phe resi-
dues. These mutations did not affect dimerization (Table S1).
Thermal shift assays performed in the presence and absence
of nucleotide and Mg2+ indicated that the apparent melting
temperature of the double C421F,I555F mutant did not change
(Figure S1B and Table S4), suggesting that themutations abolish
nucleotide binding.
We next tested whether Dm PAN3 has also retained the
ability to hydrolyze ATP in vitro. No intrinsic ATPase activity
was observed for the Dm PK+C fragment or the I555F and
C421F,I555F mutants (which were used as negative controls),
even after prolonged incubation (20 hr, Figure S4A). Under the
same conditions, calf intestinal alkaline phosphatase exhibited
robust ATPase activity, although its concentration was 3,000-
fold lower.
The PAN3 Central Coiled Coil Mediates Dimerization
Although it is known that PAN3 oligomerizes via the PK+C-term
domains (Figure 1 and Mangus et al., 2004), based on sequence
alone it was difficult to predict that the self-interaction would be
mediated via a coiled coil. Coil-forming helices are characterized
by a seven-residue (heptad) repeat. The residues within a heptad
repeat are typically denoted (a-b-c-d-e-f-g) with apolar ‘‘a’’ and
‘‘d’’ core residues located at the helical interface. The asymmetry
of the PAN3 coiled coil is most likely due to the presence of highly
conserved Glu and Gly residues at the ‘‘d’’ and ‘‘a’’ positions of
the third and fourth heptad repeats, respectively, which disrupt
the periodicity of the coiled coil (Figures 4A and 4B).
The interface between themonomers is extensive and buries a
total surface area of2,800 and3,300 A˚2 forDm andNc PAN3,
respectively. The interactions extend beyond the hydrophobic
coiled-coil interface and include salt bridges, hydrogen bonds,
and hydrophobic interactions between residues of the central
a helix and the PK domain (Figure S2F). Additional hydrophobic
interactions are also observed between the central a helix and
the CK domain of the protein.
To test whether PAN3 dimerizes in vivo in a manner similar
to that observed in the crystal structure, we introduced acidic
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residues at the ‘‘a’’ and ‘‘d’’ positions of the coiled coil and
performed coimmunoprecipitation assays. The substitutions
were introduced in the context of full-length Dm and Hs PAN3
proteins. Specifically, we generated a triple mutant (M1) and a
double mutant (M2) (Figure 4B and Table S3). These mutations
were sufficient to disrupt Dm PAN3 homodimerization in vitro
A C
B
D E
Figure 4. The Coiled-Coil Domain Mediates Homodimerization
(A) Cartoon representations of the coiled-coil domain of Dm PAN3. Residues corresponding to the ‘‘a’’ and ‘‘d’’ positions of the coiled-coil heptad repeat are
indicated.
(B) Sequence alignment of the PAN3 C-term domain. Coiled-coil heptad residues identified in theDm PAN3 structure corresponding to the ‘‘a’’ and ‘‘d’’ positions
are indicated. The ‘‘a’’ and ‘‘d’’ heptad positions that cause the helical kink are boxed. Potential ‘‘a’’ and ‘‘d’’ heptad positions C-terminal to the kink are shown in
gray italics. Residue W707 is indicated by an arrow. Symbols are as described in Figure 3A.
(C) Cartoon representation of the Dm PAN3 CK domain shown in two orientations.
(D and E) The interaction of GFP-PAN3 (wild-type or mutants) with HA-PAN3 was analyzed by coimmunoprecipitation in Dm S2 and human HEK293 cells
as described in Figure 1, except that GFP-Hs PAN3 was used. GFP-MPB served as negative control in human cells. See also Figures S2 and S4 and Tables S1,
S3, and S4.
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and in cells (Figure 4D, lanes 9 and 10) without affecting the pro-
tein fold as indicated byMALLS analysis and thermal shift assays
(Tables S1 and S4). The analogous mutations also impaired the
ability of Hs PAN3 to self-interact in vivo (Figure 4E, lanes 9
and 10). Although the Hs PAN3 M1 mutant was monomeric in
solution (Table S1),MALLS analysis indicated that theM2mutant
was in part monomeric and in part dimeric, suggesting that this
mutation is not sufficient to completely abolish dimerization of
the human protein (Table S1). Importantly, the integrity of the
ATP-binding pocket was not required for Dm or Hs PAN3 dimer
formation (Mutant M3, Figures 4D and 4E, lanes 12; and Tables
S1 and S3).
Structure of the C-Terminal Knob Domain
Despite sequence conservation, the architecture of the PAN2-
binding domain of PAN3 has remained enigmatic due to the
lack of sequence homology with known structural folds deter-
mined to date. The structures presented in this study now reveal
that the PAN2 binding domain of PAN3 can be divided into the
coiled-coil and the CK domains. The CK domain adopts a
compact conformation comprised of three a helices (a2, a3,
and a4) connected by loop L17 and a b-hairpin inserted between
a helices a3 and a4 (Figures 4B and 4C). We compared the Dm
CK domain with the structures deposited in the PDB using the
DALI server. Some helix-turn-helix (HTH) domains have remote
similarity to the CK domain (Figure S4B). However, the highest
Z score was 3.3, suggesting that the PAN3 CK domain adopts
a rather unique protein fold.
Identification of the PAN2-Binding Interface
PAN2 interacts with the PAN3 C-term fragment, which remains
monomeric in solution (Figure 1F), indicating that PAN2 binding
does not require PAN3 dimerization. Accordingly, we observed
that none of the aforementioned dimerization mutants (M1 and
M2, Table S3) disrupted PAN3 interaction with PAN2 in either
Dm or human cells (Figures S4C and S4D).
Although PAN2 binding to PAN3 does not require the PK
domain, we wondered if nucleotide binding could modulate
this interaction. We observed that the mutations of the ATP-
binding pocket alone (mutant M3) or combined with the M2
dimerization mutations (mutant M2+M3) did not affect PAN3-
PAN2 interaction in Dm S2 cells (Figure S4C and Table S3).
Together these results confirm that dimerization and nucleotide
binding are not required for PAN3 to interact with PAN2.
Next, we analyzed the surface conservation of the C-term
domain to identify surface-exposed residues that could mediate
the PAN2-PAN3 interaction (Figure 5A). This analysis identified a
number of highly conserved exposed residues clustered on the
surface of the Dm PAN3 CK domain (Figure 5A). The potential
role of these residues in PAN2 binding was tested by mutagen-
esis (Mutants M13–M16; Figures 4B, 5A, and 5B and Table S3).
The residues substituted in the M13, M14, and M16 mutants
are clustered on the surface of the CK domain and represent
the most conserved region of the whole PAN3 dimer structure
(Figures 5A and 5B). These mutations were generated in the
full-length protein and were combined with the M2 (Dm) or M1
(Hs) mutations to prevent dimerization with the endogenous
wild-type protein, which could confound the interpretation of
the results. We observed that when combined with M1, the
M13, M15, and M16 mutations strongly reduced or abolished
PAN2 binding in human cells (Figure 5C). By contrast, PAN2
binding was reduced only when mutations M15+M16 and
M14+M15+M16 were combined with M2 in Dm cells (mutants
M17 and M18, respectively; Figure 5D and Table S4), whereas
the isolated M13, M14, M15, andM16mutations (in combination
with M2) were ineffectual in inhibiting binding (Figure S4E).
Collectively, these results identify the binding surface of PAN2
on the PAN3 CK domain.
The PAN3 Dimerization Interface Harbors a W-Binding
Pocket
Unexpectedly, crystal-packing interactions within the Dm PAN3
lattice revealed the presence of a W-binding pocket at the base
of the coiled coil (Figures 6A and 6B). This hydrophobic pocket
lies in a special position on the pseudo-two-fold axis of the coiled
coil that relates two PAN3 monomers (Figures 6A–6C). There-
fore, the pocket is lined by residues M651, P652, G655, and
F658 frommonomer A and their symmetry mates frommonomer
B (Figures 3A and 4B). The pocket accommodates the exposed
W707 (loop L16) from monomer A of a neighboring molecule in
the crystal, such that the indole ring deeply stacks between
two symmetry-related proline residues (P652) located at the
base of the coiled-coil domain (Figures 6B).
Notably, W707 is flanked by T706 and S708. T/SW motifs are
frequently found in the silencing domains (SDs) of TNRC6 pro-
teins and have previously been shown to contribute to PAN3
binding (Chekulaeva et al., 2011; Huntzinger et al., 2013). We
therefore reasoned that the observed interaction might mimic a
bona fide interaction between PAN3 and TNRC6 proteins.
Consistent with this hypothesis, the pocket-forming residues
are conserved in higher eukaryotes where TNRC6 orthologs
have been identified (Figure 3A). By contrast, the pocket is
absent in the Nc PAN3 structure and appears to be absent in
most fungi, which lack GW182 orthologs.
Importantly, the polypeptide chain around W707 is ordered
only in the Dm PAN3 monomer that interacts with the pocket,
demonstrating a disorder-to-order transition upon binding
similar to that observed for disordered short-linear motifs
(Tompa, 2012). A similar mode of binding is expected for
TNRC6-derived T/SW peptides binding to the PAN3 surface.
Notably, the backbone between T706 and D712 is clearly
defined in the Dm PAN3 density, with the bulky side chain of
W707 acting as a sequence anchor and defining the register.
Although the low resolution of theDmPAN3 structure does not
allow the detailed analysis of hydrogen bonds, it is clear that the
ordered flanks ofW707 form additional contacts with the surface
of the PAN3 dimers (Figure 6C). We therefore assume that the
flanking T/S residues with their general capacity to stabilize
induced loop conformations and to form intermolecular con-
tacts are of additional importance in this context. Notably, we
observed that alanine substitution of Trp residues in the M2
region of the TNRC6C-SD, which are mostly flanked by T/S res-
idues, abolished PAN3 binding in human cells (Figure 6D and
Figure S5A). By contrast, substitutions in the CCR4-interacting
motifs 1 and 2 (CIM-1 and CIM-2) did not prevent PAN3 binding
(Figure 6D, Figure S5A, and Table S3). Thus, the W-containing
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motifs in the M2 region of TNRC6C provide a major contribution
to PAN3 binding.
To investigate if the W-binding pocket is indeed relevant for
TNRC6 binding, we substituted Hs PAN3 M546 (Dm PAN3
M651) with Phe to fill the cavity with a bulky side chain and
P547 (Dm PAN3 P652) with Gly to prevent stacking interactions
(mutant M7, Figures 3A and 5B, and Table S3). Remarkably,
these mutations strongly reduced Hs PAN3 interaction with the
TNRC6C-SD in vivo and in vitro (6C-SD, Figures 6E and 6F). Sin-
gle M546F and M546H substitutions also reduced binding of the
TNRC6C-SD in vitro in GST pull-down assays (Figure S5B).
PAN3 dimerization and binding to PAN2 were not affected by
the M7 mutation (Figures 4D and 4E, lanes 11; and Figures
S4C and S4D), indicating that the M7 mutant is properly folded.
Furthermore, MALLS analysis and thermal shift assays indicate
that the Hs PAN3 M7 mutant behaves as a well-folded dimer
that is capable of binding ATP in vitro (Tables S1 and S4).
Because the W-binding pocket forms at the dimer interface,
we expected that the PAN3 dimerization mutants would also
affect TNRC6C binding, in a manner similar to that of the M7
mutant. Consistent with this expectation, the dimerization mu-
tants (M1 and M2) were strongly impaired in TNRC6C-SD bind-
ing (Figure 6E). Importantly, the Hs PAN3 M7 mutation also
reduced the interaction with the silencing domain of TNRC6B
(Figure 6G). Similar results were obtained when single or double
mutants of the Dm PAN3 protein were tested for binding to
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Figure 5. The PAN2 Binding Surface
(A) Surface representation of Dm PAN3 colored by sequence conservation on monomer A (monomer B is shown in transparent gray surface representation).
(B) Surface representation of Dm PAN3, shown in the same orientations as in (A), with mutated residues introduced in this study highlighted. Only mutated
residues of monomer A are shown. Mutations in the PK and C-term domains are shown in red and orange, respectively.
(C andD) The interaction of GFP-PAN3 (wild-type ormutants) with HA-PAN2was analyzed inDm and human cells as described in Figure 1. See also Figure S4 and
Table S3.
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TNRC6B-SD in vitro (Figure S5C). This interaction was tested
because TNRC6 proteins complement silencing in Dm cells
(Huntzinger et al., 2013). We conclude that theW-binding pocket
represents a major binding site for TNRC6B and TNRC6C on the
PAN3 protein.
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Figure 6. AW-Binding Pocket at theDimeric
Dm PAN3 Interface Is Required for Binding
to TNRC6 Proteins
(A) Surface representation of Dm PAN3 homo-
dimer. The binding pocket at the base of the
molecule formed by the symmetric proline resi-
dues is highlighted in yellow, and monomer A of a
symmetry-related Dm PAN3 homodimer is shown
in red.
(B) Close-up view of the W-binding pocket. The
Dm PAN3 homodimer is shown as a transparent
surface with cartoon representation underneath. A
loop harboring T706-W707-S708 frommonomer A
of a symmetry-related Dm PAN3 homodimer is
shown as cartoon and stick representation
(colored in red).
(C) Final 2Fo Fc density for the W-binding pocket
and for the L16 loop is shown as a gray mesh and
contoured at 1s. The Dm PAN3 homodimer is
shown as yellow sticks, and the L16 loop of a
symmetry mate is colored in red. For clarity, some
side chains and residues have been omitted.
(D) Interaction between GFP-TNRC6C-SD (6C-
SD, wild-type, or mutant) and HA-Hs PAN3.
(E) Interaction of GFP-Hs PAN3 (wild-type or
mutant) with the silencing domain of TNRC6C.
(F and G) GST pull-downs using recombinant
MBP-Hs PAN3 (wild-type or M7 mutant) and
GST-6C-SD (F) or GST-6B-SD (G). MBP served
as a negative control. See also Figure S5 and
Table S3.
PAN2 Binding and the Integrity of
the Nucleotide Binding Pocket Are
Required for mRNA Degradation
To evaluate the relevance of PAN3
dimerization, nucleotide binding, and
PAN2 interaction in mRNA degradation,
we compared the activity of Dm PAN3
mutants with the wild-type protein using
a well-established mRNA degradation
assay in Dm S2 cells. This assay involves
the expression of a lN-HA-fusion of
PAN3 that binds with high affinity to
five consecutive BoxB sites (5BoxB) in
the 30UTR of a firefly luciferase (F-Luc)
reporter mRNA (Braun et al., 2011).
Tethered Dm PAN3 reduced steady-
state mRNA levels; this activity was only
slightly affected by mutations that disrupt
dimerization (M1,M2, Figures 7A and 7B).
To determine whether the reduction on
mRNA levels was due to mRNA destabili-
zation, we measured mRNA half-lives.
In control cells, the half-life of F-Luc-
5BoxB mRNA was 153 ± 8 min (Figure 7C). Expression of
wild-type PAN3 or the M2 dimerization mutant accelerated the
degradation of the mRNA reporter, resulting in shorter mRNA
half-lives (20 ± 4 min and 32 ± 7 min, respectively; Figures 7D
and 7E).
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Figure 7. The Integrity of the Nucleotide Binding Site and PAN2 Binding Are Required for mRNA Degradation
The decay of the F-Luc-5BoxBmRNA reporter was monitored at steady state and following transcription inhibition by actinomycin D in control cells (expressing
the lN-HA peptide) and in cells expressing PAN3 (either wild-type or the indicated mutants).
(A, I, and M) Northern blot analysis of representative RNA samples at steady state.
(B, J, and N) The levels of the F-Luc-5BoxBmRNAwere normalized to that of the transfection control (R-LucmRNA). The values were set at 100% in control cells
expressing the lN-HA peptide. Bars represent mean values, and error bars represent standard deviations from at least three independent experiments.
(C, D, E, F, G, and L) The panels show northern blot analysis of representative RNA samples. The levels of F-Luc-5BoxBmRNA were normalized to the levels of
long-lived rp49mRNA andwere plotted against time. ThemRNA half-lives (t1/2) ± standard deviations calculated from the decay curves (data not shown) obtained
from three independent experiments are indicated below the panels.
(H, K, and O) Western blots showing comparable expression of Dm PAN3 wild-type and mutants. See also Figure S6 and Table S3.
Molecular Cell
PAN3 Homodimers Harbor a W-Binding Pocket
370 Molecular Cell 51, 360–373, August 8, 2013 ª2013 Elsevier Inc.
Remarkably, mutations that disrupt the nucleotide-binding
pocket (M3) impaired Dm PAN3 activity in tethering assays,
resulting in an mRNA half-life of 63 ± 10 min (Figures 7A, 7B,
and 7F). The activity of the M3 mutant was further decreased
when it was combined with mutations that prevent dimerization
(M2+3; Figures 7A and 7B), resulting in an mRNA half-life (141 ±
13 min) comparable to that observed in the absence of PAN3
(Figure 7G versus Figure 7C). All proteins were expressed at
comparable levels (Figure 7H). These results indicate that the
integrity of the nucleotide-binding pocket is required for PAN3-
mediated mRNA degradation.
Importantly, the mutations that impair PAN2 binding (M17 and
M18) also abolished PAN3 activity in this assay (Figures 7I and
7J), although the mutants were expressed at levels comparable
to those of wild-type PAN3 (Figure 7K). For example, in cells
expressing the M18 mutant, the half-life of the F-Luc-5BoxB
mRNA (148 ± 9 min) was similar to that observed in control cells
(Figure 7L versus Figure 7C). This result further demonstrates
that the degradation of the mRNA reporter is mediated by the
PAN2-PAN3 complex.
The impact of mutations in the nucleotide-binding pocket on
PAN3 activity was surprising because thismutation did not affect
PAN2 binding (Figure S4C, lane 12). These results suggest that
although the PK domain does not contribute to PAN2 binding,
it may exert a regulatory function. To identify additional residues
in the PK domain that could potentially regulate mRNA degrada-
tion, we analyzed the surface conservation of the domain and
identified a number of conserved surface-exposed residues (Fig-
ure 5A). The potential role of these residues in mRNA degrada-
tion was tested by mutagenesis. In particular, we deleted the
surface loop L6, which connects strands b4 and b5 within the
N-lobe of the PK domain (mutant M8; Figures 3A and 5B and
Table S3). We also introduced charge reversal mutations of
highly conserved residues (mutant M9 and M10). These muta-
tions are clustered on one side of the PK domain and were com-
bined with M2 to abrogate the contribution of the endogenous
wild-type protein.
Remarkably, deletion of the conserved surface loop L6 in the
PK domain (M8) abolished Dm PAN3 activity in tethering assays.
By contrast, the M9 andM10mutations were ineffectual (Figures
7M and 7N). The mutant proteins were expressed at levels com-
parable to wild-type (Figure 7O). Because the M8 deletion does
not affect PAN2 binding (Figure S4F), these results suggest that
mRNA degradation by the PAN2-PAN3 complex requires
conformational rearrangements or the interaction with additional
partners that are not possible with the M8 deletion. Importantly,
neither PAN3 nor the mutants affected the expression of a F-Luc
reporter lacking the BoxB elements (Figure S6), indicating that
PAN3 must bind to the mRNA reporter in order to promote its
degradation.
DISCUSSION
Although PAN2 provides the catalytic activity for deadenylation,
PAN3 is key in orchestrating the interactions that recruit PAN2 to
mRNA targets. This is achieved through interactions with PABP
and GW182/TNRC6 proteins in general and miRNA-mediated
mRNA degradation, respectively (Mangus et al., 2004; Siddiqui
et al., 2007; Uchida et al., 2004; Braun et al., 2011; Chekulaeva
et al., 2011; Fabian et al., 2011; Huntzinger et al., 2013). Through
a combined structural and functional analysis, we identified crit-
ical residues that mediate PAN3 interaction with PAN2 and
TNRC6 proteins. Our study provides a detailed molecular model
for the assembly of the PAN2-PAN3 complex that significantly
improves our understanding of PAN2-PAN3-mediated mRNA
degradation.
PAN3 Dimerizes through an Asymmetric Coiled Coil
Our data demonstrate that PAN3 homodimerizes via an asym-
metric coiled coil that connects the PAN3 PK and CK domains.
The strict conservation of the Glu-Gly pair at the ‘‘d’’ and ‘‘a’’
positions of the third and fourth heptad repeat, respectively, in
the PAN3 coiled coil together with the presence of the asym-
metric coiled-coil conformation in both Nc and Dm PAN3 pro-
teins and in two different crystal-packing environments indicates
that asymmetric dimerization is likely a conserved feature of
PAN3 proteins. Although dimerization is not required for PAN2
binding, it is clearly required to generate the W-binding pocket
and thus for the recruitment of PAN2-PAN3 to miRNA targets.
It is possible that other protein partners similarly use this pocket
to recruit the PAN2-PAN3 complex to their targets or to regulate
its activity.
Molecular Insights into the PAN2-PAN3 Interaction
PAN2 recruitment to mRNA targets is dependent on its interac-
tion with PAN3. Characterization of this interaction is therefore
essential in understanding PAN2-PAN3 function. We have
demonstrated that the C-term domain of PAN3 mediates PAN2
binding in Dm and human cells (Figure 1) and identified sol-
vent-exposed residues on the PAN3CK domain that are required
for this interaction (Figure 5). These results, together with the
observation that PAN3 homodimerization is not required for
PAN2 binding, suggest that each PAN3 monomer has a PAN2
interaction surface. However, whether it is sterically possible
for two PAN2 proteins to interact simultaneously with a PAN3
dimer remains to be determined.
The W-Binding Pocket Provides a Binding Site
for TNRC6 Proteins
GW182 family proteins are characterized by their richness in
tryptophan residues, which are usually located in a sequence
environment of predicted structural disorder. These W-contain-
ing motifs are frequently flanked either by glycine (termed GW
motifs) or by serines/threonines (termed S/TW motifs), and the
Trp residues in these sequence contexts have been shown to
mediate the interactions of GW182 proteins with a number of
protein partners via cumulative avidity effects (Fabian et al.,
2011; Chekulaeva et al., 2011; Huntzinger et al., 2013).
In molecular terms, it has been speculated that the Trp resi-
dues are accommodated in hydrophobic pockets of the protein
partners and that several such pockets and their spatial arrange-
ment could confer increased affinity and specificity. This hypoth-
esis has been confirmed by the crystal structure of human
Argonaute2 (AGO2), which revealed tandem W-binding pockets
occupied by free tryptophan that was included in the crystal-
lization condition (Schirle and MacRae, 2012). However, this
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structure could not address the important question of the degree
to which the flanking sequences might play a role because the
tryptophans were not in the context of a polypeptide.
The present structure reveals that sequences flanking trypto-
phan residues become ordered upon binding and can contribute
to the interaction. Serine and threonine residues are particularly
suited for such additional interactions, either forming direct con-
tacts to the binding partners or stabilizing the induced conforma-
tion of the peptide backbone by internal hydrogen bonds. By
contrast, flanking glycines may provide additional conforma-
tional freedom for the peptide backbone to explore surfaces of
the binding partners.
Increasing evidence indicates that tryptophans can contribute
to the molecular recognition of intrinsically disordered peptides
in different ways. One example is the PAM2 motif of TNRC6/
GW182 proteins, which binds to the C-terminal domain of
PABPC and contains an additional tryptophan that adds signifi-
cant binding energy (Jinek et al., 2010; Kozlov et al., 2010). How-
ever, this tryptophan is not recognized specifically, although one
face of its indole ring contacts the shallow surface of PABPC. Its
contribution is primarily indirect, stabilizing the bound peptide
internally. By contrast, PAN3 and AGO2 rely on a different mech-
anism to interact with W-containing sequences. This interaction,
unlike that of the TNRC6/GW182 PAM2 motif, is predominantly
mediated by the Trp side chain that is directly and specifically
buried within deep binding pockets, potentially assisted by
flanking backbone residues to variable degrees. In the case of
PAN3 it is even possible that PAN3 dimers are prone to regulated
conformational flexibility. This is suggested by the presence of
ATP-binding domains, as well as its asymmetric structure, which
is presumably switching conformations between monomers A
and B at a certain rate. This opens the exciting possibility of a
regulated rather than constitutive recruitment of the PAN2-
PAN3 deadenylase complex by GW182/TNRC6 proteins.
The Integrity of the PAN3 Nucleotide-Binding Pocket
Is Required for mRNA Degradation
The PAN3 structures determined in this study represent one of
the most conformationally divergent kinase folds determined to
date. Surprisingly, PAN3 proteins are capable of binding ATP
in a Mg2+-dependent manner utilizing noncanonical residues
for the interaction (Figures 3D and Figures S2B and S2C).
Furthermore, mutations that prevent ATP binding impair degra-
dation of an mRNA reporter in vivo (Figure 7). These results
reveal an unexpected role for the integrity of the nucleotide-bind-
ing pocket in mRNA degradation. An open question is whether
nucleotide binding induces conformational changes that are
used to regulate deadenylation or eventually couple deadenyla-
tion to the energetic state of the cell, as suggested by studies
linking glucose homeostasis and mRNA half-lives (Munchel
et al., 2011).
In conclusion, the structural and functional insights into PAN3-
PAN2 and PAN3-TNRC6 interactions, the identification of a
conserved surface in the PK domain required for mRNA degra-
dation, and the finding that nucleotide binding is required for
the activity of the PAN2-PAN3 complex in vivo provide a frame-
work for future studies in the elucidation of the role of this com-
plex in posttranscriptional mRNA regulation.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Detailed protocols for protein expression, purification, MALLS, and thermal
shift assays can be found in the Supplemental Experimental Procedures.
Crystallization and Structure Determination
Crystals ofNc andDm PAN3 were grown and data were collected, processed,
and refined as described in the Supplemental Information. Diffraction data
were collected on a PILATUS 6M detector at the PXII beamline of the Swiss
Light Source (SLS). Native data for Dm PAN3 and Nc PAN3 were collected
at 1.0 A˚. SAD data were collected at the SeMet peak (0.9792 A˚) for the
SeMet-derivatized Nc PAN3 crystals. The refinement statistics are summa-
rized in Table 1.
GST Pull-Down, Coimmunoprecipitation, and Tethering Assays
GST pull-downs, coimmunoprecipitation, and tethering assays were per-
formed as previously described (Braun et al., 2011). Detailed protocols can
be found in the Supplemental Experimental Procedures. The mutations intro-
duced in this study are described in Table S3.
ACCESSION NUMBERS
The atomic coordinates of Nc PAN3 wild-type and mutant and Dm PAN3 are
deposited in the Protein Data Bank (PDB) under ID codes 4BWK, 4BWX,
and 4BWP, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.molcel.2013.07.011.
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Supplemental Experimental Procedures 
Protein Expression and Purification 
An Nc PAN3 cDNA encoding the PK and C-term domains (residues 234-656) was 
cloned into the pnEA-NpM expression vector (Diebold et al., 2011). Dm and Hs 
PAN3 PK+C fragments (residues 349-790 and 245-687, respectively) were cloned 
into the pnYC-NpM expression vector (Diebold et al., 2011). Proteins were expressed 
in E. coli BL21 (DE3) STAR cells in LB media, induced with 0.5 mM IPTG and 
grown overnight at 20ºC. Bacterial cells expressing MBP-Dm PAN3 were 
resuspended in 50 mM HEPES (pH 7.6), 250 mM NaCl, 5% (w/v) glycerol and 2 mM 
DTT supplemented with complete, EDTA-free protease inhibitor cocktail (Roche), 
lysozyme and DNase I. The cells were lysed by sonication at 4°C. Bacterial lysates 
were cleared by centrifugation and incubated with amylose resin (NEB) for 1 hr at 
4°C. MBP-Dm PAN3 was eluted in resuspension buffer supplemented with 10 mM 
maltose. AMP-PNP and MgCl2 (final concentration of 2 mM) were added to the 
protein solution, and the MBP tag was cleaved using HRV 3C protease diluted at 
1:200 (protease-to-protein ratio) overnight at 4ºC. Dm PAN3 was further purified 
using gel filtration (HiLoad 26/60 Superdex 200; GE Healthcare) and ion exchange 
chromatography (HiTrap Q FF; GE Healthcare) in 10 mM HEPES (pH 7.6), 250 mM 
NaCl, 5% glycerol, 2 mM DTT and 2 mM MgCl2. Purified Dm PAN3 protein was 
snap frozen in liquid nitrogen and stored at -80°C. Nc PAN3 and Hs PAN3, PAN3 
fragments and mutants (Tables S1 and S4) were subjected to similar purification 
procedures. Purified Nc PAN3 was concentrated to 5 mg/ml in 10 mM HEPES (pH 
7.2), 200 mM NaCl and 1 mM DTT, snap frozen in liquid nitrogen and stored at -
80°C. Purified Hs PAN3 was snap frozen in 10 mM Tris-HCl (pH 8.5), 250 mM NaCl, 
5% glycerol and 2 mM DTT. 
	
 
Crystallization 
Crystals of wild-type Nc PAN3 and of the seleno-methionine-substituted Nc PAN3 
were obtained by the sitting drop vapor diffusion method over a 50 μl reservoir at 
22°C after mixing 0.2 μl protein solution with 0.2 μl reservoir solution containing 0.1 
M MES (pH 6.5), 10% PEG 5000 and 12% isopropanol. Crystals were reproduced by 
hanging-drop vapor diffusion in 0.1 M HEPES (pH 7.5), 7% PEG 6000 and 6% 
isopropanol at 18°C, using 5 mg/ml Nc PAN3 protein solution containing 2 mM ATP-
Ȗ-S and 2 mM MgCl2. Crystals of Nc PAN3M were obtained in 0.1 M HEPES (pH 
7.0), 15% PEG monomethyl ether 5000 (MME) and 0.1 M potassium chloride, using 
5 mg/ml protein solution containing 2 mM ATP- Ȗ-S and 2 mM MgCl2. Crystals were 
flash-frozen in liquid nitrogen in the reservoir solution supplemented with 25% 
glycerol as cryoprotectant. Crystals of Dm PAN3 were obtained by hanging drop 
vapor diffusion method at 22ºC in 220 mM Na-citrate (pH 7.0), HEPES (pH 6.8) and 
2% PEG 3350, using 8 mg/ml Dm PAN3 protein supplemented with 2 mM AMP-
PNP and 2 mM MgCl2. Crystals were transiently soaked in mother liquor 
supplemented with 25% glycerol and flash-frozen in liquid nitrogen.  
 
Data Collection and Structure Determination 
Diffraction data were collected on a PILATUS 6M detector at the PXII beamline of 
the Swiss Light Source (SLS). Native data for Dm PAN3 and Nc PAN3 were 
collected at a wavelength of 1.0 Å. SAD data were collected at the SeMet peak 
(0.9792 Å) for the SeMet derivatized Nc PAN3 crystals. Diffraction images were 
processed with XDS (Kabsch, 2010). Se sites and phases were calculated using 
AutoSol (PHENIX package, Afonine et al., 2012). Iterative cycles of manual model 
	
building in real space (COOT, Winn et al., 2011) and refinement directly against the 
SAD data (REFMAC; Vagin et al., 2004) were performed. Native crystals of Nc 
PAN3 wild-type, Nc PAN3M and Dm PAN3 diffracted to a resolution of 3.3 Å, 2.8 Å 
and 3.6 Å, respectively, and molecular replacement was performed using PHASER 
(McCoy et al., 2007) using the SeMet Nc PAN3 as a search model. Final refinement 
rounds for the Dm PAN3 were done in REFMAC, keeping local NCS restraints and 
refining TLS parameters (one group per chain) in addition to individual B-factors. 
Final refinement rounds for the Nc PAN3 wild-type and mutant were done in 
PHENIX, keeping torsion NCS restraints and refining TLS parameters and individual 
B-factors. The structural images presented in figures were prepared with PyMOL 
(http://www.pymol.org). The refinement statistics are summarized in Table S3. 
 
Multi-angle Static Laser-light Scattering (MALLS) 
Purified Dm PAN3, Nc PAN3 and Hs PAN3 proteins were loaded onto a Superdex-
200 10/300 GL column (GE Healthcare) equilibrated with a buffer containing 10 mM 
HEPES (pH 7.6), 250 mM NaCl, 5% glycerol and 2 mM DTT. The column was 
connected to a miniDAWN TREOS multi-angle laser light scattering (MALLS) 
detector and Optilab rEX differential refractometer (Wyatt Technologies). Molecular 
weight calculations were performed using ASTRA software (Wyatt Technologies).  
 
Thermal Shift Assays 
Thermal shift assays were performed as previously described (Cummings et al., 2006). 
Sypro orange (5x final concentration, Sigma) was added to purified PAN3 proteins 
(diluted to ~ 2 μM in 50 mM HEPES [pH 7.6], 50 mM HEPES [pH 7.2] and 50 mM 
Tris-HCl [pH 8.5] for Dm PAN3, Nc PAN3 and Hs PAN3, respectively) in the 
	
presence or absence of 2 mM of nucleotide (resuspended in 50 mM HEPES [pH 7.6]) 
and 2 mM MgCl2. Protein-dye solutions were dispensed into the wells of a 96-well 
RT-PCR plate (Thermo Scientific) and loaded into a Bio-Rad C1000 thermal cycler. 
The temperature was gradually increased from 10°C to 95°C in 0.5°C increments in 
10 sec steps. The fluorescence of the SYPRO orange dye was followed at 570 nm as a 
function of temperature. The data were analyzed using CFX Manager software (Bio-
Rad) and apparent melting temperatures were obtained via the maximum value of the 
first derivative of the melting curve. Assays were performed in triplicate, and the 
apparent melting temperature (Tmapp) represent the mean value obtained.  
 
GST Pull-Down Assays 
GST-tagged TNRC6 silencing domains were expressed in E. coli BL21(DE) STAR 
cells following induction with 0.5 mM IPTG at 20ºC overnight. Cells were 
resuspended in 50 mM Tris-HCl [pH 8.5], 250 mM NaCl, 5% glycerol and 2 mM 
DTT and lysed by sonication at 4ºC. Cleared lysates of cells expressing GST-TNRC6-
SDs (6C-SD or 6B-SD) and MBP-PAN3 were mixed and incubated with Protino 
Glutathione agarose 4B beads (Machery Nagel) for 1 hr at 4°C. The beads were 
washed three times in resuspension buffer and eluted with SDS-PAGE loading buffer. 
Bound proteins were analyzed using 12% SDS-PAGE. 
 
Coimmunoprecipitation Assays 
Plasmids for the expression of PAN3, PAN2 and GW182/TNRC6s proteins in human 
and Dm S2 cells were described previously (Braun et al., 2011; Huntzinger et al., 
2013). PAN3 mutants were generated by site-directed mutagenesis using the 
QuikChange Site-Directed Mutagenesis kit from Stratagene and the appropriate 
	
oligonucleotide sequences. For coimmunoprecipitation assays in human cells, 
HEK293 cells were grown in 10-cm dishes and transfected using Lipofectamine 2000 
(Invitrogen). Dm S2 cells were grown in 6-well dishes and transfected using Effectene 
(Qiagen) transfection reagent and harvested 3 days after transfection. 
Immunoprecipitation was performed as described by Braun et al. (2011). Cell lysates 
were treated with Micrococcal nuclease for 30 min and spun at 18,000 x g for 15 min 
at 4°C prior to immunoprecipitation.  
HA- and GFP-tagged proteins were detected using HRP-conjugated 
monoclonal anti-HA (Roche 3F10; 1:5,000) and anti-GFP antibodies (Roche 
11814460001; 1:2,000), respectively. V5-tagged proteins were detected with anti-V5 
antibodies (Invitrogen, 1:5,000). All western blots were developed with the ECL 
western blotting detection system (GE Healthcare) as recommended by the 
manufacturer.  
 
Tethering Assays in S2 Cells  
The tethering assays in S2 cells were performed essentially as described previously 
(Braun et al., 2011). S2 cells were grown in 6-well dishes and transfected using 
Effectene (Qiagen). The following plasmids were cotransfected: 0.1 g reporter 
plasmid (F-Luc-5BoxB or F-Luc), 0.4 g pAc5.1-R-Luc as transfection control and 
25 ng of pAc5.1N-HA construct for the expression of N-HA-PAN3 (wild type or 
mutants). R-Luc and F-Luc activities were measured 3 days after transfection using 
the Dual-Luciferase Reporter Assay System (Promega). To measure the mRNA half-
life, transfected cells were treated with actinomycin D (5 µg/ml final concentration) 3 
days after transfection and harvested at the indicated time points. Total RNA was 
isolated using Trifast Reagent (Peqlab) and analyzed by Northern blot as described 
	
previously (Braun et al., 2011).  
 
ATPase Assay 
For the experiment shown in Figure S4A, Dm PAN3 (65 pmol) or calf intestinal 
alkaline phosphatase (20 fmol) was incubated at 25oC for 20 hours with 10 nM [Ȗ-
32P]ATP (1µM cold ATP), in a total reaction volume of 20 µl containing buffer A (75 
mM Bis-Tris propane [pH 7.2], 100 mM KCl, 150 mM NaCl, 1 mM DTT, 10 mM 
MgCl2 and 1 mM DTT). The reaction was stopped by adding 1 volume 0.5 M EDTA 
and 1.5 µl aliquots were spotted onto polyethyleneimine cellulose plates for 
chromatography (Merck) that were developed in 0.75 M LiCl. ATPase activity was 
assayed by the formation of [32P]Pi. 
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SUPPLEMENTAL FIGURES 
 
 
 
Figure S1. The Dm PAN3 PK domain binds ATP analogs. Related to Figure 2. 
(A and B) Thermal-shift assays performed with the Dm PAN3 PK+C-term fragment 
(wild-type or mutants) in the presence and absence of nucleotide and Mg2+. The 
apparent melting temperatures are indicated in Tables S2 and S5. 
	 
 
 
	
Figure S2. Structures of the Dm and Nc PAN3 PK+C-term domain. Related to 
Figures 2 and 3. 
(A) Close-up view of the ATP-binding pocket of Dm PAN3 with simulated annealing 
Fo-Fc omit map contoured at 3σ shown in grey mesh. The AMP-PN molecule is 
overlaid and the residues that prevent ATP binding when mutated are shown in red 
stick representation.  
(B and C) Close-up view of the ATP-binding pocket of Nc PAN3M superimposed 
onto the ATP-binding site of the canonical PKA ((B); PDB ID 1ATP) or Nek2 kinase 
((C); PDB ID 2W5B). Strands ȕ2-ȕ5 of Nc PAN3M were used for the superposition. 
The Nc PAN3M ATP-Ȗ-S and Mg2+ molecules are shown in green stick and blue 
sphere representation respectively. The ATP and Mn2+ molecules from PKA are 
shown in black stick and purple sphere representation, respectively. The ATP-Ȗ-S and 
Mg2+ molecules from the Nek2 kinase are shown in black stick and purple sphere 
representation, respectively. For clarity, the PKA and Nek2 kinase structures are 
shown in transparent grey cartoon representation. 
(D) Superposition of the wild-type Dm PAN3 (grey) and Nc PAN3M structures (teal) 
in two orientations.  
(E) Superposition of the Nc PAN3 wild-type (yellow) and mutant (teal) in two 
orientations.  
(F) Close-up view of the Nc PAN3M mutant dimerization interface. Monomer A and 
B are shown in gray and teal, respectively. Atomic distances are indicated in Å. 
	 
 
Figure S3. Comparison of monomeric Dm and Nc PAN3 PK and C-term 
domains. Related to Figure 2. 
(A) Ribbon representation of the individual monomers and superposition of both 
monomers of Dm PAN3. Residues 378-678 were used for superposition. The different 
angles between the CK domains relative to the PK domain caused by the helical kink 
are indicated. 
(B) Ribbon representation of the individual monomers and superposition of both 
monomers of Nc PAN3M. Residues 235-537 were used for superposition. The 
different angles between the CK domains relative to the PK domain caused by the 
helical kink are indicated. 
 
	 
 
Figure S4. The PAN3 PK domain does not have ATPase activity in vitro. Related 
to Figures 3, 4 and 5. 
(A) Thin-layer chromatography analysis of Dm PAN3 (wild type and mutants) 
ATPase activity. Calf intestinal alkaline phosphatase served as the positive control. 
The positions of the [-32P] phosphate-labeled ATP and free [32P] released phosphate 
are indicated. 
	
(B) Superposition of the Dm PAN3 CK domain (blue) and Tm WhiA HTH domain 
structures (orange; PDB ID 3HYI). Secondary structure elements are labeled. 
(C–F) The interaction of GFP-PAN3 (wild type or mutants) with HA-PAN2 was 
analyzed by coimmunoprecipitation in Dm S2 and Hs HEK293 cells as described in 
Figure 1. 
 
 
	
Figure S5. The PAN3 W-binding pocket is required for binding to the TNRC6 
proteins in vitro. Related to Figure 6. 
(A) Domain organization of Hs TNRC6C. ABD: AGO-binding domain; UBA: 
ubiquitin associated-like domain; QQQ: region rich in glutamine; Mid: middle region 
containing the PAM2 motif (dark blue), which divides the Mid region into the M1 and 
M2 regions; RRM: RNA recognition motif; C-term: C-terminal region and SD: 
silencing domain. The position of the conserved CIM-1, CIM-2 motifs are indicated. 
Amino acid positions at domain boundaries are indicated below the protein outlines. 
Vertical red lines within the ABD indicate the positions of GW repeats involved in 
AGO-bonding. Vertical green lines within the M2 region indicate the positions of 
T/SW repeats implicated in PAN3-binding. The sequences of the CIM-1, CIM-2 and 
T/SW motifs are indicated. Amino acids substituted by Alanine are shown in in red. 
 (B) Interaction between recombinant MBP-Hs PAN3 (PK+C domain wild type or 
mutants) and GST-6C-SD. Inputs (5%) and bound fractions (20%) were analyzed by 
SDS-PAGE. MBP served as a negative control. 
(C) Interaction between recombinant MBP-Dm PAN3 (PK+C domain wild type or 
mutants) and GST-6B-SD analyzed as described in (A).  
	 
 
Figure S6. The integrity of the nucleotide binding site and PAN2-binding are 
required for mRNA degradation. Related to Figure 7. 
(A, B and C) A F-Luc reporter lacking the BoxB hairpins was coexpressed with the 
indicated proteins. The corresponding experiment with a F-Luc-5BoxB reporter is 
shown in Figure 7. The levels of the F-Luc mRNA were normalized to that of R-Luc 
mRNA. The values were set at 100% in cells expressing the N-HA peptide (white 
bar). Bars represent mean values and error bars represent standard deviations from at 
least three independent experiments. Representative Northern blots are shown below 
the graphs. 
	
 
Table S1. Multi-angle laser light scattering analysis of PAN3 proteins  
 
Related to Figures 1, 3, 4 and 6. 
 
 
Protein construct Alternative names  Expected 
molecular weight 
(kDa) 
Observed 
molecular weight 
(kDa) 
Dm PAN3 349-790 Dm PAN3 PK+C 50.9 100 
Dm PAN3 349-790 + 
AMP-PNP + MgCl2 
Dm PAN3 PK+C 50.9 96 
Dm PAN3 349-655 Dm PAN3 PK 35.2 38 
Dm PAN3 641-790 C-term + αI  18.1 18 
Dm PAN3 PK+C 
CI555F 
ATP binding mutant 50.9 97 
Dm PAN3 PK+C C421F ATP binding mutant 50.9 96 
Dm PAN3 PK+C 
C421F,I555F 
ATP binding mutant 51.0 100 
Dm PAN3 PK+C  
F658E,L662E,L665E 
M1 dimerization mutant 51.0 53 
Dm PAN3 PK+C  
L676E,G683E 
M2 dimerization mutant 51.0 51 
Nc PAN3 234-656 Nc PAN3 PK+C 49.2 104 
Hs PAN3 245-687 Hs PAN3 PK+C 50.9 100 
Hs PAN3 PK+C  
M546F 
Hs PAN3 PK+C 
W-binding mutant 
50.9 102 
Hs PAN3 PK+C  
M546H 
Hs PAN3 PK+C  
W-binding mutant 
50.9 101 
Hs PAN3 PK+C  
M546F,P547G 
M7 W-binding mutant 50.9 100 
Hs PAN3 PK+C  
F553E,L557E,A560E 
M1 dimerization mutant 51.0 56 
Hs PAN3 PK+C  
L571E,G578E 
M2 dimerization mutant 51.0 86 
 
	
 
Table S2. Apparent melting temperatures of Nc, Dm and Hs PAN3 PK+C 
fragments. Related to Figures 2 and 3. 
Condition	 TmApp Nc PAN3 TmApp	Dm PAN3 TmApp	Hs	PAN3Buffer	only	 Ͷͷ.ʹ	 ͵͹.Ͳ	 Ͷʹ.ͷ	ʹ	mM	MgClʹ	 Ͷͷ.ͷ	 ͵͹.ʹ	 Ͷʹ.͵	ʹ	mM	AMP	 ͷʹ.ͷ	 ͶͲ.ʹ	 Ͷ͹.ͷ	ʹ	mM	ADP	 ͷ͵.͹	 ͶͲ.ͷ	 Ͷ͸.Ͳ	ʹ	mM	ATP	 Ͷͷ.Ͳ ͵͹.ʹ Ͷ͵.ͷ	ʹ	mM	AMP	+	MgClʹ	 ͷʹ.ͷ	 Ͷͳ.Ͳ	 Ͷ͹.ʹ	ʹ	mM	ADP	+	MgClʹ	 ͷʹ.ͷ ͵ͻ.ͷ Ͷ͹.ʹ	ʹ	mM	ATP	+	MgClʹ	 ͷͶ.͹	 ͶͲ.͹	 ͷͳ.͵	ʹ	mM	AMPPNP	+	MgClʹ	 ͷͶ.͵ ͵ͻ.ͷ Ͷͻ.ͷ	ʹ	mM	ATP‐γ‐S	+	MgClʹ	 ͷͶ.ͷ	 ͵ͻ.ͷ	 ͷͲ.ͷ	ʹ	mM	GMP	+	MgClʹ	 Ͷͷ.Ͳ	 ͵͹.ͷ	 Ͷʹ.͵	ʹ	mM	GDP	+	MgClʹ	 ͶͶ.ͺ	 ͵͹.ʹ	 Ͷʹ.Ͳ	ʹ	mM	GTP	+	MgClʹ	 Ͷͷ.Ͳ	 ͵͹.ʹ	 Ͷʹ.Ͳ	
 
	
Table S3. Mutants used in this study  
Related to Figures 2, 4, 6 and 7, and Table 1. 
 
Name Dm PAN3 
(NP_647767.1) 
Hs PAN3 
(BC128180.1) 
Location 
M1 F658E,L662E,L665E F553E,L557E,A560E Dimer interface 
M2 L676E,G683E L571E,G578E Dimer interface 
M3 T408F,C421F,I555F C319F,L447F Nucleotide binding  
M2+M3 T408F,C421F,I555F+M2 C319F,L447F+M2 Nucleotide binding 
M7 M651F,P652G M546F,P547G W-pocket 
M8 460-465  
replaced by GSSG
358-363 
replaced by GSSG
PK surface 
M9 R429D R327D PK surface 
M10 D575R D468R PK surface 
M13 S708A,T710A S603A,T605A CK 
M14 K717S,D721S,H725S - CK 
M15 H739E,K746E,D748K H634E,K641E,D643K CK 
M16 R760T,D761T R655T,D656T CK 
M17 M2+M15+M16  CK 
M18 M2+M14+M15+M16  CK 
 
 
The Nc PAN3M mutant carries the following substitutions: L510M, G511P, G512M, 
T514G, T515A, H516R, L517F. The Nc PAN3 residues were substituted with 
residues found at equivalent positions in Dm PAN3 with the aim to generate a W-
binding pocket and promote alternative crystal packing arrangements for the Nc 
PAN3 protein. However, the pocket formed in Nc PAN3M protein appears to be too 
narrow to accommodate a tryptophan.  
 
TNRC6C mutants CIM1+CIM2 and M2 are as shown in Figure S5A. 
 
  
	
 
Table S4. Apparent melting temperatures of PAN3 mutants 
Related to Figures 3, 4 and 6, and Table 1. 
 
 Dm 
PAN3 
C421F 
Dm 
PAN3 
I555F 
Dm 
PAN3 
I555F/ 
C421F 
Dm 
PAN3 
M1 
Dm 
PAN3 
M2 
Hs 
PAN3 
M1 
Hs 
PAN3 
M2 
Hs 
PAN3 
M7 
Nc 
PAN3
M
 
Buffer 
only 
35.5 35.7 32.0 36.0 36.5 32.5 34.0 38.5 44.8 
2 mM 
MgCl2 
35.5 35.7 32.0 36.0 35.8 32.7 33.7 38.8 44.5 
2 mM 
ADP + 
MgCl2 
37.5 35.7 32.0 37.3 37.5 37.3 37.5 40.33 50.8 
2 mM 
ATP + 
MgCl2 
39.8 35.7 32.0 39.5 39.3 41.3 39.5 43.67 56.0 	
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The CCR4–NOT deadenylase complex has a crucial role in post-
transcriptional mRNA regulation. It catalyzes the removal of mRNA 
poly(A) tails and consequently represses translation and promotes 
mRNA degradation1,2. Remarkably, the CCR4–NOT complex can also 
repress translation independently of deadenylation, and it facilitates 
dissociation of the cytoplasmic poly(A)-binding protein (PABP) from 
mRNA poly(A) tails3–6.
In addition to its central role in bulk and specific mRNA degrada-
tion, the CCR4–NOT complex has been implicated in transcription 
initiation and elongation, in DNA repair and in ubiquitination and 
protein modification1,2. Given the diverse activities associated with 
the CCR4–NOT complex, it is not surprising that it has a role in a 
wide range of biological processes, including cell proliferation, apop-
tosis, oogenesis and embryogenesis, spermatogenesis, heart function, 
bone formation and energy metabolism1,2.
The conserved core of the CCR4–NOT complex consists of two 
major modules: a catalytic module comprising two deadenylases 
(CAF1 or its paralog POP2, and CCR4a or its paralog CCR4b) and the 
NOT module, which minimally consists of NOT1, NOT2 and NOT3. 
Additional subunits within the complex have been described, includ-
ing NOT4, CAF40 and the species-specific subunits CAF130, NOT10 
and NOT11 (refs. 1,2). NOT1 functions as a modular scaffold to pro-
vide binding sites for the NOT10–NOT11 module at its N terminus, 
the CAF1–CCR4 catalytic module and CAF40 in its middle region and 
the NOT2 and NOT3 subunits at the C terminus. Thus, NOT1 is essen-
tial for the assembly of the complete CCR4–NOT complex3,7–16.
The precise molecular function of the NOT module remains 
unclear. Current evidence indicates that it regulates the stability and 
activity of the catalytic module. Another crucial role for the NOT 
module is the recruitment of the CCR4–NOT complex to a plethora 
of specific mRNAs2,17. These include microRNA targets and mRNAs 
containing AU-rich elements, to which the CCR4–NOT complex 
is recruited through interactions of NOT1 with GW182 proteins 
and tristetraprolin, respectively4,18–21. Furthermore, a multitude of 
translational regulators, which include Nanos, Bicaudal-C, CUP and 
Smaug, recruit the CCR4–NOT complex to their targets through 
interactions with NOT-module subunits17.
The mechanistic understanding of the assembly, regulation and 
function of the NOT module requires elucidation of its three- 
dimensional structure, specifically of the C-terminal regions of NOT1, 
NOT2 and NOT3, which mediate NOT-module assembly1–3,12,22,23. 
These regions comprise a highly conserved NOT1 superfamily homol-
ogy (SH) domain in NOT1 and a conserved NOT-box domain22,23 in 
NOT2 and NOT3. Currently there are no structural models available 
for these regions, owing to the lack of sequence homology to known 
structural folds.
To provide the missing structural framework for understanding 
the assembly and functions of the NOT module, we determined 
the crystal structure of a ternary complex formed by the human 
CNOT1-C, CNOT2-C and CNOT3-C regions. This was achieved by 
a stepwise approach wherein we first determined the boundaries and 
crystal structures of the isolated human CNOT2 and CNOT3 NOT-
box domains and of the Chaetomium thermophilum (Ct) NOT1 SH 
domain. We then used this information for the assembly and struc-
ture determination of the ternary CNOT1–CNOT2–CNOT3 com-
plex. The structures reveal a rigid scaffold for the NOT1 SH domain, 
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Structure and assembly of the NOT module of the human 
CCR4–NOT complex
Andreas Boland1,2, Ying Chen1,2, Tobias Raisch1,2, Stefanie Jonas1,2, Duygu Kuzuoğlu-Öztürk1, Lara Wohlbold1, 
Oliver Weichenrieder1 & Elisa Izaurralde1
The CCR4–NOT deadenylase complex is a master regulator of translation and mRNA stability. Its NOT module orchestrates 
recruitment of the catalytic subunits to target mRNAs. We report the crystal structure of the human NOT module formed by 
the CNOT1, CNOT2 and CNOT3 C-terminal (-C) regions. CNOT1-C provides a rigid scaffold consisting of two perpendicular 
stacks of HEAT-like repeats. CNOT2-C and CNOT3-C heterodimerize through their SH3-like NOT-box domains. The heterodimer 
is stabilized and tightly anchored to the surface of CNOT1 through an unexpected intertwined arrangement of peptide regions 
lacking defined secondary structure. These assembly peptides mold onto their respective binding surfaces and form extensive 
interfaces. Mutagenesis of individual interfaces and perturbation of endogenous protein ratios cause defects in complex  
assembly and mRNA decay. Our studies provide a structural framework for understanding the recruitment of the CCR4–NOT 
complex to mRNA targets.
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consisting of two perpendicularly arranged stacks of α-helices, and 
an SH3-like fold for the CNOT2 and CNOT3 NOT boxes, which 
mediate heterodimerization. Perhaps the most remarkable structural 
features are the intertwined N-terminal extensions of CNOT2 and 
CNOT3 that wrap around their partners in the heterodimer and also 
form an extended interface with CNOT1. Functional studies reveal 
the relevance of the interaction interfaces for complex assembly and 
mRNA degradation.
RESULTS
Mutual interactions between CNOT1, CNOT2 and CNOT3
Our previous studies indicated that the interactions between 
Drosophila melanogaster (Dm) NOT1, NOT2 and NOT3 are medi-
ated by their C-terminal regions3. Coimmunoprecipitations in human 
cells demonstrated that this mode of interaction is conserved in the 
human orthologs (Supplementary Fig. 1a–e). Moreover, although 
CNOT1 interacted with both CNOT2 and CNOT3, the inter-
action with CNOT3 was enhanced in cells coexpressing CNOT2 
(Supplementary Fig. 1f).
To determine whether the observed interactions are direct and to 
further define the domain boundaries, we performed pulldown assays 
with isolated C-terminal protein fragments expressed in Escherichia 
coli. We observed direct interactions for all possible binary domain 
combinations (Supplementary Fig. 1g–j). Further analysis indi-
cated that the CNOT2-C fragment (residues 344–540) interacts with 
both CNOT1 and CNOT3, whereas a shorter fragment (residues 
429–540) binds CNOT3 but is not sufficient for CNOT1 binding 
(Fig. 1a and Supplementary Fig. 1g,h). The 
smallest CNOT3 fragment that maintained 
CNOT2 binding comprised residues 656–753 
(Supplementary Fig. 1i). On the basis 
of these results and our structural analysis, 
we will refer to residues 429–525 of CNOT2 and residues 656–747 
of CNOT3 as the NOT-box domains (Fig. 1a). We conclude that the 
NOT-box domains mediate the CNOT2-CNOT3 interaction, whereas 
additional N-terminal sequences are required for CNOT1 binding.
The NOT1 SH domain features two perpendicular HEAT stacks
To determine the structure of the CNOT1-C domain, we initially 
identified a proteolytically stable fragment in CNOT1 (residues 
1842–2371; Fig. 1a) that was expressed in a soluble form but failed 
to crystallize. We then expressed an equivalent fragment of Ct NOT1 
(residues 1676–2193; Supplementary Fig. 2), which yielded crystals 
that diffracted X-rays to 3.2-Å resolution (Table 1).
The overall architecture of Ct NOT1-C is L-shaped and consists of 
two tightly interacting subdomains connected by a surface-attached 
and well-structured linker loop (loop L11; Fig. 1b–d). The two 
subdomains correspond to two perpendicularly arranged stacks of 
α-helices: an N-terminal subdomain (N-SD, helices α1–α14) that runs 
left to right and a C-terminal subdomain (C-SD, helices α15–α23) 
that runs bottom to top (Fig. 1b–d). The helices are packed as antipar-
allel HEAT-like pairs, with six hairpins in the N-SD and four hairpins 
in the C-SD. The arrangement of HEAT-like repeats in perpendicular 
stacks is different from the usually continuous arrangement24, and it 
occurs more than once in the context of NOT1 (ref. 10).
Our structural analysis redefines the boundaries of the NOT1 
SH domain and reveals that most of the highly conserved residues 
map to the extensive interface (1,151 Å2) between the N- and C-SDs 
(Supplementary Fig. 2), indicating that the mutual arrangement 
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Figure 1 Domain organization of Homo sapiens 
(Hs) CNOT1–CNOT3 and the structure of  
the Ct NOT1 superfamily homology domain.  
(a) Diagrams of CNOT1 with N-terminal, middle 
and C-terminal regions (CNOT1-N, CNOT1-M 
and CNOT1-C, respectively). The CNOT1-N 
consists of two HEAT-repeat domains. CNOT1-M 
contains a MIF4G domain and a domain of 
unknown function (DUF3819). CNOT1-C 
contains the NOT1 superfamily homology (SH) 
domain. The C-terminal regions of both CNOT2 
and CNOT3 contain a NOT1 anchor region 
(NAR), a connector sequence (CS) and a NOT-
box domain (38% sequence identity for the 
CNOT2 and CNOT3 NOT boxes)22,23. CNOT3 
displays an N-terminal coiled coil domain 
(CNOT3-N) and a linker region (CNOT3-M).  
The numbers below the protein outline  
represent amino acid positions at the domain 
boundaries as defined in this study. (b,c) Cartoon 
representations of the Ct SH domain. Two views, 
related by 60° rotation, are shown in b and c.  
The N- and C-terminal subdomains (N-SD 
and C-SD, respectively) are each colored in a 
gradient from green to dark blue from the N to 
C terminus. HEAT repeats are indicated. Loop 
L11 linking the two lobes is highlighted in red. 
(d) Schematic drawing of the Ct NOT1 structure 
with the same colors as in b. (e) Surface 
conservation of NOT1 SH domain colored in a 
gradient from white to blue. The orientation of 
the top structure corresponds to that shown in c.
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between the two subdomains is evolutionarily conserved. Additional 
conserved surface residues map to only one of the two helical surfaces 
of the domain (Fig. 1e).
The NOT-box domain adopts an SH3-related fold
The CNOT3 NOT-box domain crystallized as a homodimer (2.4-Å  
resolution; Table 1 and Fig. 2a), consistent with the results from 
multiangle static laser light scattering and size-exclusion chromatog-
raphy, which also indicated that the protein was dimeric in solution 
(Supplementary Fig. 3a).
The structure of the NOT-box domain consists of three N-terminal 
α-helices (α1–α3) followed by a C-terminal SH3-like five-stranded 
open β-barrel (β1–β5), with β-strands β4 and β5 strongly bent 
(Fig. 2a,b). The N-terminal helices form an antiparallel bundle that 
packs against one side of the β-barrel. Notably, the inner core of the 
β-barrel and the interface with the N-terminal helices consist almost 
exclusively of aromatic side chains (Supplementary Fig. 3b,c).
The N-terminal helices also provide the interface for the dimeriza-
tion of the NOT-box domain (Fig. 2a). The dimer has a two-fold sym-
metry with a parallel arrangement of the α2 helices, which provide 
Table 1 Data collection and refinement statistics
Ct NOT1 (Se) Ct NOT1 Hs CNOT2 (Se) Hs CNOT2 Hs CNOT3 (Se) Hs CNOT3 Hs CNOT1–2–3
Data collectiona
Space group P212121 P21 P41 P6522 P212121 P212121 P21212
Cell dimensions
 a, b, c (Å) 126.6, 129.6, 
154.1
77.8, 127.2,  
130.2
76.4, 76.4,  
86.3
64.8, 64.8,  
412.3
52.2, 97.3,  
142.3
52.3, 97.6,  
141.5
91.6, 165.9,  
78.8
 α, β, γ (°) 90, 90, 90 90, 93.1, 90 90, 90, 90 90, 90, 120 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (Å) 90.9–3.6  
(3.69–3.6)
90.9–3.2  
(3.28–3.2)
76.4–3.4  
(3.49–3.4)
49.3–2.4  
(2.46–2.4)
80.3–2.5  
(2.57–2.5)
49.1–2.4  
(2.46–2.4)
48.5–3.2  
(3.28–3.2)
Rsym (%) 17.2 (73.1) 10.6 (54.5) 16.2 (68.4) 9.6 (80.2) 8.6 (73.5) 5.4 (70.4) 11.9 (55.9)
I / σI 16.4 (5.1) 11.3 (2.9) 17.5 (4.9) 13.2 (2.4) 17.7 (3.7) 18.1 (3.2) 10.1 (2.2)
Completeness (%) 100.0 (100.0) 99.9 (99.9) 99.7 (96.0) 99.2 (99.1) 99.9 (99.1) 99.5 (99.8) 98.9 (98.9)
Redundancy 26.8 (27.9) 5.4 (5.2) 20.1 (18.1) 6.7 (6.7) 12.9 (12.9) 5.9 (6.2) 3.3 (3.4)
Refinement
Resolution (Å) 63.6–3.2 49.3–2.4 49.1–2.4 48.5–3.2
No. reflections 41,820 21,287 28,937 20,241
Rwork / Rfree (%) 21.7 / 25.9 21.7 / 26.3 22.1 / 25.7 22.4 / 27.3
No. atoms
 Protein 15,737 3,483 4,984 6,864
 Water – 102 76 –
B factors (Å2)
 Protein 88 51 69 71
 Water – 48 52 –
r.m.s. deviations
 Bond lengths (Å) 0.002 0.002 0.002 0.002
 Bond angles (°) 0.53 0.64 0.62 0.52
aOne crystal was used per data set. Values in parentheses are for highest-resolution shell.
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Figure 2 Structures of the CNOT2 and CNOT3 NOT-box domains. (a) 
Structure of the CNOT3 NOT-box dimer. Monomers are colored in dark and 
light green. Secondary-structure elements are labeled. (b) Structure of the 
CNOT3 NOT-box monomer. (c,d) Structure of the CNOT2 NOT-box dimer 
in two orientations. Monomers are colored purple and rose. The three α-
helices involved in the domain swap are labeled in d. (e,f) Superposition 
of CNOT2 (purple) and CNOT3 (green) monomers. The similarity of the 
β-barrels and the open (CNOT2) and closed (CNOT3) conformations of the 
N-terminal α-helices are highlighted (e). A cross-connection of the two 
peptide backbones at the dashed line in d results in a compact model of 
the CNOT2 NOT box that is highly similar to the CNOT3 NOT box (b,f).
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most of the contacts with additional contributions from helices α1 
and loops L1. The contacts are mainly hydrophobic and lead to an 
interface of 560 Å2.
The CNOT2 NOT-box domain forms a domain-swapped dimer
The CNOT2 NOT-box domain packs as a dimer of dimers (2.4-Å  
resolution, Fig. 2c,d and Table 1), consistent with its behavior in 
solution (Supplementary Fig. 3d,e). As expected on the basis of 
sequence homology (Supplementary Fig. 3f), 
the CNOT2 and CNOT3 NOT boxes adopt 
a similar fold (Fig. 2c–f). However, in the 
CNOT2 crystals the N-terminal helices 
adopt an extended (open) conformation 
(Fig. 2c–e), in which helices α1 and α2 of 
one monomer interact with helix α3 and 
the open β-barrel of the other monomer 
(Fig. 2d). Consequently, the dimers that 
result from this domain swap are structur-
ally distinct from the CNOT3 homodimers, 
burying a large interface of 1,900 Å2.
The ability of the NOT-box domains to homodimerize in two 
different ways and to adopt an open (CNOT2) or a closed (CNOT3) 
conformation is intriguing. With regard to the assembly of the NOT 
module, CNOT2 and CNOT3 may form heterodimers that corres-
pond to one of the two crystallized arrangements. To discriminate 
between these two potential interaction modes, we determined the 
structure of the ternary complex, which also includes CNOT1.
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Figure 3 Structure of the CNOT1–CNOT2–
CNOT3 ternary complex. (a,b) Structural 
overview. CNOT2 (purple) and CNOT3 (green) 
form a heterodimer through their NOT-box 
domains and preceding connector sequences 
(CS; magenta and cyan, respectively). The NOT1 
anchor regions (NAR) tether the heterodimer 
onto the surface of CNOT1 (gray). They consist 
of an N-terminal α-helix (αN) and a NAR  
C-terminal region (NAR-C). The CNOT2  
C-terminal tail is shown in orange.  
(c) Schematic drawing of the CNOT1–CNOT2–
CNOT3 structure with colors as in a.  
(d) Superposition of the CNOT2 NOT-box 
domain in the complex (purple) with the 
isolated domain (gray). (e) Superposition of the 
CNOT2–CNOT3 heterodimer (purple and green) 
with the CNOT3 NOT-box homodimer (gray). 
(f) Structures of CNOT2 and CNOT3 from the 
ternary complex. The heterodimer (left) is taken 
apart (right) to show the extended conformation 
of the NAR and CS regions.
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Figure 4 The CNOT2–CNOT3 heterodimerization interface. (a) Close-up of the interface between the NOT-box domains of CNOT2 and CNOT3, with 
interface residues shown as sticks. (b) The corresponding interface of the CNOT3 homodimer. Underlined residues indicate marked differences between 
the interfaces of the CNOT2–CNOT3 heterodimer and the CNOT3 homodimer. (c) Packing of the CNOT2 CSs (magenta) against the CNOT3 NOT-box 
domain (green surface) and of the CNOT3 CS (cyan) against the CNOT2 NOT-box domain (purple surface). Interacting residues are shown as sticks in 
purple (CNOT2) and green (CNOT3). Proline residues in CNOT3 CS are shown in gray. (d,e) Circular locks for CNOT2 (d) and CNOT3 (e). Residues locking 
back the N-terminus of the CS to its own NOT-box domain are drawn as sticks. For CNOT2, contacts are mediated by hydrogen bonds (orange).  
For CNOT3, contacts are hydrophobic.
n
p
g
©
 2
0
1
3
 N
a
tu
re
 A
m
e
ri
c
a
, 
In
c
. 
A
ll
 r
ig
h
ts
 r
e
s
e
rv
e
d
.
NATURE STRUCTURAL & MOLECULAR BIOLOGY VOLUME 20 NUMBER 11 NOVEMBER 2013 1293
A R T I C L E S
Crystal structure of the assembled NOT-module core
The core of the human NOT module comprising CNOT1 (residues 
1565–2371), CNOT2 (residues 344–540) and CNOT3 (residues 
607–753) was coexpressed in E. coli cells and co-purified. Limited 
proteolysis by thermolysin removed the N-terminal part of CNOT1, 
resulting in a stable fragment corresponding to the NOT1 SH domain 
(Supplementary Fig. 4a). Surprisingly, limited proteolysis did not 
affect the N-terminal extensions of the CNOT2-C and CNOT3-C 
fragments, although they are predicted to lack secondary structure. In 
the absence of CNOT1, thermolysin rapidly degraded CNOT2-C and 
CNOT3-C, a result suggesting that large portions of the two proteins 
are flexible and unfolded in isolation (Supplementary Fig. 4a,b).
The 3.2-Å-resolution structure of the heterotrimeric complex 
(Fig. 3, Supplementary Fig. 4c–f and Table 1) contains CNOT1 
(1842–2353), CNOT2 (350–540) and CNOT3 (607–748) in a stoi-
chiometry of 1:1:1. The complex is organized into two lobes: an 
asymmetric lobe containing CNOT1 is fixed by an unusual junction 
to a roughly two-fold-symmetric lobe containing the NOT boxes of 
CNOT2 and CNOT3 (Fig. 3a–c).
The structure of human CNOT1 in the complex is similar 
to the structure of the isolated Ct NOT1-C (r.m.s. deviation of 
1.99 Å over 397 equivalent Cα positions; Supplementary Fig. 4g), 
thus indicating that CNOT1 does not 
undergo major structural rearrangements 
upon binding the CNOT2–CNOT3 hetero-
dimer. Similarly, the CNOT3 NOT-box 
domain in the complex adopts an almost 
identical conformation as does its isolated 
counterpart (r.m.s. deviation of 0.55 Å over 
90 equivalent Cα atoms; Supplementary 
Fig. 4h). In contrast to the isolated structure, 
the CNOT2 NOT-box domain adopts the 
closed conformation in the ternary complex, 
and its helix α1 is partially melted (Fig. 3d 
and Supplementary Fig. 4i).
The symmetric lobe
CNOT2 and CNOT3 interact with each 
other through their NOT-box domains in 
the same arrangement that was observed for 
the CNOT3 homodimer (Fig. 3e,f), thereby 
leading to a highly symmetric heterodimer. 
Heterodimerization is mediated by hydropho-
bic interactions between helices α1 and α2 and loop L7 of both pro-
teins. Importantly, the interface of the CNOT2–CNOT3 heterodimer 
exhibits a higher degree of complementarity than does the interface 
in the CNOT3 homodimer (Fig. 4a,b). This is especially apparent for 
CNOT2 residues Y439 and L443, which form knobs that fit neatly into 
the holes on the CNOT3 surface, whereas the corresponding CNOT3 
residues L666 and T670 fill these holes less efficiently.
The heterodimer interface is extended by N-terminal sequences 
that we named connector sequences (CSs) and that wrap like clamps 
around the NOT-box domains of their partners (Figs. 3f and 4c and 
Supplementary Fig. 5a,b). The CSs describe a full circle starting 
from their C termini and wrap around the L2 loops of their respec-
tive partners (Fig. 3f), inserting into the cleft formed between the 
β-barrel and the N-terminal α-helices (Fig. 4c). In the vicinity of 
their N termini, the CSs lock themselves back through side chain inter-
actions with helix α2 of their own NOT-box domain (Fig. 4c–e). The 
side chain interactions at the locks are different for the two proteins. 
In CNOT2, polar residues are involved for the most part (interaction 
of CS residues R409, P410 and Q411 with Y446, M450 and N451 in 
helix α2; Fig. 4d), whereas in CNOT3, the interactions are mainly 
hydrophobic (interaction of CS residues Y637 and L638 with resi-
dues F673, Y677 and L678 in helix α2; Fig. 4e). Most remarkably, 
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Figure 5 The interface between CNOT1 and 
the CNOT2–CNOT3 heterodimer. (a) Packing 
of the NARs (purple, CNOT2; green, CNOT3) 
against the surface of CNOT1 (gray, cartoon 
representation on the right). Interacting  
residues are shown as sticks and are labeled  
on the left for CNOT2 and CNOT3 and on the 
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to CNOT1 mutants M1 (yellow) and M5 (cyan). 
(b) Close-up view of a hydrophobic canyon on 
the surface of CNOT1 filled with side chains  
of CNOT2. (c) Interactions of the CNOT2  
C-terminal tail (C-term, orange) with CNOT3 
and CNOT1. Labeling of interacting residues 
is as in a. (d) Close-up views of the junction 
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the ternary NOT-module complex. (e) Overview 
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rectangles indicate the views shown in a–d.
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the CSs are interlocked, thereby providing a 
topological constraint for the dissociation of 
the two proteins and suggesting a hierarchi-
cal assembly.
The CSs probably favor heterodimeriza-
tion over homodimerization because they 
differ substantially in sequence and in length 
(Figs. 3f and 4c). Notably, the CNOT3 CS is 
shorter and highly enriched in prolines (38%; 
Fig. 4c and Supplementary Fig. 5a,b). Thus, 
the interactions mediated by the CSs in the 
heterodimer are unlikely to occur in the 
context of the homodimers. This view is supported by the observa-
tion that the CNOT2 and CNOT3 fragments (containing the CSs 
in addition to the NOT boxes) aggregate and precipitate in isola-
tion, thus indicating that the CSs do not participate favorably in the 
formation of homodimers. Upon coexpression, however, CNOT2-C 
and CNOT3-C remain soluble and form exclusively heterodimers 
(Supplementary Fig. 3g).
The asymmetric lobe
The CNOT2–CNOT3 heterodimer interacts predominantly with 
the conserved helical surface of the CNOT1 N-SD (Fig. 3a,b). 
The interaction does not use the NOT-box domains and involves only 
the NOT1 anchor regions (NARs) of both proteins, which consist 
of an N-terminal α-helix (αN) and a C-terminal region (NAR-C) 
entirely devoid of secondary structure (Fig. 3f and Fig. 5a–d). The αN 
helices insert into grooves on the lateral surface of CNOT1 (Fig. 5a). 
The extreme N-terminal residues of CNOT2 enter a cleft formed by 
loops L15 and L19 and helix α21 in the CNOT1 C-SD (Fig. 5a).
The NAR-Cs mold into the conserved helical surface of the 
CNOT1 N-SD (Fig. 5a). The short CNOT3 NAR-C crosses over the 
surface of helices α4, α6 and α8 of CNOT1, with which it interacts 
through hydrophobic and polar residues (Fig. 5a) before entering 
the junction. The long CNOT2 NAR-C zigzags across the CNOT1 
surface and contains a series of aromatic residues (Y396, F399 and 
W403) that stick into the hydrophobic cleft between CNOT1 heli-
ces α8, α9 and α11 (Fig. 5a,b). Furthermore, residues 382–395 
extensively interact with helix α11 of CNOT1 and exhibit several 
well-defined contacts (Fig. 5a).
The junction and the orientation of the two lobes
The NAR-Cs link to the CSs at the junction of the two lobes in the 
structure (Fig. 3a). The core of this junction is stabilized by hydrophilic 
interactions between the N-terminal ends of the CSs, which include res-
idues from CNOT2 (R409, Q411, D412 and D414) and CNOT3 (E632, 
R633, R635 and R640; Fig. 5d). Furthermore, the relative orientation 
of the two lobes is stabilized by the C-terminal tail of CNOT2, which 
clamps the CNOT3 CS into a tunnel and hooks back onto CNOT1 
(helix α11) while crossing over the CNOT3 NAR-C (Fig. 5c). Clearly, 
the interactions of the CNOT2 C-terminal tail must occur late in the 
assembly of the NOT module and impose additional topological con-
straints, thereby preventing the dissociation of CNOT3 in the presence 
of CNOT2. Surface conservation analysis indicated that the interfaces 
in the trimeric complex are conserved (Supplementary Fig. 6a–e), 
suggesting a similar assembly mode across multiple species.
In vivo assembly and mutagenesis of the NOT module
To determine the structural requirements for the assembly of the NOT 
module in vivo, we tested whether overexpressed protein variants 
are incorporated into endogenous CCR4–NOT complexes in human 
cells. To this end, we performed coimmunoprecipitation assays and 
used available anti-CNOT1 and anti-CNOT3 antibodies (Fig. 6). We 
included hemagglutinin (HA)-tagged CNOT2 in the transfection 
mixtures because of the lack of specific antibodies. Collectively, these 
experiments revealed the following observations.
First, GFP-CNOT1 interacted with HA-CNOT2 and endogenous 
CNOT3 (Fig. 6a, lane 8). As expected, a deletion of the CNOT1 N-SD 
(∆N-SD) prevented these interactions (Fig. 6a, lane 9). Remarkably, 
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Figure 6 Mutagenesis of the NOT1-NOT2- 
NOT3 interfaces in human and Dm S2 cells. 
(a–c) Interaction of GFP-tagged CNOT1,  
CNOT2 or CNOT3 (either wild-type or the 
indicated mutants) with the indicated proteins 
(either endogenous CNOT3 and CNOT1 
or CNOT2 tagged with human influenza 
hemagglutinin (HA)). GFP-tagged maltose 
binding protein (MBP) served as a negative 
control. (d) Interaction of HA-tagged Dm NOT1 
(either wild-type or mutants) with the indicated 
endogenous proteins in S2 cells. HA-MBP 
served as a negative control. (e,f) Interaction 
of GFP-tagged Dm NOT2 or NOT3 (either wild-
type or mutants) with the indicated endogenous 
proteins in S2 cells. GFP-tagged firefly 
luciferase (GFP-F-Luc) served as a negative 
control. In all panels, cell lysates were treated 
with RNase A before immunoprecipitation.  
IP, immunoprecipitated fraction. Size markers 
(kDa) are shown on the right of each panel. 
Original western blots shown in this figure  
can be found in Supplementary Figure 8.
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it was sufficient to substitute only two or three surface residues on 
CNOT1 that make direct contact with CNOT2 (mutants M5 and M6) 
or CNOT3 (mutant M1; Fig. 5a and Supplementary Fig. 2) to achieve 
a similar effect (Fig. 6a, Supplementary Fig. 7a and Supplementary 
Table 1). These CNOT1 mutants still interacted with CNOT7 
(Supplementary Fig. 7b,c), a result suggesting that the mutations 
do not affect the CNOT1 fold. Consequently, subtle alterations of the 
CNOT1 binding surface are sufficient to prevent its interaction with 
CNOT2 and CNOT3 in vivo, a result consistent with a specific but 
rather weak, entropically costly interaction.
Second, GFP-CNOT2 interacted with endogenous CNOT1 and 
CNOT3 (Fig. 6b, lane 8). A deletion of the NAR-C region strongly 
reduced binding to endogenous CNOT1 (Fig. 6b, lane 12). This dele-
tion also abolished binding to endogenous CNOT3 (Fig. 6b, lane 12), 
although a CNOT2 mutant lacking the entire NAR still interacted with 
CNOT3 in vitro (Supplementary Fig. 1h). This observation confirms 
that our assay detects the incorporation of CNOT2 into endogenous 
CCR4–NOT complexes, rather than detecting binary interactions alone. 
The results also suggest that there is no excess of free CNOT3 in the 
cell to interact with CNOT2. Conversely, a deletion of the CNOT2 CS 
also prevented the interaction with both CNOT1 and CNOT3 (Fig. 6b, 
lane 9). In contrast, a point mutation at the NOT-box interface (W507E) 
or the deletion of αN were ineffectual (Fig. 6b, lanes 10,11). These 
results highlight the importance of the CNOT2 CS and the NAR-C for 
NOT-module assembly.
Third, GFP-CNOT3 interacted with endogenous CNOT1 and with 
HA-CNOT2 (Fig. 6c, lane 7). As observed for CNOT2, the deletion of 
the CS prevents interaction not only with HA-CNOT2 but also with 
endogenous CNOT1 (Fig. 6c, lane 8), thus indicating that mutated 
GFP-CNOT3 is not incorporated into endogenous NOT modules. 
In contrast, a single amino acid substitution in CNOT3 helix α2 (F673E) 
disrupted HA-CNOT2 binding, but this mutant maintained inter-
action with endogenous CNOT1 (Fig. 6c, lane 9), a result suggest-
ing that the CNOT3 NAR could be sufficient for incorporation into 
NOT modules even when the interaction with CNOT2 is disrupted. 
Consistent with this, the deletion of the NAR abrogated binding to 
endogenous CNOT1 (Fig. 6c, lane 10).
Finally, analogous experiments in Dm Schneider cells (S2 cells), dem-
onstrated that all of the aforementioned mutations and deletions abol-
ished the interaction of Dm NOT1, NOT2 and NOT3 with the other 
two endogenous partners (Fig. 6d–f). These results confirm the conclu-
sion that endogenous NOT1, NOT2 and NOT3 are fully assembled into 
NOT modules and indicate that each subunit requires interaction with 
both of its partners to be incorporated into the NOT modules in Dm 
S2 cells. Together with the topological constraints seen in the structure, 
the results also suggest a highly coordinated and hierarchical assembly 
with built-in quality controls.
The integrity of the NOT module and mRNA degradation
To test whether a disturbed assembly of the NOT module has conse-
quences on mRNA degradation, we used a heat-shock mRNA reporter 
containing the coding region of the Dm alcohol dehydrogenase gene 
(Adh) fused to the hsp70 (official symbol Hsp70Ab) 3′ untrans-
lated region (construct denoted adh-hsp70), which is sufficient to 
recapitulate hsp70 mRNA decay25 and results in a half-life of 25 ±  
6 min (Fig. 7a).
In the first round of experiments, we overexpressed the NOT1 protein 
in S2 cells. We found that wild-type NOT1 had no effect on mRNA 
half-life (Fig. 7a and Supplementary Fig. 7d), whereas the expres-
sion of the NOT1 ∆N-SD mutant resulted in a two-fold increase of 
the mRNA half-life (57 ± 11 min; Fig. 7a and Supplementary Fig. 7d). 
Because this mutant still interacts with CAF1 (Supplementary Fig. 7e), 
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Figure 7 Effects on mRNA degradation. (a) Northern blot analysis showing the decay of the adh-hsp70 mRNA in control cells (expressing MBP) and in 
cells expressing NOT1 (either wild-type or mutant). The mRNA half-lives (t1/2) ± s.d. calculated from the decay curves obtained from three independent 
experiments (Supplementary Fig. 7d) are indicated at bottom. Rp49 served as a loading control. (b) Western blot analysis of S2 cells depleted of NOT1, 
NOT2 or NOT3. Dilutions of control cell lysates were loaded in lanes 1–4 to estimate the efficacy of the depletion. Tubulin served as a loading control.  
KD, knockdown. Size markers (kDa) are indicated on the right. (c,d) Northern blots showing the decay of the adh-hsp70 mRNA in control cells (treated 
with GFP dsRNA and expressing MBP) or in cells depleted of NOT1 (c) or NOT3 (d) expressing MBP or the indicated proteins. The mRNA half-lives  
(t1/2) ± s.d. calculated from the decay curves of three independent experiments (Supplementary Fig. 7f,g) are indicated at bottom. (e) Western blot 
showing the expression levels of the dsRNA-resistant, HA-tagged NOT1 and NOT3 proteins used in the complementation assays. Size markers (kDa)  
are indicated on the right. Original images of western and northern blots shown in this figure can be found in Supplementary Figure 8.
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it probably sequesters the catalytic module into inactive complexes or 
it is assembled into defective complexes that are no longer recruited to 
the mRNA reporter.
In the second round of experiments, we depleted the individual 
subunits. Western blot analysis indicated that the depletion of single 
subunits of the ternary NOT1–NOT2–NOT3 complex co-depleted 
the other two subunits (Fig. 7b), in agreement with previous 
studies11,13,15,25,26 (Fig. 7b). These observations demonstrate that the 
respective protein ratios are strictly controlled in the cell.
Because the depletions of NOT1 and NOT3 efficiently co-depleted 
the other two partners, we expected that such depletions would affect 
adh-hsp70 mRNA degradation in a similar manner. Consistent with 
this expectation and a previous study25, the half-life of the hsp70 
mRNA reporter in NOT1- and NOT3-depleted cells increased almost 
ten-fold relative to control cells (210 ± 30 and 220 ± 20 min, respec-
tively; Fig. 7c,d and Supplementary Fig. 7f,g).
Next, we performed complementation assays, wherein NOT1 or 
NOT3 mutants were tested for their ability to restore mRNA degra-
dation in cells that were depleted of the corresponding endogenous 
protein. Reintroduction of a double-stranded RNA (dsRNA)-resistant 
version of wild-type NOT1 partially restored the degradation of the 
reporter and reduced the mRNA half-life to 49 ± 3 min in NOT1-
depleted cells (Fig. 7c and Supplementary Fig. 7f). In contrast, 
the NOT1 ∆N-SD mutant did not restore degradation, and the 
adh-hsp70 mRNA half-life (220 ± 23 min) was similar to that observed 
in NOT1-depleted cells (Fig. 7c and Supplementary Fig. 7f), even 
though expression was higher for the NOT1 mutant than for the 
wild-type (Fig. 7e).
Similarly, the reintroduction of a dsRNA-resistant version of 
wild-type NOT3 restored the degradation of the reporter and 
reduced the mRNA half-life to 62 ± 30 min in NOT3-depleted cells 
(Fig. 7d and Supplementary Fig. 7g). In contrast, the NOT3 ∆NAR 
mutant did not restore degradation (half-life > 240 min; Fig. 7d), 
even though the mutant was expressed at similar levels to wild-type 
NOT3 (Fig. 7e).
In summary, these experiments demonstrate a strict requirement 
for the cell to balance the levels of the NOT-module protein compo-
nents. They also show that a properly assembled NOT module, as 
observed in the crystal structure, is essential for the activity and/or 
recruitment of the CCR4–NOT complex and hence is crucial for 
mRNA degradation.
DISCUSSION
Unusual assembly principles for the NOT module
A remarkable and unexpected structural feature of the NOT mod-
ule is the role that the NAR and CS regions of CNOT2 and CNOT3 
have in the assembly of the trimer. Particularly striking is that these 
regions not only hook up onto their prefolded molecular partners, 
as observed in assemblies such as the ribosome27,28, but also stabi-
lize each other and exclusively orchestrate the three-dimensional 
assembly of the entire NOT module. This mode of assembly is rather 
unusual and is clearly distinct from the classical principle of mutual 
recognition by complementary tertiary structures such as observed 
for the interaction of CAF1 with the NOT1 MIF4G domain10,14. 
In particular, the embracement of the NOT-box domains by the CSs, 
the formation of the junction and the adaptation of the NAR-Cs to the 
CNOT1 surface could not happen without disorder-to-order transi-
tion and cofolding29.
According to the most general definition, the NAR and CS regions 
could be classified as intrinsically disordered, i.e., as protein sequences 
that are largely unstructured in the absence of their specific binding 
partners and that adopt their three-dimensional shape only upon bind-
ing30,31. This classification is based primarily on the lack of secondary-
structure elements and of intramolecular contacts, which means that 
the relative orientation of the amino acids as observed in the complex 
will not be fixed in the absence of the binding partner. Consequently, 
the sequences are presumably disordered in isolation, as reflected 
by the susceptibility to proteolytic degradation (Supplementary 
Fig. 4a,b). However, sequence analysis does not identify the NAR and 
CS regions as typical intrinsically disordered regions30,31.
In summary, we report the following new observations: first, even 
upon binding, the NAR and CS regions remain largely devoid of 
α-helices and β-strands, thus demonstrating that specific surface rec-
ognition and the formation of the structured core in the junction are 
possible without such elements. Second, rather than only threading 
along surface grooves, peptide regions of sufficient length, such as 
the CNOT2 NAR-C, can read out entire molecular surfaces by zig-
zagging back and forth. Third, synergistic cofolding29 of the CNOT2 
and CNOT3 assembly peptides leads to a mutual stabilization and 
a specific hydrophilic core at the junction between the two lobes of 
the complex. Fourth, the interaction with these peptides is the sole 
determinant for NOT-module assembly and for the relative orienta-
tion of the two structured lobes, thus demonstrating that assembly 
peptides without secondary structure can guide and determine the 
shape of multimolecular complexes. Finally, topological constraints 
such as the described interlocks between the CSs increase the struc-
tural complexity and additionally stabilize the assembly.
Control of protein ratios and NOT-module assembly
The unexpected topological complexity of the NOT module suggests a 
requirement for a hierarchical and coordinated assembly of the individ-
ual subunits with the CNOT3 NAR binding the CNOT1 surface before 
CNOT2. Additional complexity arises from both CNOT2 and CNOT3 
being able to form homodimers in the absence of their preferred bind-
ing partner, and these homodimers might compromise CCR4–NOT 
complex assembly or interfere with its function. Consequently, it is not 
surprising that the relative protein ratios of the NOT-module compo-
nents are tightly controlled in the cell. In this context, the NAR and 
CS regions could have additional functions. They could interact with 
general chaperones or even specialized assembly factors that prevent 
nonspecific aggregation and/or promote the ordered incorporation 
into the CCR4–NOT complex. Alternatively, the NAR and CS regions 
could trigger an accelerated degradation of the proteins in the absence 
of their binding partners32, owing to their susceptibility to cellular pro-
teases, thus providing a simple mechanism to coordinate the expres-
sion of the subunits of the complex.
Recruitment of the CCR4–NOT complex to mRNA targets
The CCR4–NOT complex is assembled through the interaction of a 
catalytic module with the NOT module. Although the catalytic subunits 
catalyze deadenylation, the NOT module orchestrates the recruitment 
of these subunits to mRNA targets. This is achieved through interac-
tions with RNA-associated proteins2,17 (including GW182, Bicaudal-C, 
Nanos, CUP and Roquin), which have been shown to interact with 
NOT-module components4,18–20,33–37. The molecular details of these 
interactions remain unknown. In this context, our structural analysis 
reveals a highly conserved solvent-exposed surface on the NOT mod-
ule that extends from the CNOT1 C-SD over the CNOT2 NAR to the 
CNOT3 NOT box (Supplementary Fig. 6a), and this surface probably 
provides a binding platform for conserved binding partners.
Remarkably, for the binding partners that have been characterized 
in more detail (GW182, Nanos and CUP)4,18–20,35,36, the regions that 
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mediate binding to the NOT module are predicted to be unstruc-
tured. Thus their interactions with the NOT module may follow a 
similar structural principle as observed for the NAR and CS regions of 
CNOT2 and CNOT3. For example, the GW182 proteins interact with 
the CCR4–NOT complex through tryptophan-containing motifs4,18–20 
that probably bind in hydrophobic pockets along the CNOT1 scaf-
fold and that may function similarly to the aromatic residues in the 
CNOT2 NAR-C. Understanding such interactions in molecular terms 
remains an important challenge for future studies.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Coordinates for the structures have been deposited 
in the Protein Data Bank under accession codes 4C0D (ternary com-
plex of CNOT1–CNOT2–CNOT3), 4C0E (SH domain of Ct NOT1), 
4C0F (NOT-box domain of CNOT2) and 4C0G (NOT-box domain 
of CNOT3).
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Coimmunoprecipitation assays and western blotting. Plasmids expressing 
CCR4–NOT deadenylase subunits and coimmunoprecipitation assays in human 
and Dm S2 cells have been previously described18. HA- and GFP-tagged proteins 
were detected with horseradish peroxidase–conjugated anti-HA18 (Roche 3F10; 
1:3,000) and anti-GFP antibodies18 (Roche 11814460001; 1:2,000), respectively. 
Endogenous human CNOT1 was detected with a polyclonal anti-CNOT1 anti-
body generated by immunization of rabbits with the purified untagged MIF4G 
domain of human NOT1 expressed in E. coli14 (1:2,000). Endogenous CNOT3 was 
detected with a commercially available anti-CNOT3 antibody (Abcam ab55681; 
1:1,000). The specificity of this antibody is shown in Figure 6. Endogenous Dm 
NOT1, NOT2 and NOT3 were detected with antibodies kindly provided by 
E. Wahle25,33. All western blots were developed with the ECL western blotting 
detection system (GE Healthcare).
In vitro pulldown assays. The indicated GST- or MBP-tagged CNOT1, CNOT2 
and CNOT3 fragments were expressed separately in BL21 (DE3) Star cells 
(Invitrogen) at 20 °C overnight. Cells were lysed in 10 mM HEPES, pH 7.6, 
300 mM NaCl and 1 mM DTT supplemented with lysozyme (1 µg/ml), DNaseI 
(5 µg/ml) and protease inhibitors. Cell lysates were sonicated and cleared by 
centrifugation. The cleared supernatants containing the respective binding part-
ners were mixed to obtain an approximately 1:1 ratio of the protein partners and 
incubated in binding buffer (10 mM HEPES, pH 7.6, 150 mM NaCl, 0.4% Triton 
X-100, 1 mM DTT, and protease inhibitors) for 20 min at 4 °C. After this, 50 µl 
(50% slurry) of Protino Glutathione agarose 4B beads (Macherey Nagel) or 50 µl 
(50% slurry) of amylose resin (New England BioLabs) was added to each sample, 
and incubation was continued for another hour at 4 °C with gentle rotation. Beads 
were washed three times with binding buffer. Bound proteins were eluted with 
2× sample buffer and analyzed by SDS-PAGE.
His6-tagged CNOT1 (residues 1565–2371) was expressed in E. coli BL21 (DE3) 
Star cells in LB medium at 20 °C overnight and purified through nickel-affinity 
chromatography followed by anion-exchange chromatography and finally size-
exclusion chromatography, with a running buffer containing 50 mM HEPES, 
pH 8.0, 400 mM NaCl, 10% glycerol and 2 mM DTT. The purified protein 
(20 µg) was added to 200 µl of lysate expressing the respective MBP-tagged 
CNOT2 or CNOT3 and incubated in binding buffer (10 mM HEPES, pH 7.6, 
300 mM NaCl, 1 mM DTT and protease inhibitors) for 20 min at 4 °C. After this, 
50 µl (50% slurry) of amylose resin was added to each sample, and incubation was 
continued for another hour at 4 °C with gentle rotation. Beads were washed three 
times with binding buffer. Bound proteins were eluted with 2× sample buffer and 
analyzed by SDS-PAGE.
In the experiment shown in Supplementary Figure 3g, MBP-tagged CNOT2 
and His6-tagged CNOT3 were coexpressed in E. coli. The heterodimers were 
co-purified with MBP pulldown and subsequent Ni-affinity purification (lanes 1 
and 2) or Ni-affinity purification and subsequent MBP pulldown (lanes 3 and 4). 
The stoichiometry of the complex was similar in all cases, thus indicating that the 
proteins heterodimerize in solution and that there was no excess of MBP-NOT2 
or His6-NOT3 homodimers.
Protein expression and purification. The DNA encoding Ct NOT1-C (residues 
1676–2193) was amplified by PCR from a synthetic template (Gene Art, codon-
optimized for E. coli) and inserted into XhoI and BamHI restriction sites of the 
pnYC vector, which provides an N-terminal His6-tag followed by a TEV protease 
site38. His6-tagged Ct NOT1-C was expressed in E. coli BL21 Star (DE3) cells at 
20 °C overnight. After an initial Ni-affinity purification step (Hi-Trap chelating 
HP Nickel column; GE Healthcare), the protein was purified by gel filtration 
(HiLoad Superdex 200 26/60; GE Healthcare), in a buffer containing 10 mM 
HEPES, 200 mM NaCl and 2 mM DTT, and concentrated to 7 mg/ml.
The DNA encoding the CNOT2 NOT-box domain (residues 429–540) was 
amplified from total human cDNA and inserted into the NdeI and BamHI restric-
tion sites of a pnYC vector downstream of a His6-MBP tag. The fusion protein was 
expressed in E. coli BL21 Star cells at 37 °C for 5 h and purified over a Ni-NTA 
column. After cleavage by HRV3C protease at 4 °C overnight, the His6-MBP tag 
was removed from the solution by binding to amylose resin and subsequent size-
exclusion chromatography (HiLoad 16/60 Superdex 75; GE Healthcare). Finally, 
the protein was purified with a MonoQ GL 15/50 column, dialyzed overnight 
into 10 mM CHES, pH 9.0, 100 mM NaCl and 1 mM DTT and concentrated 
to 3.5 mg/ml.
The DNA encoding the CNOT3 NOT-box domain (residues 656–753) was 
amplified by PCR using total human cDNA as template and inserted into the 
NcoI and KpnI sites of the pETM60 vector, which provides an N-terminal His6-
NusA tag (Novagen). The fusion protein was expressed in E. coli BL21 Star cells 
at 20 °C overnight. After initial purification with Ni-NTA affinity chromatogra-
phy, the His6-NusA tag was cleaved by TEV protease at 4 °C overnight. CNOT3 
was separated from the tag by size-exclusion chromatography (HiLoad 16/60 
Superdex 75, GE Healthcare) and concentrated to 4.5 mg/ml in 10 mM CHES, 
pH 9.0, 150 mM NaCl and 1 mM DTT.
To obtain selenomethionine-substituted proteins, the CNOT2 NOT-box, 
CNOT3 NOT-box and Ct NOT1-C proteins were expressed in minimal medium 
supplemented with selenomethionine39 and purified as described for the respec-
tive native proteins.
The trimeric complex consisting of CNOT1 (residues 1565–2371), CNOT2 
(residues 344–540) and CNOT3 (residues 607–753) was coexpressed in E. coli 
BL21 (DE3) Star cells in LB medium at 20 °C overnight. CNOT1 was expressed 
with an N-terminal His6-tag cleavable with TEV protease. CNOT2 and CNOT3 
were expressed from a bicistronic plasmid, wherein CNOT2 contained an 
N-terminal MBP tag cleavable by HRV3C protease, and CNOT3 contained a 
noncleavable His6 tag.
CNOT1, CNOT2 and CNOT3 were co-purified from crude lysates in 
lysis buffer (50 mM sodium phosphate, pH 7.5, 300 mM NaCl and 2 mM 
β-mercaptoethanol, supplemented with protease inhibitors, lysozyme and 
DNaseI) with amylose resin and eluted with lysis buffer supplemented with 
25 mM maltose. The purified complex was digested overnight with HRV3C and 
TEV proteases during dialysis into imidazole buffer (10 mM Tris-HCl, pH 8.6, 
200 mM NaCl, 2 mM β-mercaptoethanol, 10% glycerol and 20 mM imidazole). 
The complex was further purified by Ni-affinity chromatography and finally 
by size-exclusion chromatography (HiLoad Superdex 75 16/60 column; GE 
Healthcare) in gel-filtration buffer (10 mM Tris-HCl, pH 8.6, 200 mM NaCl and 
2 mM DTT). The ternary complex was subjected to limited proteolysis for 4.5 h 
in proteolysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 50 µM CaCl2 and 
2 mM DTT) supplemented with 21 µg/ml thermolysin (Sigma-Aldrich) and 
separated from the protease and smaller CNOT1 fragments by gel filtration.
For the experiment shown in Supplementary Figure 4b, the ternary complex 
was assembled in 30 µl of proteolysis buffer with CNOT2 (residues 344–540) and 
CNOT3 (residues 607–753) at a concentration of 0.3 mg/ml and 0.63 mg/ml 
CNOT1 (residues 1833–2361). The binary complex of CNOT2 (residues 344–
540) and CNOT3 (residues 607–753) was diluted in 30 µl of proteolysis buffer 
to a concentration of 0.3 mg/ml. After addition of 8 µl thermolysin (0.3 mg/ml) 
and incubation on ice, the reaction was stopped at different time points with 
10 µl 5× SDS gel loading buffer and analyzed on a 15% SDS-PAGE gel.
Crystallization. Crystals of the native and selenomethionine-substituted 
Ct NOT1-C constructs were obtained by hanging-drop and sitting-drop vapor 
diffusion, respectively, at 18 °C and 22 °C. The best crystals for data collection and 
phase determination were obtained with selenomethionine-substituted protein, 
from a condition containing 0.1 M MES, pH 6.0, 0.18 M MgCl2, 5% PEG 20000 
and 10 mM proline with a 1:1 protein/reservoir ratio. Crystals were cryoprotected 
by addition of a final concentration of 25% glycerol to the reservoir solution and 
then flash-frozen in liquid nitrogen before data collection.
Crystals of the native CNOT2 NOT-box domain were grown by hanging-drop 
vapor diffusion at 18 °C. The protein solution was mixed in a 1:1 ratio with a 
reservoir solution containing 100 mM trisodium citrate, pH 5.6, 10% PEG 4000 
and 10% isopropanol. Crystals were optimized by hair seeding. Before being flash 
frozen in liquid nitrogen, the crystals were cryoprotected in the reservoir solution 
supplemented with 15% or 20% glycerol (final concentration). Crystals of the 
selenomethionine-substituted CNOT2 construct were obtained by sitting-drop 
vapor diffusion at 22 °C over a reservoir of 100 mM HEPES, pH 7.5, 10% PEG 
4000 and 10% isopropanol.
Crystals of the native and selenomethionine-substituted CNOT3 NOT-box 
domain were grown by hanging-drop vapor diffusion in a 1:1 protein/reservoir 
ratio, with the reservoir buffer containing 100 mM HEPES, pH 7.8, 13% PEG 
4000, 2% glycerol and 12% isopropanol at 18 °C. Crystals were optimized by hair 
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seeding and were flash frozen in liquid nitrogen. Glycerol (supplemented to 20% 
in the reservoir solution) was used as a cryoprotectant.
Crystals of the CNOT1–CNOT2–CNOT3 complex were obtained once in a 
single condition. They grew after one day by sitting-drop vapor diffusion at 22 °C 
in a drop consisting of 0.2 µl of the protein complex solution (5 mg/ml) and 
0.2 µl of the reservoir solution containing 0.1 M MES, pH 6.5 and 12% PEG 
20000. The crystals were cryoprotected with the reservoir solution supplemented 
with glycerol (15% final concentration) and flash frozen in liquid nitrogen.
Data collection, structure solution and refinement. All diffraction data sets 
were recorded on a PILATUS 6M detector at the PXII beamline of the Swiss Light 
Source (SLS) at a temperature of 100 K. Data sets for different crystal forms of Ct 
NOT1-C were collected at a wavelength of 0.97925 Å with high redundancy and 
processed with XDS40. Selenium sites were identified with data sets from crystal 
form I (space group P212121, 3.6 Å) with SHELX41. These sites were used to 
obtain phases, and an initial backbone model was built with PHENIX AutoSol42. 
This model was fed into Buccaneer43 from the CCP4 package44 for assigning and 
autobuilding side chains. The sequence register was confirmed by inspection 
of the anomalous difference Fourier maps from the selenomethionine data set, 
with peaks corresponding to the methionine positions. After several rounds of 
refinement in PHENIX45 and manual model improvement in Coot46, the model 
was used for molecular replacement (Phaser)47 with a data set of crystal form II 
(space group P1211, 3.2 Å). The structure was finalized by several cycles of man-
ual building in Coot and refinement in PHENIX against this high-resolution 
data set. For Ct NOT1, 98.3% of all residues lie in the favored regions of the 
Ramachandran plot, with outliers totaling 0.2%.
Data for the native CNOT2 NOT-box domain were collected at a wavelength 
of 1.0 Å, whereas data from selenomethionine-labeled crystals were recorded 
at a wavelength of 0.97925 Å (peak). The best native crystal of CNOT2 led to a 
data set of 2.4-Å resolution with space group P6522, whereas the best data set 
of selenomethionine-substituted protein reached a resolution of 3.4 Å with a 
space group of P41. Data sets were processed in XDS40. Initial selenium sites 
were identified by SAD with SHELX and refined with SHARP48. Additional sites 
were identified upon inspection of the anomalous difference density map and 
refined with SHARP. The resulting electron density map was used for initial 
model building with Buccaneer. The model was subsequently improved manually 
in Coot and refined with PHENIX. The high-resolution structure of the native 
protein was solved by molecular replacement (Phaser) with the structure of the 
selenomethionine-substituted protein as the search model. The structure of the 
native protein was finalized by iterative refinement cycles with PHENIX and 
model building in Coot.
The data sets for the CNOT3 NOT-box domain were collected at wavelengths 
of 0.9795 Å (peak) and 1.0000 Å (low-energy remote) and processed with XDS. 
Selenium sites were identified by SAD with SHELX. The heavy-atom model was 
further improved with SHARP as described for CNOT2. The model was ini-
tially built with Buccaneer and manually completed in Coot. Refinement was 
done in PHENIX against the low-energy remote data set, which had the highest 
resolution (2.4 Å). For the NOT-box domains of CNOT2 and CNOT3, there are 
98.3% and 97.4% of all residues in the favored regions of the Ramachandran plot, 
respectively, and no outliers.
Diffraction data for the complex of CNOT1–CNOT2–CNOT3 were recorded 
at a wavelength of 0.99999 Å. The best data set was processed and scaled with 
XDS/XSCALE. Initial phase information was obtained by molecular replace-
ment with Phaser, with the structure of Ct CNOT1-C as a search model. The 
initial electron density was improved by solvent flattening with PARROT49 from 
the CCP4 package, and the previously determined models of the CNOT2 and 
CNOT3 NOT-box domains were manually placed into the density map with 
Coot. The CNOT1 model was subsequently rebuilt with the sequence of the 
human protein. Additional parts of the structure, which primarily consisted of 
the N-terminal extensions of the CNOT2 and CNOT3 NOT-box domains, were 
manually built in Coot. The model was subsequently improved by iterative cycles 
of refinement and building with PHENIX and Coot. For the ternary complex, 
96.7% of all residues were in the favored regions of the Ramachandran plot, and 
there were no outliers. The correct stereochemical properties of all the structures 
were verified with MolProbity50, and structure figures were generated in PyMOL 
(http://www.pymol.org/). The data collection and refinement statistics are sum-
marized in Table 1.
Multiangle static laser light scattering (MALLS). The purified CNOT2 NOT-
box and CNOT3 NOT-box proteins were diluted to a final concentration of 
20 µM in their respective storage buffers. For both proteins, a volume of 100 µl 
was loaded onto an analytical gel-filtration column (Superdex 200 10/300, 
GE Healthcare) connected to the miniDAWN TREOS and Optilab rEX instru-
ments (Wyatt Technologies). Samples were analyzed by static light scattering, and 
the absolute molecular weight of each protein was calculated from the MALLS 
data with ASTRA (Wyatt Technologies).
Functional assays in S2 cells. The adh-hsp70 reporter was described previ-
ously51. Cells were transfected with 300 ng of plasmid DNA for expression of 
the adh-hsp70 reporter per well in six-well plates. Knockdowns with dsRNA were 
performed as described previously18. For the measurement of the mRNA half-life, 
transfected cells were treated with actinomycin D (final concentration 5 µg/ml) 
3 d after transfection and harvested at the indicated time points. Total RNA was 
isolated with TriFast (PeqLab Biotechnologies) and analyzed as described previ-
ously51. Adh-hsp70 mRNA levels were normalized to the levels of long-lived rp49 
mRNA and were plotted against time.
Original images of gels and western and northern blots used in this study can 
be found in Supplementary Figure 8.
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Supplementary Figure 1 CNOT1, CNOT2 and CNOT3 interact via their C-termini. (a,b) Interaction between GFP-tagged 
CNOT2 (full-length or fragments) and HA-tagged CNOT1 (a) and CNOT3 (b). GFP-tagged MBP served as a negative control. 
In all panels, cell lysates were treated with RNase A. (c,d) Interaction between GFP-tagged CNOT3 (full-length or fragments) 
and HA-tagged CNOT2 (c) and CNOT1 (d). (e,f) Interaction between GFP-tagged CNOT1 (full-length or fragments) and 
HA-tagged CNOT2 (e) and CNOT3 (f). In panel (f), the interaction with CNOT3 was analyzed in the absence (lanes 2 and 6) 
or presence (lanes 4 and 8) of CNOT2. (g) Interaction between MBP-CNOT2 fragments and His6-tagged CNOT1 (residues 
1565–2371). (h) Interaction between MBP-CNOT2 fragments and GST-CNOT3 (residues 589–753). (i) Interaction between 
MBP-CNOT2 (residues 344–540) and GST-CNOT3 fragments. (j) Interaction between MBP-CNOT1 (residues 1595–2376) 
and GST-CNOT2 (residues 344–540) or GST-CNOT3 (residues 589–753). 
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Supplementary Figure 2 Structure-based sequence alignment of the NOT1 superfamily homology (SH) domain. Secondary 
structure elements as determined from the Hs CNOT1 structure are shown above the alignment. Residues conserved in all aligned 
sequences are shown with a yellow background and residues with >70% similarity are highlighted in orange. Residues interacting 
with CNOT2 and CNOT3 are indicated by purple and green dots, respectively. Residues involved in CNOT1 subdomain interactions 
are indicated by blue dots. Residues mutated in this study are marked by red asterisks. Residues substituted in mutant M1 and M5 
are indicated. The species abbreviations are as follows: Hs (Homo sapiens), Dm (Drosophila melanogaster), Xt (Xenopus tropicalis), 
Ce (Caenorhabditis elegans), Ct (Chaetomium thermophilum) and Sc (Sacchromyces cerevisiae).
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Supplementary Figure 3 CNOT2 and CNOT3 multimerize in solution. (a,d) MALLS analysis of the CNOT3 and CNOT2 NOT-box domains, 
respectively. The molecular weight of the protein in solution is indicated in the elution profile. (b) Interfaces between the CNOT3 NOT-box 
α-helices and the β-barrel. Residues along the interfaces are shown as sticks. (c) Hydrophobic core of the CNOT3 NOT-box β-barrel.
(e) Structure of the CNOT2 tetramer as observed in the crystal. The tetramer consists of two pairs of dimers (orange-yellow vs. purple-rose) 
with a perpendicular orientation to each other. (f) Structure-based sequence alignments of the NOT2 and NOT3 NOT-box domains. 
Secondary structure elements as determined from the CNOT2 and CNOT3 structures are shown above the alignment. Residues conserved 
in all aligned sequences are shown with a yellow background, and residues with >70% similarity are highlighted in orange. A NOT2-specific 
insertion is boxed in purple. Black squares mark residues that form the interface between the NOT-Box N-terminal α-helices and the 
β-barrel. Gray squares mark residues that form the hydrophobic core of the β-barrel. The species abbreviations are the same as those in 
Supplementary Fig. 2. (g) Pulldowns showing that CNOT2-C and CNOT3-C exclusively form heterodimers in solution. MBP-tagged CNOT2 
and His6-tagged CNOT3 were coexpressed in E. coli. The heterodimers were copurified using MBP pulldown followed by Ni-affinity 
purification (lanes 1 and 2) or Ni-affinity purification followed by MBP pulldown (lanes 3 and 4). 
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Supplementary Figure 4 Structure of the NOT module. (a) Time course of a limited proteolysis of the ternary complex between CNOT1 
(residues 1565–2371), CNOT2 (residues 344–540) and CNOT3 (residues 607–753) by thermolysin. CNOT1 is digested into a stable 
C-terminal fragment corresponding to the SH and an N-terminal fragment (which comigrates with CNOT2), while CNOT2 and CNOT3 
remain uncleaved. (b) Time course of a limited proteolysis of CNOT2 (residues 344–540) and CNOT3 (residues 607–753) by thermolysin 
in the absence or presence of CNOT1 SH (1833–2361). In the absence of CNOT1, CNOT2 and CNOT3 are digested into stable C-terminal 
fragments corresponding approximately to the NOT-boxes and the CSs, but they remain largely uncleaved in the presence of CNOT1 
(c,d) Omit electron density map of the CNOT2 (c) and CNOT3 (d) NAR-Cs folded onto the CNOT1 surface. The electron density (black 
mesh, 2F0-FC of a composite omit map, calculated with Phenix.AutoBuild) is contoured at 1.0 σ. (e,f) Refined electron density of the 
CNOT2 (e) and CNOT3 (f) NAR-C regions in stereo view. The views correspond to panels (c) and (d), respectively. The electron density 
(black mesh, 2F0-FC map) is contoured at 1.0 σ. (g) Superposition of Ct NOT1 (blue) and Hs CNOT1 (gray) showing strong structure 
conservation. (h) Superposition of the CNOT3 NOT-box domain in isolation (gray) and in the complex (green). (i) Superposition of the 
NOT-box domains of CNOT2 (purple) and CNOT3 (green) as observed in the ternary complex. 
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Supplementary Figure 5 Structure-based sequence alignment of the CNOT2 and CNOT3. Secondary structure elements as 
determined from the CNOT2 and CNOT3 structure are shown above the alignment. Symbols are as described in Supplementary Fig. 2. 
Residues interacting with the respective partner proteins are indicated by dots above the alignments and are colored blue for CNOT1, 
purple for CNOT2 and green for CNOT3. Residues forming the lock are marked with black diamonds, and residues at the junction 
between the symmetric and asymmetric lobes of the ternary complex are marked with pink triangles. The species abbreviations are the 
same as those in Supplementary Fig. 2.
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Supplementary Figure 6 Surface conservation of the trimeric complex. (a–e) The conservation scores of the 
individual residues are represented on the surface by color gradients from light (no conservation) to dark colors 
(100% conservation) for CNOT1 (blue), CNOT2 (purple) and CNOT3 (green). Conservation scores were calculated 
based on well-balanced multiple alignments covering all eukaryotic strata. (a) View from the CNOT1 surface that 
binds CNOT2 and CNOT3 (a) or the opposite surface (b). Conservation of the CNOT1 surface contacting CNOT2 
and CNOT3 (c). The view is the same as that shown in Fig. 5a. (d) Conservation of CNOT2 surface residues 
contacting the CNOT3 connector sequence (CS). The CNOT3 residues involved in the interaction with CNOT2 are 
shown as sticks. (e) Conservation of CNOT3 surface contacting the CNOT2 connector sequence (CS). The CNOT2 
residues involved in CNOT3 binding are shown as sticks.
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Supplementary Figure 7 Mutagenesis of the NOT1-NOT2-NOT3 interfaces in human and Dm S2 cells. (a) Interaction of 
GFP-CNOT1 (either wild-type or the indicated mutants) with endogenous CNOT3 and HA-CNOT2. (b,c) Interaction of 
GFP-CNOT1 (either wild-type or the indicated mutants) with HA-CNOT7 in human cells. (d) The decay of the adh-hsp70 
mRNA was monitored in control cells (expressing MBP) and in cells expressing NOT1 (either wild-type or mutant). Adh-hsp70 
mRNA levels were normalized to the levels of long-lived rp49 mRNA and plotted against time. A representative Northern blot is 
shown in Fig. 7a. The mRNA half-lives (t1/2) ± standard deviations calculated from the decay curves obtained from three 
independent experiments are indicated. (e) Interaction of GFP-tagged Dm CAF1 with wild-type NOT1 or NOT1ΔN-SD in S2 
cells. F-Luc-GFP served as a negative control. (f,g) The decay of adh-hsp70 mRNA was analyzed in control cells (treated with 
GFP dsRNA and expressing MBP) or in cells depleted of NOT1 or NOT3 and expressing MBP or the indicated proteins. 
Northern blots corresponding to the decay curves are shown in Fig. 7c and 7d, respectively. Adh-hsp70 mRNA levels were 
normalized to the levels of rp49 mRNA and plotted against time. The mRNA half-lives (t1/2) ± standard deviations obtained 
from three independent experiments are indicated. 
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Supplementary Figure 8 Original images of gels, western and northern blots used in this 
study.
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Supplementary Table 1. Mutants used in this study 
 
Name Dm NOT1 Hs CNOT1 
ΔN-SD Δ1967-2251 Δ1844-2133 
M1 P2150Y, F2152C, 
E2158A, P2205Q, 
L2208E 
P2032Y, Y2036C, 
E2040A 
M2 P2150Y, F2152C, 
E2158A, P2205Q, 
L2208E, E2421A 
P2032Y, Y2036C, 
E2040A, P2087Q, 
I2090E, E2302A 
M3 P2150Y, F2152C, 
E2158A, P2205Q, 
E2421A, L2208E, 
R2215D 
P2032Y, Y2036C, 
E2040A, P2087Q, 
I2090E, R2097D, 
E2302A, I2313R 
M4  P2150Y, F2152C, 
E2158A, P2205Q, 
E2421A, L2208E, 
R2215D, I2432R 
 
M5  E2302A+I2313R 
M6  R2097D+I2313R 
CNOT1-N  1–1089 
CNOT1-M  1085–1605 
CNOT1-C  1595–2376 
 
 
Name Dm NOT2 Hs CNOT2 
ΔN-CS Δ 458−482 Δ 409−432 
ΔαN Δ 393−429 Δ 344−380 
ΔN-NAR-C Δ 429−453 Δ 380−404 
L7 W556E W507E 
CNOT2-N  1–352 
CNOT2-C  344–540 
 
 
Name Dm NOT3 Hs CNOT3 
ΔN-CS Δ 723−745 Δ 632−654 
ΔNAR Δ 698−725 Δ 607−634 
α2 F764E F673E 
CNOT3-N  1–241 
CNOT3-M  239–590 
CNOT3-C  589–753 
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SUMMARY
CCR4-NOT is a major effector complex in miRNA-
mediated gene silencing. It is recruited to miRNA
targets through interactions with tryptophan (W)-
containing motifs in TNRC6/GW182 proteins and is
required for both translational repression and degra-
dation of miRNA targets. Here, we elucidate the
structural basis for the repressive activity of CCR4-
NOT and its interaction with TNRC6/GW182s. We
show that the conserved CNOT9 subunit attaches
to a domain of unknown function (DUF3819) in the
CNOT1 scaffold. The resulting complex provides
binding sites for TNRC6/GW182, and its crystal
structure reveals tandemW-binding pockets located
in CNOT9. We further show that the CNOT1 MIF4G
domain interacts with the C-terminal RecA domain
of DDX6, a translational repressor and decapping
activator. The crystal structure of this complex dem-
onstrates striking similarity to the eIF4G-eIF4A com-
plex. Together, our data provide themissing physical
links in a molecular pathway that connects miRNA
target recognition with translational repression,
deadenylation, and decapping.
INTRODUCTION
miRNAs are endogenous noncoding RNAs that associate with
Argonaute proteins (AGOs) into miRNA-induced silencing com-
plexes (miRISCs) and posttranscriptionally silence the expres-
sion of mRNAs containing complementary sequences (Ameres
and Zamore, 2013). In animals, most mRNA targets are only
partially complementary to the miRNA. As a result, even catalyt-
ically active AGOs cannot cleave the mRNA target and recruit
additional proteins to mediate silencing (Fabian and Sonenberg,
2012; Braun et al., 2013).
GW182 proteins are the best-characterized AGO-binding
partners required for miRNA-mediated silencing in animal
cells (Fabian and Sonenberg, 2012; Braun et al., 2013). There
are three GW182 paralogs (termed TNRC6A, TNRC6B, and
TNRC6C) in vertebrates and only one family member in
Drosophila melanogaster (DmGW182; Braun et al., 2013). These
proteins bind directly to AGOs via multiple GW (glycine and tryp-
tophan) repeats present in the N-terminal AGO-binding domain
and then recruit effector complexes, such as the CCR4-NOT
and PAN2-PAN3 deadenylase complexes (Braun et al., 2013).
Similar to the interaction with AGOs, GW182 proteins interact
with the deadenylase complexes through W-containing motifs,
which in this case are located in their C-terminal silencing do-
mains (SDs) (Figure 1A; Braun et al., 2011; Chekulaeva et al.,
2011; Christie et al., 2013; Fabian et al., 2011; Huntzinger
et al., 2013). The crystal structures of human AGO2 and Dm
PAN3 homodimers have revealed the molecular basis for their
interaction with the W-containing motifs in GW182 proteins
(Schirle and MacRae, 2012; Christie et al., 2013). However, it is
not known how the W motifs interact with the CCR4-NOT
complex.
The CCR4-NOT complex consists of several independent
modules that dock with the NOT1 subunit, which serves as a
scaffold for complex assembly (Wahle and Winkler, 2013).
NOT1 consists of an N-terminal (NOT1-N), middle (NOT1-M),
and C-terminal (NOT1-C) region (Figures 1A and S1A available
online). The NOT1-M region comprises two domains: a MIF4G
domain that is structurally related to the middle domain of
eIF4G and a domain of unknown function (DUF3819). The
MIF4G domain interacts with the catalytic module of the
CCR4-NOT complex, comprising the two deadenylases CAF1
(or its paralog POP2) and CCR4a (or its paralog CCR4b) (Wahle
and Winkler, 2013). The DUF3819 domain interacts with the
highly conserved Armadillo (ARM) repeat domain of the
CNOT9 subunit (Figure 1A; also known as CAF40, RQCD1, or
RCD1) (Bawankar et al., 2013). Importantly, the CNOT1-M region
has been shown to mediate the interaction of CCR4-NOT with
the silencing domain of TNRC6C (6C-SD) (Huntzinger et al.,
2013). Furthermore, the RNA helicase DDX6 (also known as
Dhh1, RCK/p54, or Me31B) also interacts with CNOT1 (Coller
et al., 2001; Hata et al., 1998; Maillet and Collart, 2002). DDX6
functions as a translational repressor and decapping activator
(Presnyak and Coller, 2013) and has previously been implicated
in the miRNA pathway (Chu and Rana, 2006; Eulalio et al., 2007;
Nishihara et al., 2013).
The CCR4-NOT complex not only mediates mRNA deade-
nylation, but it is also required both for the translational
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repression and degradation of miRNA targets (Braun et al., 2011;
Chekulaeva et al., 2011; Fabian et al., 2011; Huntzinger et al.,
2013; Zekri et al., 2013). miRNA target degradation is catalyzed
by the enzymes of the 50-to-30 mRNA decay pathway (Hunt-
zinger and Izaurralde, 2011). In this pathway, mRNAs are first
deadenylated by the CCR4-NOT complex, decapped by the
decapping enzyme DCP2 and additional coactivators, and
finally degraded from the 50 end by the exonuclease XRN1.
However, it has remained unclear whether and how decay
factors, including the decapping enzyme DCP2 and the 50
exonuclease XRN1, would be recruited directly by the CCR4-
NOT complex. Similarly, the mechanism of translational repres-
sion by CCR4-NOT has remained elusive, although it has
recently been proposed that the DEAD-box protein eIF4A2
may play a role (Meijer et al., 2013). In particular, it was sug-
gested that the CNOT1 MIF4G domain could recruit eIF4A2
via an interaction similar to the one observed in the eIF4G-
eIF4A complex (Meijer et al., 2013). eIF4A2 could then prevent
ribosome scanning by clamping onto the 50 UTR of the mRNA
(Meijer et al., 2013).
In this study, we investigated the molecular basis for the inter-
actions mediated by the human CNOT1-M region and its role in
silencing. We show that the CNOT1 DUF3819 domain forms a
binary complex with the ARM repeat domain of the CNOT9 sub-
unit and was hence termed the CN9BD (CAF40/CNOT9 binding
domain). We pinpoint the CN9BD-CNOT9 complex as a primary
binding site for the TNRC6 silencing domains (TNRC6-SDs) in
the CNOT1-M region. The crystal structure of the CN9BD-
CNOT9 complex shows that the CN9BD adopts a defined fold
that is recognized and stabilized by CNOT9 binding. This struc-
ture also reveals tandemW-binding pockets in CNOT9, suggest-
ing a mechanism for the recruitment of the CCR4-NOT complex
by W-rich GW182/TNRC6 proteins. Furthermore, we identified
the CNOT1 MIF4G domain as a specific binding partner for
DDX6 rather than eIF4A2. The crystal structure of the MIF4G-
DDX6 complex reveals an eIF4G-eIF4A-like interaction, which
is compatible with the simultaneous binding of CAF1 to the
MIF4G domain and the recruitment of decapping factors
(EDC3, LSm14A, or Pat) by DDX6. Together, our data now allow
us to trace the direct molecular interactions that ultimately lead
from miRNA target recognition to the translational repression,
deadenylation, and decapping of the mRNA target.
RESULTS
Dual Functions of the CNOT1 DUF3819 Domain in
TNRC6 and CNOT9 Binding
To pinpoint the TNRC6-SD binding site within the CNOT1-M re-
gion (Figures 1A andS1A), we performed coimmunoprecipitation
assays in human embryonic kidney 293T (HEK293T) cells. We
found that TNRC6A-SD and TNRC6C-SD interacted primarily
with the DUF3819 domain rather than with the MIF4G domain
(Figures 1B and 1C, lane 9), overlapping with the sequences
required to bind the ARM repeat domain of CAF40/CNOT9 in
human cells (Figures 1B and 1C, lane 9, and S1B) and in Dm
Schneider (S2) cells (Figure S1C; Bawankar et al., 2013). The
DUF3819 domain was therefore termed the CAF40/CNOT9
binding domain or CN9BD.
To elucidate the molecular basis for the observed interac-
tions, we expressed suitable protein constructs in Escherichia
coli (Table S1) and used specific tags for pull-down assays
(Figure S1B) and protein purification. The ARM repeat domain
of CNOT9 (residues 19–285) formed homodimers in solution,
as observed previously (Garces et al., 2007) and as con-
firmed by size-exclusion chromatography and multiangle static
laser light scattering (MALLS; Figure S1D). Protein constructs
corresponding to the CN9BD precipitated upon removal of
the solubility tag, indicating instability or improper folding
in the absence of CNOT9. However, several CN9BD con-
structs (residues 1,356–1,581, 1,356–1,607, and 1,356–1,628)
could be coexpressed and copurified with the ARM repeat
domain of CNOT9 (Figure S1B). Under these conditions, size-
exclusion chromatography and MALLS indicate the forma-
tion of a binary CN9BD-CNOT9 complex that appears to
be mutually exclusive with CNOT9 homodimerization (Figures
S1D and S1E).
We obtained crystals of the CN9BD-CNOT9 complex that
diffracted X-rays to a 1.65 A˚ resolution (Table 1). Crystals
were exclusively obtained using the CN9BD 1,356–1,607
construct, although a shorter construct (CN9BD 1,356–1,581)
was also soluble and formed a binary complex with CNOT9
(Figure S1B). In a bid to identify putative TNRC6 binding sites,
we also crystallized the complex in the presence of L-trypto-
phan (W). These crystals diffracted X-rays to a 2.05 A˚ resolution
(Table 1).
Figure 1. Structure of the CNOT1 CN9BD Bound to the CNOT9 ARM Repeat Domain
(A) Diagram of CNOT1 with N-terminal, middle, and C-terminal regions (CNOT1-N, CNOT1-M, and CNOT1-C, respectively). CNOT1-N consists of two HEAT-like
repeat domains. CNOT1-M contains an MIF4G domain and the CN9BD (previously DUF3819). CNOT1-C contains the NOT1 superfamily homology domain
(SHD). CNOT9 contains an armadillo (ARM) repeat domain. TNRC6C contains and N-terminal AGO-binding domain (ABD), a ubiquitin-associated-like domain
(UBA), and a C-terminal silencing domain (SD). The SD comprises a Mid region, an RNA recognition motif (RRM), and a C-terminal (C-term) region. The positions
of the CCR4-NOT interacting motifs 1 and 2 (CIM-1 and CIM-2) and the PAM2motif (PABP-interacting motif 2) are indicated. Vertical green and red lines indicate
the positions ofW-containingmotifs binding to AGOs and deadenylases, respectively. Amino acid positions at domain boundaries are indicated below the protein
outlines. See also Figure S1A.
(B and C)Western blot showing the interaction between GFP-CNOT1 fragments and HA-MBP-tagged CNOT9 and HA-tagged TNRC6A-SD (6A-SD) or TNRC6C-
SD (6C-SD) in HEK293T cells. GFP-F-Luc served as a negative control. See also Figures S1B–S1H.
(D and E) Overall structure of the CN9BD-CNOT9 binary complex in two orientations. CNOT9 is shown in cyan; the three long a helices in the CNOT1 CN9BD are
shown in pink, yellow, and green. Bound W residues are shown as magenta sticks. Secondary structure elements are labeled in blue for CNOT9 and in black for
CNOT1.
(F) Cartoon representation of the ARM repeat domain of CNOT9. The ARM repeats are colored in a gradient from pink to dark blue from the N to C terminus.
(G) Surface representation of the CN9BD-CNOT9 binary complex in the same orientation as that in (D) and colored according to surface potential contoured
from 5 kT/e (red) to +5 kT/e (blue). The position of the DNA/RNA binding surface is indicated. See also Figures S1F and S1G.
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Crystal Structures of the CN9BD-CNOT9 Complex
The structures were solved by molecular replacement using the
CNOT9 structure (Protein Data Bank ID code [PDB] 2FV2; Gar-
ces et al., 2007) as a search model and refined to final Rfree
values of 17.9% in the absence and 21.5% in the presence of
L-tryptophan (Table 1 and Figures 1D and 1E). Overall, the two
structures are highly similar and superpose with a root-mean-
square deviation (rmsd) of 0.16 A˚ over 431 Ca atoms. The
CN9BD-CNOT9 complex adopts a V-shaped architecture result-
ing from the rod-shaped CN9BD bound to the N-terminal,
convex surface of the crescent-shaped CNOT9 (Figure 1E).
CNOT9 consists of 17 a helices arranged into 6 imperfect ARM
repeats (Figures 1F and S2). The structure of CNOT9 in the com-
plex is virtually identical to the structure of the isolated CNOT9
ARM repeat domain (rmsd of 0.51 A˚ over 246 equivalent Ca
positions; Figure S1F; Garces et al., 2007), indicating that
CNOT9 does not undergo major structural rearrangements
upon binding to CNOT1. The CN9BD-CNOT9 interface partially
overlaps with the CNOT9 homodimerization interface, as deter-
mined from the structure of the isolated CNOT9 (Figure 1D
versus S1G and Figures S3A–S3D; Garces et al., 2007). This
observation explains why CNOT1 binding is mutually exclusive
with CNOT9 homodimerization. In both of these alternative com-
plexes, a positively charged cleft located on the opposite,
concave face of the CNOT9 crescent remains exposed and fully
accessible to interact with potential RNA or DNA ligands (Fig-
ure 1G; Garces et al., 2007).
Intriguingly, the C-terminal tail of the CN9BD (residues 1,589–
1,607) is largely disordered but required for crystallization. It
makes a crystal contact with a neighboring CNOT9 molecule,
inserting W1603 into a specific W-binding pocket (pocket 1).
Consequently, W1603 is clearly defined in both structures
(Figures 1D and 1E; W1); at 1.65 A˚ resolution, the back-
bone of the flanking residues 1,601–1,604 is also visible (see
below). A second W-binding pocket (pocket 2) on CNOT9
becomes apparent and occupied in the presence of addi-
tional L-tryptophan in the crystallization solution (Figures 1D
and 1E; W2).
CN9BD Folds into a Defined Domain Arranged as a
Three-Helix Bundle
In contrast to all CNOT1 subdomains structurally determined so
far, the CN9BD is not organized into HEAT-like repeats. Instead,
it is composed of seven a helices, with helices a2–a4 arranged as
an antiparallel, rod-shaped bundle of three kinked a helices (Fig-
ures 1D and 1E). These helices comprise 42–44 residues and are
kinked once (a3) or twice (a2 and a4). The side of the bundle that
binds CNOT9 is flanked by three additional short helices (helices
a5–a7; Figures 1E and S4). Two of these helices (a6 and a7),
together with the connecting loop L6, are part of the interaction
interface and are likely adaptable. In the crystal, their position
might also be influenced by packing interactions because loop
L6 and helix a6 contact the equivalent structural elements of a
neighboring symmetry mate (Figure S4B). However, a CNOT1
fragment lacking helix a7 (1,356–1,561) did not interact with
CNOT9 in solution (Figure S1B), indicating that these helices
and the spatial arrangement observed in the crystal are indeed
relevant for complex formation.
One remarkable structural feature of the CN9BD is that both
the N- and C-terminal peptides fold back on the three-helix
bundle, forming multiple hydrophobic interactions (Figures 2A,
2B, and S4C). As a result, the N and C termini of the domain
enter close proximity and form a main-chain contact between
Y1357 and F1582 (Figures 2A and 2B). Furthermore, the C-ter-
minal peptide (around P1580-G1581) becomes locked into its
conformation by interactions with CNOT9 residues V71 and
P75 (Figure 2C), consistent with the observation that a deletion
of the C-terminal peptide destabilizes the interaction between
the Dm proteins (Figure S1C). Overall, the CN9BD adopts a
rather unique protein fold that has no close structural homologs
in the PDB.
Table 1. Data Collection and Refinement Statistics
Data Set
CNOT1-
CNOT9
Complex
CNOT1-
CNOT9-W
Complex
CNOT1-
DDX6
Complex
Space group C2 C2 P21 21 21
Unit Cell
Dimensions
(a / b / c) (A˚)
154.8 / 67.2 /
72.3
154.1 / 66.8 /
72.0
43.9 / 90.8 /
95.8
Angles (a / b / g) () 90 / 99.6 / 90 90 / 100.3 / 90 90 / 90 / 90
Data Collection
Wavelength (A˚) 1.000 1.000 1.000
Resolution range (A˚) 76.3–1.65
(1.69–1.65)
61.1–2.05
(2.10–2.05)
65.9–1.75
(1.80–1.75)
Rsym (%) 2.9 (63.6) 6.0 (78.6) 5.3 (78.9)
Completeness (%) 99.5 (99.0) 99.5 (99.0) 99.2 (99.5)
Mean I/s(I) 19.8 (1.8) 14.9 (1.8) 17.1 (2.3)
No. of unique
reflections
87,658 (6,377) 45,149 (3,317) 39,120 (2,837)
Multiplicity 3.4 (3.4) 6.8 (6.4) 5.0 (5.0)
Refinement
Data range (A˚) 76.3–1.65 61.1–2.05 47.9–1.75
Rwork (%) 16.0 17.6 16.2
Rfree (%) 17.9 21.5 20.3
No. of Atoms per Asymmetric Unit
All atoms (no H) 4,590 4,178 3,386
Nonsolvent 4,116 4,030 3,193
Water 474 148 193
Average B Factor (A˚2)
All atoms 38.5 64.3 31.3
Nonsolvent 37.9 64.5 30.7
Water 43.6 58.7 41.3
Ramachandran Plot
Favored regions (%) 99.0 98.8 99
Disallowed
regions (%)
0 0 0
Root-Mean-Square Deviation from Ideal Geometry
Bond lengths (A˚) 0.011 0.006 0.011
Bond angles () 1.27 0.88 1.31
Values in parentheses are for highest-resolution shell.
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CNOT9Recognizes and Stabilizes the Fold of theCN9BD
The interface between CNOT1 and CNOT9 is larger than the
interface for CNOT9 homodimerization (3,170 A˚2 versus
2,005 A˚2; Figures S3B–S3D) and thus likely favored in vivo. It is
predominantly hydrophobic and centered on the first three
N-terminal ARM repeats (ARM1–ARM3) of CNOT9, which
engage a surface composed of helices a2, a3, a6, a7, loop L6,
and the very C-terminal end (C-term) of the CNOT1 CN9BD (Fig-
ures 1D, 1E, 2A, 2C, and 2D).
ARM1 includes an important serine (S30) and fixes loop L6
and helix a7, whereas ARM3, which includes an important
phenylalanine (F118), contacts helices a2 and a3 (Figure S2).
ARM2 makes numerous contacts, including each of the
CNOT1 interface elements. In particular, the central F60 in
the elbow loop L3, between ARM2 helices a3 and a4, and the
following helix a4 insert into a hydrophobic groove of the
CN9BD that is flanked by CNOT1 helices a2, a3, and a7 (Figures
2A–2D, S2, and S4). The respective interface residues include
F60 (L3), G61 (L3), A64 (a4), L67 (a4), V71 (a4), Y74 (L4), P75
(L4), and P79 (L4) on the side of CNOT9. On the side of
CNOT1, there are T1419 (a2), I1423 (a2), K1426 (a2), D1427
(a2), F1428 (a2), M1444 (a3), L1448 (a3), G1451 (a3), I1455
(a3), M1452 (a3), R1458 (a3), L1559 (L6), V1564 (L6), Q1568
(L6), L1569 (L6), V1571 (a7), Y1572 (a7), F1575 (a7), P1580
(C-term), and G1581 (C-term). These complex hydrophobic
contacts allow CNOT9 to recognize and stabilize the CN9BD
as a folded domain.
Additional polar flanking interactions provide further speci-
ficity and, in particular, allow helix a6 of the CN9BD to adapt to
the surface of CNOT9. Here, CNOT9 H58 plays an important
role. It is read out by water-mediated hydrogen bonds from
Q1549 (a6) and from the invariant lysine K1426 (a2) of the
CN9BD and additionally stacks on Y1548 (a6; Figure 2D).
To validate the interface, we initially generated single point
mutations, but these only reduced the interaction (e.g., F60A)
or had no effect (A64Y; Figure S4D). To disrupt the interface, it
was necessary to introduce four mutations in CNOT9 (Mut1;
H58A, F60A, A64Y, V71Y) or in the CNOT1 CN9BD (43M;
K1426S, G1451Y, R1458A, Q1549A; Figures S4D and S4E).
Importantly, the CNOT9 Mut1 retained the ability to homodimer-
ize (Figure S1H), indicating that themutations do not disrupt pro-
tein folding.
For in vivo coimmunoprecipitation assays in HEK293T cells, it
was also necessary to use the quadruple CNOT9 mutation
(Mut1) to disrupt the interaction with full-length CNOT1 or with
the CNOT1-M region (Figures 2E and S4F). In CNOT1, it was
even necessary to generate a quintuple mutation (53M;
I1423D plus 43M) because the quadruple mutation still showed
residual binding (Figures 2F and S4G). These results are consis-
tent with a rather extensive and high-affinity interaction.
Finally, to demonstrate the conservation of the interface, we
repeated the coimmunoprecipitation experiments in Dm S2
cells. Notably, double mutations in CNOT9 and single G1562E
or K1537S mutations in CNOT1 (corresponding to human
G1451 and K1426) were sufficient to disrupt the interaction in
this case (Figures 2G, 2H, and S4H). These results suggest
that the interface is indeed conserved, but that affinities may
vary among orthologs.
CNOT9 Harbors Tandem Tryptophan-Binding Pockets
Perhaps one of the most striking features of the CNOT1-CNOT9
structure is the presence of tryptophan residues bound to tan-
dem hydrophobic pockets in CNOT9. These pockets are located
on ARM5, on either side of the kink between helices a12 and a13,
on the convex surface of the crescent (Figures 3 and S2).
Pocket 1 is flanked by helix a15 of ARM6 and lined by residues
C200, Q201, T202, Y203, F206, R244, A245, and A248 (Figures
3A–3C). It accommodates W1603 (W1) from a symmetry-related
CNOT1 molecule in both crystal structures. W1603 stacks be-
tween Y203 and R244 and is specifically recognized on its N7 ni-
trogen by the carbonyl group of C200 (Figures 3A–3C). Pocket 2
is flanked by helix a10 of ARM4 and lined by residues I164, P165,
L168, Y198, I199, R205, H208, and V209. It accommodates a
free L-tryptophan (W2) that is absent in the high-resolution struc-
ture obtained in the absence of L-tryptophan in the crystallization
condition. W2 stacks between P165 and R205 and is also recog-
nized specifically on its N7 nitrogen by a hydrogen bond to H208
(Figures 3B, 3D, and S2).
Similar to the situation in the AGO2 structure, the distance be-
tween the two bound tryptophan residues is 20–25 A˚. This is a
typical intervening distance between tryptophan residues in
TNRC6 proteins and can be spanned by approximately 8–10 res-
idues in an extended conformation (Schirle and MacRae, 2012).
The CNOT9 W-Binding Pockets Are Binding Sites for
GW182/TNRC6 Proteins
To test whether the W-binding pockets in CNOT9 represent
bona fide binding sites for TNRC6 proteins, we substituted
residues lining the pockets and performed pull-down assays
in vitro. In pocket 1, we substituted A248 with phenylalanine to
fill the cavity with a bulky side chain. We also substituted Y203
and R244 with alanine to prevent stacking interactions. In pocket
2, we substituted P165with glycine and R205with alanine to pre-
vent stacking interactions and H208 with alanine to prevent spe-
cific recognition of theW ligand via hydrogen bonding (Table S1).
We observed that the TNRC6A-SD (6A-SD), which was ex-
pressed in E. coli with a maltose-binding protein (MBP) tag,
pulled down CNOT9 in the absence of CNOT1, indicating that
the interaction is direct (Figures 4A, lane 7, and 4B). Furthermore,
efficiently disrupting this interaction required mutating both
W-binding pockets simultaneously, demonstrating that they
are indeed responsible for binding TNRC6 SDs (Figure 4A, lanes
10–12 as compared to lanes 8 and 9). Similar results were
obtained for the TNRC6C-SD (Figure S5A). Importantly, the
mutations in the W-binding pockets did not affect CNOT9
homodimerization (as shown by MALLS; Figures S5B–S5G) or
binding to the CNOT1 CN9BD (Figure S5H), indicating that the
mutations do not disrupt the CNOT9 fold.
Finally, a complex containing the CN9BD bound to the CNOT9
P1+P2a mutant did not interact with the 6A-SD (Figure S5I), indi-
cating that the W-binding pockets in CNOT9 represent the pri-
mary binding sites for TNRC6 proteins in the CN9BD-CNOT9
complex and that the CN9BD is not sufficient to recruit TNRC6
proteins.
Next, we investigated the contribution of the CNOT9 W-bind-
ing pockets to TNRC6 binding in a cellular context. To this end,
the mutations described above were introduced into full-length
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Figure 2. The CN9BD-CNOT9 Binding Interface
(A–D) Overview and close-up views of the interface between the CNOT1 CN9BD and the CNOT9 ARM domain, with selected interface residues shown as
sticks. Residues mutated in this study are underlined and shown as red sticks (CNOT1) or dark blue sticks (CNOT9). The small and large rectangles in (A)
indicate the views shown in (C) and (D), respectively. Residues and secondary structure elements are labeled in black for CNOT1 and in blue for CNOT9.
Hydrogen bonds are shown as red dashed lines. See also Figures S2–S4.
(E) Interaction of GFP-CNOT9 (full-length wild-type or quadruple mutant, Mut1) with HA-CNOT1 (full length) in human cells. See also Figure S4.
(legend continued on next page)
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CNOT9 and tested for interaction with TNRC6s. The CN9BD-
CNOT9 complex interacts with the 6A-SD and 6C-SD (Figures
4C and S5J, lane 8). These interactions were abolished by muta-
(F) Interaction of GFP-CNOT1 (full-length wild-type or mutants) with CNOT9-HA-MBP in HEK293T cells.
(G) Interaction of GFP-tagged Dm NOT9 (wild-type or mutants) with HA-NOT1 in Dm S2 cells.
(H) Interaction of GFP-tagged Dm NOT9 with HA-NOT1 (wild-type or mutants) in Dm S2 cells. In all panels, cell lysates were treated with RNase A prior to
immunoprecipitation. See also Figure S4 and Table S1.
A
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D
Figure 3. CNOT9 Harbors Tandem W-Bind-
ing Pockets
(A) Overview of the CN9BD-CNOT9 complex is
shown for orientation. The W residues (W1 and
W2 corresponding to CNOT1 W1603 and free W,
respectively) bound to CNOT9 are shown as sticks.
(B) Close-up views of the W-binding pockets. The
right panel shows a surface representation of the
view in the left panel, with the CNOT9 surface
colored white to yellow with increasing hydropho-
bicity (scores according to Kawashima et al., 2008).
(C and D) Close-up views of W-binding pocket 1 (C)
(high-resolution structure) and W-binding pocket 2
(D) (low-resolution structure). The electron differ-
ence densities (Fo-Fc, contoured at 2.5 s) for the
W-containing peptide and the free W residue are
shown as a gray mesh, and the corresponding
structural models are displayed as magenta sticks.
Residues mutated in this study are underlined.
Hydrogen bonds are shown as red dashed lines.
See also Figures S2 and S4 and Table S1.
tions in the CNOT9 W-binding pockets
(Figures 4C and S5J, lanes 9–11). As ex-
pected, the pocket mutations did not
interfere with CNOT1 binding (Figures
4C, 4D, and S5J). Surprisingly, CNOT9
Mut1, which cannot interact with CNOT1,
also failed to interact with the TNRC6 pro-
teins (Figures 4C and S5J, lane 12),
although this mutant interacts with the
6A-SD in vitro (Figure 4B, lane 12). These
observations suggest that, in vivo,
CNOT9 only binds TNRC6s when it is
assembled into the CCR4-NOT complex.
Importantly, CNOT1 (or the CCR4-NOT
complex) provides binding sites for
TNRC6s independentlyofCNOT9because
full-length CNOT1 mutants (43M and
53M) that are defective in binding CNOT9
(Figure 2F) still interact with 6C-SD and
6A-SD (Figures 4E and S5K).
To investigate whether the role of the
W-pockets in NOT9 is conserved, we
performed similar coimmunoprecipitation
assays with the Dm NOT9 and GW182
proteins in Dm S2 cells. In agreement
with the results in human cells, we made
the following observations. First, the
NOT9 W-binding pockets are the major
GW182-binding sites in the CN9BD-
NOT9 complex because mutations in these pockets abrogate
the interaction with GW182 without affecting complex formation
(Figure 4F, lanes 8–11). Second, NOT9 interacts with GW182
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only when bound to NOT1 in cell lysates (Figure 4F, lane 12).
Third, an extended M region of NOT1 is sufficient for binding to
GW182 proteins, independent of CNOT9 (Figures S5L and
S5M, lane 6 versus 5).
Collectively, our results indicate that CNOT1 (or the CCR4-
NOT1 complex) provides multiple binding sites for GW182/
TNRC6 proteins, with two sites located in the CN9BD-CNOT9
module. The presence of multiple binding sites in CNOT1 is
consistent with the observation that the GW182/TNRC6 pro-
teins contact CNOT1 through multiple W-containing motifs that
A B
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Figure 4. The CNOT9 W-Binding Pockets
Mediate Binding to the TNRC6s
(A) MBP pull-downs using recombinant MBP-
tagged 6A-SD and His-tagged CNOT9 ARM
domain (wild-type or the indicated mutants). MBP
served as a negative control. See also Figure S5.
(B) MBP pull-downs using recombinant MBP-
tagged 6A-SD and His-tagged CNOT9 ARM
domain (wild-type or the indicated mutants).
(C) Interaction between GFP-CNOT9 (wild-type
or the indicated mutants) and HA-6A-SD in the
presence of HA-MBP-tagged CN9BD in HEK293T
cells.
(D) Interaction between GFP-CNOT9 (wild-type or
the indicated mutants) and full-length HA-CNOT1
in HEK293T cells.
(E) Interaction between GFP-CNOT1 (wild-type or
the 43M and 53M mutants that do not bind
CNOT9) and HA-6A-SD in HEK293T cells.
(F) Interaction between GFP-CNOT9 (wild-type or
the indicated mutants) and HA-GW182 in the
presence of HA-tagged CN9BD in Dm S2 cells.
See also Figure S5 and Table S1.
(G) HeLa cells (transfected with a control shRNA)
or cells depleted of CNOT1were transfectedwith a
mixture of three plasmids: the psiCHECK-83Let-7
or the corresponding reporter carrying mutations
in Let-7-binding sites (R-Luc-Mut), a plasmid ex-
pressing F-Luc as a transfection control, and a
plasmid expressing shRNA-resistant versions of
GFP-CNOT1 (wild-type or 53M mutant) or GFP.
For each condition, Renilla luciferase activity was
measured, normalized to that of the F-Luc trans-
fection control, and set at 100% in cells expressing
R-Luc-Mut (black bars). Mean values ± SD from
five independent experiments are shown.
(H) Western blots showing the efficiency of the
CNOT1 knockdown and the expression levels of
endogenous CNOT9. Dilutions of control cell
lysates were loaded in lanes 1–4 to estimate the
efficacy of the depletion. a-tubulin served as a
loading control. The asterisk indicates the position
of the GFP-CNOT1 used in the complementation
assay. See also Figures S5N and S5O.
contribute additively to the interaction
(Braun et al., 2011; Chekulaeva et al.,
2011; Fabian et al., 2011; Huntzinger
et al., 2013).
In agreement with the redundancy of
binding sites, we observed that the
CN9BD-CNOT9 interaction contributes
to, but is not essential for, silencing. Indeed, the CNOT1 53M
mutant that does not interact with CNOT9was still able to rescue
silencing of a Let-7 reporter (psiCHECK-83Let-7; Iwasaki et al.,
2009) in cells depleted of endogenous CNOT1, although not as
efficiently as wild-type CNOT1 (Figure 4G). Western blot analysis
indicated that the levels of CNOT1 in the depleted cells were
reduced to 10% of the control levels (Figure 4H). Interestingly,
CNOT9 levels were also strongly reduced, suggesting that
CNOT9 is destabilized in the absence of CNOT1 (Figure 4H,
lane 5). In contrast, the levels of endogenous AGO2 and TNRC6A
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were not affected (Figure S5N). The CNOT1 proteins were ex-
pressed at comparable levels (Figure S5O). We conclude that
the W-binding pockets in CNOT9 assist in the recruitment of
the CCR4-NOT complex to miRNA targets.
The MIF4G Domain of CNOT1 Interacts with DDX6
To investigate the hypothesis that the CNOT1 MIF4G domain
could directly recruit eIF4A2, we performed coimmunoprecipita-
tion assays using HEK293T cell lysates treated with ribonuclease
A
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Figure 5. Structure of the CNOT1 MIF4G
Domain Bound to the DDX6 RecA-C Domain
(A) DDX6 consists of two RecA-like domains,
termed RecA-N and RecA-C, connected by a
flexible linker.
(B–D) Interaction of GFP-CNOT1 or GFP-eIF4G
with HA-tagged DDX6 (B), eIF4A1 (C), or eIF4A2 (D)
in HEK293T cells. See also Figure S6.
(E and F) Overall structure of the CNOT1 MIF4G-
DDX6 RecA-C complex (this study) (E) and
the Saccharomyces cerevisiae eIF4G MIF4G-
eIF4A complex (2VSO; Schu¨tz et al., 2008) (F).
Selected secondary structure elements are
indicated.
(G and H) Close-up views of the interface between
the CNOT1 MIF4G domain and the DDX6 RecA-C
domain showing the DDX6 arginine anchor residue
R375 (G) and loop L3 (H). Selected interface resi-
dues are shown as sticks and colored green
(CNOT1) or orange (DDX6). Residues and sec-
ondary structural elements are labeled in green for
CNOT1 and in black for DDX6. Residues mutated
in this study are underlined.
(I) Superposition of Sc eIF4A loop L3 (residues
255–262) onto Hs DDX6 L3 (329–336). Selected
interface residues in loop L3 of the DDX6 and
eIF4A RecA-C domains are shown as sticks and
colored in orange (DDX6) and gray (eIF4A). The
CNOT1 MIF4G residues that specifically form
hydrogen bonds with DDX6 residues are shown in
green. The residues that contribute to the speci-
ficity of the interaction are underlined and shown in
bold. eIF4A residues are labeled in italics. Back-
bone cartoons of Sc eIF4G and eIF4A are omitted
for clarity.
(J) A structural model built by superposition of
DDX6 bound to the EDC3 FDF peptide (PDB
2WAX), DDX6 bound to the CNOT1MIF4G domain
(this study), and the CNOT1MIF4G bound to CAF1
(PDB 4GMJ). The RNA is modeled based on the
structure of Vasa bound to RNA (PDB 2DB3). See
also Figure S6J.
A (RNase A). We included eIF4A1 as well
as DDX6 (Figure 5A) because this helicase
has previously been shown to interact
with the CCR4-NOT complex in yeast
and Dm cells (Coller et al., 2001; Hata
et al., 1998; Maillet and Collart, 2002;
Temme et al., 2010).
We could not observe an interaction
between the CNOT1 MIF4G domain
and either eIF4A2 or eIF4A1, but we obtained a clear signal
with DDX6 (Figures 5B–5D, lane 5). Conversely, eIF4G
interacted with both eIF4A1 and eIF4A2 as expected (Yoder-
Hill et al., 1993) but exhibited no affinity for DDX6 (Fig-
ures 5B–5D, lane 6), indicating that the respective interactions
are specific. Further studies indicated that the C-terminal
RecA (RecA-C) domain of DDX6 interacted with the CNOT1
MIF4G domain and that this interaction was direct (Figures
S6A–S6D).
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Crystal Structure of CNOT1 MIF4G-DDX6 RecA-C
Complex
To understand themolecular basis for the CNOT1-DDX6 interac-
tion, we cocrystallized the CNOT1 MIF4G domain with the DDX6
RecA-C domain and determined the structure of the complex at
a 1.75 A˚ resolution with a final Rfree of 20.3% (Table 1). Themodel
contains all residues of the CNOT1 MIF4G domain, as well as all
residues from the DDX6 RecA-C domain, with the exception of
the DDX6 C-terminal residues (454–472). The structures of the
two domains from the complex superpose very well with the pre-
viously reported structures of the MIF4G domain in isolation
(rmsd 0.34 A˚; Petit et al., 2012) and the DDX6 RecA-C domain
bound to EDC3 (rmsd 0.37 A˚; Tritschler et al., 2009), indicating
that the domains do not undergo major structural rearrange-
ments upon binding.
Most importantly, the arrangement of the CNOT1 MIF4G and
DDX6 RecA-C domains is highly similar to the arrangement of
the complex of the eIF4G MIF4G domain bound to eIF4A
RecA-C (Figures 5E and 5F; Schu¨tz et al., 2008), adding to a
growing number of structurally similar, yet specific, MIF4G-
RecA-C complexes (Buchwald et al., 2013). Similar to the
eIF4G-eIF4A interaction, the RecA-C domain binds the concave
surface of the MIF4G domain, and the interface is formed by
equivalent secondary structural elements. In particular, helix a1
and the loops L3, L5, and L7 of the RecA-C domains interact
with the first two N-terminal HEAT repeats of the MIF4G domain,
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Figure 6. Validation of the CNOT1 MIF4G-
DDX6 Binding Interface
(A) Interaction between HA-DDX6 (wild-type or the
indicated mutants) and GFP-CNOT1 in HEK293T
cells. GFP-MBP served as negative control.
(B) MBP pull-downs using recombinant MBP-
tagged CNOT1 MIF4G domain and His-tagged
DDX6 RecA-C (wild-type or the R375A mutant).
MBP served as a negative control.
(C) Interaction between GFP-CNOT1 (wild-type or
the indicated mutants) and HA-DDX6 in HEK293T
cells. See also Figure S6 and Table S1.
(D) Western blots showing the efficiency of the
DDX6 knockdown. Dilutions of control cell lysates
were loaded in lanes 1–4 to estimate the efficacy of
the depletion. a-tubulin served as a loading con-
trol. The asterisk indicates the position of the
HA-DDX6 used in the complementation assay
shown in (E).
(E) A complementation assay was performed as
described in Figure 4G in cells depleted of DDX6.
Mean values ± SD from three independent ex-
periments are shown. See also Figures S5N, S6E,
and S6H.
(F) Western blot analysis showing the equivalent
expression of the DDX6 proteins used in the
complementation assay.
including mainly residues from helix a1
and a3 plus their adjacent interrepeat
loops L2 and L4 (Figures 5G and 5H).
The interface area in the CNOT1-DDX6
complex is relatively small (640 A˚2) and
dominated by polar interactions. Of particular interest is R375
in loop L7 of DDX6 (Figure 5G), which inserts deeply into a highly
conserved patch in CNOT1 and makes hydrogen bonds with the
main-chain oxygens of CNOT1 residues F1103 (helix a1) and
L1106 (loop L2) while stacking onto F1145 (loop L4). This arginine
is remarkably conserved in eIF4A1, eIF4A2, eIF4A3, and other
DEAD-box proteins (Figure S6I) and plays an equivalent role in
mediating interactions with MIF4G domains (Buchwald et al.,
2013; Schu¨tz et al., 2008). Consequently, this ‘‘arginine anchor’’
likely contributes significantly to the affinity of MIF4G-RecA-C in-
teractions, but does not explain the specificity of individual pairs.
This situation is different for residues R320, Q322, and N324 in
loop L3 of DDX6 (Figures 5H and 5I). Although the length of
this specificity loop is identical in eIF4A1-3 and other DEAD-
box helicases, the sequence is not, thereby allowing the forma-
tion of unique polar contacts to residues E1097, R1138, E1142,
and N1144 of CNOT1 and explaining the preference of CNOT1
for DDX6 (Figures 5H, 5I, and S6I).
To validate the interface experimentally, we mutated specific
interface residues to alanine and performed pull-downs and
coimmunoprecipitation assays. In DDX6, we substituted the
anchor arginine (R375) or both Q322 and N324 (Q,N) from the
specificity loop. These mutations abolished or strongly reduced
binding of DDX6 to CNOT1 full length, the CNOT1-M fragment,
or the MIF4G domain (Figures 6A, 6B, and S6E–S6G). In
CNOT1, the deletion of helix a1 and loop L2 (CNOT1 Dhl) led
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to a reduced interaction with DDX6, which was disrupted
completely when we additionally substituted R1138 (in a3) and
N1144 and F1145 in loop L4 with alanine (Figure 6C, lanes
9–12, and S6H). Importantly, the mutations did not destroy the
fold of the MIF4G domain because CAF1 binding was not
affected (Figure S6H).
A Role for the CNOT1-DDX6 Interface in Silencing
To test the functional relevance of the CNOT1-DDX6 interaction
in silencing, we used the complementation assay described
above with the exception that DDX6 was depleted. Western
blot analysis indicated that the levels of DDX6 in the depleted
cells were reduced to 10% of the control levels (Figure 6D),
without affecting endogenous AGO2 and TNRC6A expres-
sion (Figure S5N). In DDX6-depleted cells, silencing of the
psiCHECK-83Let-7 reporter was suppressed, leading to a
7-fold increase in F-Luc activity (Figure 6E), in agreement with
previous studies (Chu and Rana, 2006; Eulalio et al., 2007).
Silencing was rescued by expression of an shRNA-resistant
version of wild-type DDX6, but not by the DDX6 R375A mutant,
whereas the Q322A N324A double mutant was partially active
(Figure 6E), in agreement with its residual binding to CNOT1
(Figure S6E, lane 12). The DDX6 proteins were expressed at
similar levels (Figure 6F). These levels were comparable to the
levels of endogenous DDX6 in control cells (Figure 6D, lane 6
versus lane 1). Our data support a role for the DDX6-CNOT1
interaction in silencing.
The CNOT1 MIF4G Domain Is a Central Node for
CCR4-NOT Function
Structural superposition of the human CNOT1MIF4G-DDX6 and
CNOT1MIF4G-CAF1 complexes demonstrates that CNOT1 can
bind DDX6 and the CAF1 deadenylase simultaneously (Figures
5J and S6J). Similar superpositions show that the interaction of
the DDX6 RecA-C domain with the isolated CNOT1 MIF4G
domain does not interfere structurally with the recruitment of
either EDC3, LSm14A, or Pat to their common binding surface
on DDX6 RecA-C (reviewed by Jonas and Izaurralde, 2013).
Together, these interactions provide a missing direct physical
link between the major deadenylation complex (CCR4-NOT)
and the decapping network where EDC3 and Pat act as decapp-
ing activators. In other words, the interaction of DDX6 with the
CNOT1 MIF4G domain provides a plausible molecular explana-
tion for the coupling of deadenylation to decapping and for the
ability of the CCR4-NOT complex to repress translation in the
absence of deadenylation. TNRC6-binding to the adjacent
CN9BD-CNOT9 complex illustrates how the CCR4-NOT com-
plex is recruited to miRNA targets.
DISCUSSION
The mechanisms by which the CCR4-NOT complex is recruited
to miRNA targets and represses translation have remained
elusive. Here, we show that the middle region of CNOT1 assists
in the recruitment of the complex tomiRNA targets viaW-binding
pockets in the CN9BD-CNOT9 module and orchestrates deade-
nylation, translational repression, and decapping via the MIF4G
domain, which can bind to the CAF1 and CCR4 deadenylases
and to the translational repressor and decapping activator
DDX6. Notably, similar findings are reported by Mathys et al.
(2014) in this issue.
The Functional Repertoire of CNOT9
In this study, we reveal an unexpected role for the highly
conserved CNOT9 subunit of the CCR4-NOT complex in
miRNA-mediated gene silencing. CNOT9 is required for retinoic
acid-induced cell differentiation in mammals and is overex-
pressed in breast cancer cells (Hiroi et al., 2002; Ajiro et al.,
2009). However, it remains unclear whether the role of CNOT9
in cell differentiation and proliferation is linked to or independent
of its role as subunit of the CCR4-NOT complex. Through our
structural analysis, we have generated CNOT9 mutants that
retain the ability to homodimerize but are not incorporated in
the CCR4-NOT complex, which provides an important tool to
study CNOT9 function in vivo.
CNOT9 interacts with several protein partners in different
cellular contexts. These interacting partners include Grb10 inter-
acting proteins GIGYF1 and GIGYF2 that are involved in
epidermal growth factor receptor (EGFR) signaling (Ajiro et al.,
2009). Notably, GIGYF2 (also known as TNRC15) is aW-rich pro-
tein, which raises the possibility that some CNOT9 partners may
compete with TNRC6s for binding to the W pockets. Clearly, the
identification of the W-binding pockets increases the functional
repertoire of CNOT9 that needs to be considered when studying
CNOT9 function.
Interaction of GW182 Proteins with Their Binding
Partners
GW182 proteins interact with AGOs and the PAN2-PAN3 and
CCR4-NOT deadenylase complexes through W-containing mo-
tifs (Fabian and Sonenberg, 2012; Braun et al., 2013). Previous
studies on the interaction of these motifs with AGOs and PAN3
indicate that molecular recognition is predominantly restricted
to the W residues, which insert into hydrophobic pockets on
the respective protein partners (Schirle and MacRae, 2012;
Christie et al., 2013; Pfaff et al., 2013).
Here, we show that this mode of molecular recognition is also
observed for the interaction of GW182 proteins with the CN9BD-
CNOT9 complex. This raises the question of how binding spec-
ificity and affinity are achieved. One possibility is that the flanking
sequences and the spatial arrangement of the Ws contribute to
the affinity of the interaction (Schirle and MacRae, 2012; Pfaff
et al., 2013). For example, a common feature of the W-binding
pockets in AGO2 and CNOT9 is that the spatial arrangement of
the pockets is similar, and both proteins can accommodate
consecutive W residues provided that they are at least 8–10 res-
idues apart (this study; Schirle and MacRae, 2012; Pfaff et al.,
2013). Concerted binding of adjacent W residuesmay contribute
to the affinity of the interaction via additive or avidity effects.
A remarkable aspect of the interaction of GW182 proteins with
the CCR4-NOT complex is that it involves multiple binding sites
(in addition to the ones identified on CNOT9), presumably lead-
ing to higher affinity and specificity. The precise location of these
additional sites remains unclear because the isolated CNOT1-N,
MIF4G, and CNOT1-C regions do not detectably interact with
TNRC6s in coimmunoprecipitation assays. However, these
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regions seem to synergize in the context of full-length CNOT1
because a CNOT1 mutant that does not bind CNOT9 retains
full TNRC6-binding capacity (Figures 4E and S5M). A key direc-
tion for future work will be to identify these multiple and redun-
dant binding sites and determine how they contribute to the
recruitment of the CCR4-NOT complex to miRNA targets.
CNOT1-M Coordinates Deadenylation, Translational
Repression, and Decapping
MIF4G domains are present in a wide variety of proteins and
have been shown to interact with and regulate the activity of
DEAD-box proteins (Buchwald et al., 2013). The MIF4G domain
of eIF4G specifically binds to eIF4A1 (Schu¨tz et al., 2008).
Remarkably, other MIF4G domain-containing proteins, such as
DAP5, CWC22, and Gle1, interact with the RecA-C domains of
eIF4A1, eIF4A3, and Dbp5, respectively, using a recognition
mode similar to that observed in the eIF4G-eIF4A complex (re-
viewed by Buchwald et al., 2013). Based on these observations,
it has been proposed that the CNOT1 MIF4G domain interacts
with eIF4A2 (Meijer et al., 2013). Here, we show that the
CNOT1 MIF4G domain interacts preferentially with DDX6. The
binding specificity is imparted by a few amino acid substitutions,
in particular in loop L3 of the RecA-C domains, which establish
specific hydrogen bonds (Figure 5I).
DDX6 plays a role in repressing translation by slowing transla-
tion elongation (Presnyak and Coller, 2013). Its role as an acti-
vator of decapping has been proposed to be an indirect
consequence of the inhibition of translation (Presnyak and
Coller, 2013). However, DDX6 interacts directly with the decapp-
ing factors EDC3 and Pat and indirectly with the catalytic core of
the decapping complex formed by the decapping enzyme DCP2
and its coactivator DCP1 (Jonas and Izaurralde, 2013). Thus,
DDX6 could play a direct role in decapping by promoting recruit-
ment of decapping complexes to the mRNA target. These
observations, together with our studies, indicate that the
CNOT1-DDX6 complex provides a missing direct physical link
between deadenylation and decapping.
The structure of the NOT1-DDX6 complex together with avail-
able structures of DDX6 bound to EDC3, EDC3 bound to meta-
zoan DCP1, and the Dcp1-Dcp2 complex (reviewed by Jonas
and Izaurralde, 2013) present snapshots of consecutive steps
in the 50-to-30 mRNA decay pathway. Along with the structure
of the CN9BD-CNOT9 complex, these structures establish a
chain of physical interactions to describe in molecular terms
how the CCR4-NOT complex is recruited to miRNA targets
and enrolls a translational repressor, which in turn engages the
decapping machinery (Figures 5J and S6J).
EXPERIMENTAL PROCEDURES
DNA constructs are described in detail in the Supplemental Information.
Mutations used in this study are listed in Table S1.
Pulldowns, Coimmunoprecipitation Assays, and Western Blotting
Coimmunoprecipitation assays in human and Dm S2 cells were performed as
previously described (Bawankar et al., 2013; Braun et al., 2011). Antibodies
used in this study are listed in Table S1. All western blots were developed using
the ECLWestern Blotting Detection System (GE Healthcare). A detailed proto-
col for the pull-down assays using recombinant proteins can be found in the
Supplemental Experimental Procedures.
Protein Expression and Purification
The CNOT1 CN9BD and the CNOT9 ARM domain were coexpressed in E. coli
BL21 Star (DE3) cells (Invitrogen) and induced at an optical density 600 (OD600)
of 0.6 with 1 mM Isopropyl b-D-1-thiogalactopyranoside (IPTG). Following in-
duction, the proteins were expressed overnight at 20C. The complex was
purified using amylose resin, a heparin column, and finally by size-exclusion
chromatography as described in the Supplemental Experimental Procedures.
The CNOT1 MIF4G domain and the DDX6 RecA-C domain were expressed
separately in E. coli Rosetta 2 cells (Novagen). The proteins were purified as
described previously (Petit et al., 2012; Tritschler et al., 2009), mixed at a ratio
of 1:1.2 (CNOT1:DDX6), and concentrated to 10 mg/ml in 10 mM HEPES
(pH 7.0), 300 mM NaCl, and 5 mM dithiothreitol (DTT).
Crystallization, Data Collection, and Structure Determination
Crystals of the CNOT1 CN9BD-CNOT9 ARM complex were obtained using the
hanging-drop and sitting-drop vapor diffusion methods over a 500 ml reservoir
at 18C. The protein solution was mixed in a 1:1 ratio (0.8 ml + 0.8 ml) with a
reservoir solution containing 100 mM MES (pH 6.0), 8% polyethylene glycol
(PEG) 6,000, and 80mMMgCl2. Alternatively, crystals were obtained bymixing
the protein solution in a 1:1 ratio (0.8 ml + 0.8 ml) with the reservoir solution con-
taining 100 mM MES (pH 6.0), 11% PEG 6,000, and 50 mM MgCl2 supple-
mented with 40 mM L-tryptophan. Crystals of the CNOT1 MIF4G-DDX6
RecA-C complex were obtained using the hanging-drop vapor diffusion
method over a 500 ml reservoir (100 mM Tris (pH 8.0) and 16% PEG 6,000)
at 20C by mixing 1.5 ml of the protein solution with 1.5 ml of the reservoir
solution. All crystals were cryoprotected using the corresponding reservoir
solution supplemented with 25% glycerol and subsequently flash frozen in
liquid nitrogen.
All diffraction data sets were recorded on a PILATUS 6Mdetector at the PXII
beamline of the Swiss Light Source (SLS) at a temperature of 100 K. A detailed
description of the structure determination process can be found in the Supple-
mental Experimental Procedures. The refinement statistics are summarized in
Table 1.
Complementation Assays in Human Cells
Knockdowns and complementation assays were performed as described in
the Supplemental Experimental Procedures.
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SUPPLEMENTAL FIGURES 
 
Figure S1, related to Figure 1. Interaction of NOT1 with NOT9 and MALLS 
analysis  
(A) Domain organization of Dm NOT1. Abbreviations are as in Figure 1A. 
(B) MBP pulldown showing the direct interaction between recombinant MBP-
CNOT1 fragments and the His-tagged CNOT9 ARM-repeat domain (residues 19–
285). See also Figure 1B,C. 
(C) Western blot showing the interaction between GFP-NOT1 fragments and HA-
   
tagged NOT9 ARM-repeat domain in Dm S2 cells.  
(D,E,H) Analytical size exclusion chromatography and multi-angle laser light 
scattering (MALLS). Isolated CNOT9 (D) or its CNOT9 Mut1 (H) form homodimers, 
which are incompatible with the CN9BD-CNOT9 binary complex (E). The expected 
molecular weights of the proteins (Mr) and the values measured in solution are 
indicated. 
(F) Superposition of the CNOT9 ARM domain from the CNOT1-CNOT9 complex 
with CNOT1 (colored as in Figure 1F) with isolated CNOT9 (gray; PDB code 2FV2). 
See also Figure 1D–G. 
(G) Cartoon representation of the CNOT9 ARM-repeat homodimer (PDB code 2FV2; 
Garces et al., 2007). The CNOT9 molecule in cyan is shown in the same orientation 
as in Figure 1D. 
   
 
Figure S2, related to Figure 2. Structure-based multiple sequence alignment of 
the CNOT9 ARM-repeat domain  
Secondary structure elements as determined from the structure are shown above the 
alignment. Residues conserved in all aligned sequences are shown with a yellow 
background, and residues with >70% similarity are highlighted in orange. Residues 
that form the interface with CNOT1 are indicated by green dots. Residues in pocket 1 
and 2 are indicated by cyan and orange dots, respectively. Residues mutated in this 
study are marked by red asterisks. The species abbreviations are as follows: Hs 
(Homo sapiens), Dm (Drosophila melanogaster), Xt (Xenopus tropicalis), Ce 
   
(Caenorhabditis elegans), At (Arabodopsis thaliana) and Sc (Saccharomyces 
cerevisiae). See also Figures 1–3. The alignments were carried out using ESPript 
(Gouet et al., 2003).  
 
 
Figure S3, related to Figures 2 and 3. Conservation and hydrophobicity of the 
CN9BD-CNOT9 interface  
   
(A) Cartoon representation of the CN9BD-CNOT9 complex (oriebtation as in Figure 
1E). To visualize the interacting surfaces, the binding partners seen in (A) were 
rotated around the horizontal axis by 90º; upwards for the surface of CNOT9 (B–F), 
and downwards for the surface of the CN9BD (G–I). Selected interface residues are 
labeled for orientation.  
(B–D) View of the CNOT9 surface that binds either CNOT9 in the homodimer or 
CNOT1 in the binary complex. The residues involved in CNOT1 binding and CNOT9 
homodimerization are shown in dark cyan (B) and gray (C), respectively. Panel D 
shows a superposition of the views in panels B and C. The overlap between the two 
binding interfaces is shown in salmon. See also Figure 2. 
(E and F) Surface representation of CNOT9 colored according to hydrophobicity (E) 
and conservation (F). The upper panels show a view of the CNOT1-binding interface 
in the same orientation as in panel (B). The lower panels show the opposite surface. 
(G) View of the CN9BD surface that binds CNOT9 in the binary complex. The 
residues involved in CNOT9 binding are shown in purple.  
(H and I) Surface representation of the CN9BD colored according to hydrophobicity 
(H) and conservation (I). The upper panels show a view in the same orientation as in 
panel (G). The lower panels show the opposite surface. The conservation scores of the 
individual residues are represented on the surface by color gradients from light (no 
conservation) to dark orange. Surfaces are colored white to yellow with increasing 
hydrophobicity as described in Figure 3. 
   
 
Figure S4, related to Figure 4. Structure-based sequence alignment of the 
CNOT1 CN9BD and interaction with CNOT9 
(A) Secondary structure elements as determined from the CN9BD structure are shown 
above the alignment. Residues interacting with CNOT9 are indicated by cyan dots. 
   
Residues that are not visible in the structure are shown in gray. Residue W1603, 
which inserts into the W-binding pocket in CNOT9, is shown in orange. Colors and 
species abbreviations are as described in Figure S2. See also Figures 1–4. 
(B) Cartoon representation showing the crystal packing (left panel) and close-up view 
on the interactions between symmetry mates in the crystal lattice around a two-fold 
axis (right panel).  
(C) Cartoon representation of the CN9BD (top panel) and close-up view (lower panel) 
showing how the N-terminal extension folds back and interacts with helix α4. N-
terminal residues are shown in bold and are underlined. See also Figure 2. 
(D and E) MBP pulldown using recombinant MBP-CNOT1 CN9BD (wild-type or the 
indicated mutants) and His-tagged CNOT9 ARM-repeat domain (wild-type or the 
indicated mutants).  
(F) Western blot showing the interaction between GFP-CNOT9 (wild-type or the 
indicated mutants) and HA-CNOT1-M region in HEK293T cells. See also Figure S2. 
(G) Western blot showing the interaction between GFP-CNOT1-M (wild-type or the 
indicated mutants) and HA-MBP-CNOT9 in HEK293T cells.  
(H) Interaction between GFP-NOT1 CN9BD (wild-type or the indicated mutants) and 
HA-NOT9-ARM repeat domain in Dm S2 cells.  
   
 
Figure S5, related to Figures 4 and 6. NOT9 W-binding pockets interact with 
GW182/TNRC6 proteins  
(A) MBP pulldowns using recombinant MBP-tagged 6C-SD and His-tagged CNOT9 
ARM-repeat domain (wild-type or the indicated pocket mutants). MBP served as a 
negative control. See also Figure 4 and Table S1. 
(B-G) Analytical size exclusion chromatography and MALLS analysis of the wild-
type CNOT9 homodimers or the indicated pocket mutants. The molecular weight of 
   
the proteins measured in solution is indicated. The expected molecular weight for a 
dimer is 62 kDa. 
(H) MBP pulldown showing the interaction of MBP-CNOT1 CN9BD with His-
tagged CNOT9 ARM-repeat domain (wild-type or the indicated W-binding pocket 
mutants).  
(I) MBP pulldown using recombinant MBP-tagged 6A-SD and pre-assembled 
CNOT1 CN9BD-CNOT9 ARM complexes containing CNOT9 wild-type or the 
P1+2a mutant. MBP served as a negative control.  
(J) Interaction between GFP-CNOT9 (wild-type or the indicated mutants) and HA-
6C-SD in the presence of HA-MBP tagged CN9BD in HEK293T cells.  
(K) Interaction between GFP-CNOT1 (wild-type or the 4xM and 5xM mutants that do 
not bind CNOT9) and HA-6C-SD in HEK293T cells. The mutations are described in 
Table S1. 
 (L and M) Interaction of GFP-Dm NOT1 (residues 812-1945, either wild-type or the 
3xM mutant) with CNOT9 (L) and Dm GW182 (M). 
(N) Western blot analysis showing that the expression of endogenous AGO2 and 
TNRC6A is not affected in cells depleted of either CNOT1 or DDX6. The samples 
correspond to the depletions shown in Figures 4G and 6E. 
(O) Western blot analysis showing the equivalent expression of the CNOT1 proteins 
used in the complementation assay shown in Figure 4G. 
   
 
Figure S6, related to Figures 5 and 6. The CNOT1 MIF4G-DDX6 RecA-C 
   
interaction 
(A-C) Interaction between GFP-CNOT1-M and either full-length HA-tagged DDX6 
(A), the RecA-N (B) or RecA-C (C) domains in HEK293T cells. See also Figure 5. 
(D and E) MBP pulldowns using recombinant MBP-tagged CNOT1 MIF4G domain 
and His-tagged DDX6 RecA-C domain (wild-type or mutants). MBP served as a 
negative control.  
(F and G) Interaction between GFP-CNOT1-M and HA-tagged wild-type DDX6 or 
the indicated DDX6 mutants in HEK293T cells. The coimmunoprecipitation shown in 
panel (A) was performed in parallel and served as positive control.  
(H) Interaction between GFP-CNOT1-M (wild-type or the indicated mutants) and 
HA-tagged DDX6 in HEK293T cells. The presence of endogenous CAF1 in the 
immunoprecipitates was confirmed using specific anti-CAF1 antibodies. The asterisk 
indicates crossreactivity of the antibody with an endogenous protein in the input 
lysate. See also Figures 5 and 6, Figure S8 and Table S1. 
(I) Structure-based multiple sequence alignment of DDX6 RecA-C domains with 
members of the eIF4A family and the DEAD box helicases UAP56 and DDX46. 
Secondary structure elements as determined from the structure are shown above the 
alignment. Residues that form the interface with the CNOT1 MIF4G domain are 
indicated by blue dots. Residues providing specificity are highlighted by dark blue 
dots. Residues mutated in this study are marked by red asterisks. Colors and species 
abbreviations are as described in Figure S2. See also Figures 5, 6, S7 and Table S1. 
(J) The structure of the CNOT1-DDX6 complex described in this study together with 
the available structures of CNOT1 bound to deadenylases and of DDX6 in complex 
with decapping factors, present snapshots of consecutive steps of the 5'-to-3' mRNA 
decay pathway. Together with the structure of the CN9BD-CNOT9 complex, these 
structures establish a chain of physical interactions to describe how the CCR4-NOT 
   
complex is recruited to miRNA targets and enrolls DDX6, which in turn represses 
translation and recruits the decapping machinery. See also Figure 5J. The letters in 
italics indicate the interactions supported by crystal or NMR structures. (a) Structure 
of human AGO2 bound to tryptophan (Schirle and MacRae, 2012); (b,c,d) Structures 
described in the present study. (e,f) Structure of the human CNOT1 MIF4G domain 
bound to CAF1 (Petit et al., 2012) and of S. cerevisiae Not1 bound to the Caf1-Ccr4 
complex (Basquin et al., 2012). (g) Structure of DDX6 bound to EDC3 (Sharif et al., 
2013; Tritschler et al., 2009). (h) Structure of EDC3 bound to an helical leucine rich 
motif (HLM) present in DCP1 in metazoans (Fromm et al., 2012).  (i) Structure of the 
S. pombe Dcp1-Dcp2 complex (She et al., 2008).  
  
   
 
Table S1. Mutants and antibodies used in this study 
 
Name Hs CNOT1 (1-2376) Dm NOT1 (1-2505) Location 
CNOT1-N 1–1089 1–1148  
CNOT1-M 1085–1605 1147–1717  
CNOT1-C 1595–2376 1710–2505  
CNOT1 
MIF4G 
1093–1317 1152–1377  
CNOT1 SHD 1842-2353 1963–2478  
 1318–1605   
 1386–1535   
CBD/DUF3819 1356–1588 1467–1704  
 1356–1561   
 1356–1607   
 1356–1628   
 K1426S K1537S Interface with 
CNOT9 
 G1451Y G1562E, G1562Y Interface with 
CNOT9 
 R1458A K1569A Interface with 
CNOT9 
 Q1549A Q1658A Interface with 
CNOT9 
3xM K1426S, G1451Y, R1458A K1537S,G1562E,Q1658A Interface with 
CNOT9 
4xM K1426S, G1451Y, R1458A, 
Q1549A 
 Interface with 
CNOT9 
5xM I1423D, K1426S, G1451Y, 
R1458A, Q1549A 
 Interface with 
CNOT9 
∆hl ∆1097–1110  Interface with 
DDX6 
∆hl,N,F ∆hl,N1144A,F1145A  Interface with 
DDX6 
∆hl,R1138A ∆hl,R1138A  Interface with 
DDX6 
∆hl,R,N,F ∆hl,R1138A,N1144A,F1145A  Interface with 
DDX6 
 
 
Name Hs CNOT9 (1-299) Dm NOT9 (1-304) Location 
ARM 19–285 25-291  
H58A H58A N63A Interface with 
CNOT1 
F60A F60A F65A Interface with 
CNOT1 
A64Y A64Y C69Y Interface with 
CNOT1 
V71Y V71Y V67Y Interface with 
CNOT1 
Quadruple 
Mut1 
H58A,F60A,A64Y,V71Y N63A,F65A,C69Y,V67Y Interface with 
CNOT1 
Mut2  N63A,F65A,C69Y  
P1a Y203A Y208A Pocket 1 
P1b R244A R249A Pocket 1 
P1c A248F A235F Pocket 1 
P1 Y203A,R244A Y208A,R249A Pocket 1 
P1d Y203A,A248F Y208A,A253F Pocket 1 
   
P2a P165G  Pocket 2 
P2b R205A  Pocket 2 
P2c H208A  Pocket 2 
P2 R205A,H208A R210A,H213A Pocket 2 
P1+2a Y203A,R205A,H208A,R244A  Pocket 1+2 
P1+2b Y203A,R205A,H208A,A248F Y208A,R210A,H253F,A253F Pocket 1+2 
P1+2c P165G,Y203A,R205A, R244A  Pocket 1+2 
 
 
Name Hs DDX6 (1-472)  
NCBI: NM_004397.3 
Location 
RecA-N 85–295  
RecA-C 296–463  
R375A R375A Interface with CNOT1 
Q322A Q322A Interface with CNOT1 
N324A N324A Interface with CNOT1 
Q,N Q322A,N324A Interface with CNOT1 
 
 
 
Antibody Source Catalog Number Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP (for western 
blotting) 
Roche 11 814 460 001 1:2,000 Monoclonal 
Anti-GFP (for 
immunoprecipitations) 
In house   Rabbit polyclonal 
Anti-tubulin Sigma Aldrich T6199 1:5,000 Monoclonal 
Anti-mouse-HRP GE Healthcare NA931V 1:10,000 Polyclonal 
Anti-rabbit-HRP GE Healthcare NA934V 1:10,000 Polyclonal 
Anti-DDX6 Bethyl Laboratories A300-461A 1:3,000 Rabbit polyclonal 
Anti-Hs CAF1 In house  1:2,000 Rabbit polyclonal 
Anti-Hs CNOT1 In house  1:1,000 Rabbit polyclonal 
Anti-Hs CNOT9 Proteintech 22503-1-AP 1:1,000 Rabbit polyclonal 
Anti-Hs AGO2 Sigma Aldrich SAB4200085 1:2,000 Monoclonal 
Anti-Hs GW182 
(TNRC6A) 
Bethyl Laboratories A302-329A 1:1,000 Rabbit polyclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Monoclonal 
  
   
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Plasmids  
Plasmids expressing epitope-tagged proteins in human and Dm S2 cells have been 
previously described (Bawankar et al., 2013; Braun et al., 2011; Tritschler et al., 
2009). For expression in E. coli, the DNAs coding for the human CNOT1 CN9BD 
domain (residues 1356–1607) and the ARM-repeat domain of CNOT9 (residues 19–
285) were amplified by PCR using total human cDNA as the template and inserted 
between the XhoI and BamHI restriction sites of the pnYC-NpM (which provides an 
N-terminal MBP tag followed by a HRV3C protease cleavage site; Diebold et al., 
2011) and pnEA-NpH (which provides an N-terminal 6xHis tag, followed by a 
HRV3C protease cleavage site; Diebold et al., 2011) vectors, respectively. Plasmids 
for expression of the CNOT1 MIF4G domain (residues 1093–1317) and the DDX6 
RecA-C domain (residues 296–472) were described previously (Petit et al., 2013; 
Tritschler et al., 2009). DNA fragments encoding the TNRC6 silencing domains 
(TNRC6A residues 1462–1962 and TNRC6C residues 1261–1690) were amplified by 
PCR and inserted between the XhoI and AvrII restriction sites of the pnYC-NpM 
vector. A non-cleavable C-terminal 6x-His tag was introduced by PCR. Mutations 
were introduced using the QuikChange mutagenesis kit (Stratagene) with the 
appropriate oligonucleotides and confirmed by sequencing. The mutations used in this 
study are described in Table S1.  
 
Protein Expression and Purification  
The CNOT1 CN9BD domain and the CNOT9 ARM domain were co-expressed in E. 
coli BL21 Star (DE3) cells (Invitrogen) and induced at an OD600 of 0.6 with 1 mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG). Following induction the proteins were 
expressed overnight at 20oC. The CN9BD-CNOT9 ARM complex was purified in 
   
lysis buffer (50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 2 mM ß-
mercaptoethanol) supplemented with protease inhibitors (Roche complete EDTA-
free, 1 tablet per 50 ml of lysis buffer), lysozyme (SIGMA, 1 mg/ml) and DNase I (10 
µg/ml), using amylose resin (New England Biolabs Inc.) to capture MBP tagged 
CNOT1 CN9BD as an initial purification step. The complex was digested with 
HRV3C protease while dialyzing into 20 mM HEPES buffer (pH 7.5), 150 mM NaCl 
and 1 mM DTT. The complex was further purified on a heparin column (HiTrap 
Heparin HP 5 ml, GE Healthcare) and a final size exclusion chromatography step 
(HiLoad Superdex 200 26/60 column, GE Healthcare) equilibrated in storage buffer 
(10 mM HEPES (pH 7.5), 150 mM NaCl and 1 mM DTT). The protein complex was 
concentrated to 5 mg/ml prior to use for crystallization.  
 
Structure Solution and Refinement 
Diffraction data were collected at a wavelength of 1.000 Å and processed with XDS 
(Kabsch, 2010). The structures were solved by molecular replacement in PHASER 
(McCoy et al., 2007) using the CNOT9 monomer (PDB ID code 2FV2; Garces et al., 
2007) as a search model for the CN9BD-CNOT9 complex (1.65 Å resolution). For the 
MIF4G-DDX6 complex (1.75 Å resolution), previously determined structures of the 
isolated domains were used as search models (PDB ID code 4GML; Petit et al., 2012; 
PDB ID code 2WAX; Tritschler et al., 2009). The structures were then built 
automatically using the PHENIX AutoSol wizard (Terwilliger et al., 2009) and 
BUCCANEER (Cowtan, 2006) from the CCP4 package (Winn et al., 2011). The 
models were subsequently improved manually in COOT (Emsley et al., 2010) and 
refined using PHENIX (Afonine et al., 2012). Final refinement rounds were carried 
out in PHENIX, refining TLS parameters in addition to individual B-factors and 
including hydrogens in the riding positions. The final model of the CN9BD-CNOT9 
   
complex was then used as a molecular replacement model for the complex at 2.05 Å 
resolution using PHASER. This structure contains additional free tryptophan as a 
ligand and was refined without the use of hydrogens. All models were subsequently 
improved by iterative cycles of refinement and building using PHENIX and COOT. 
The correct stereochemical properties of the structures were verified with 
MOLPROBITY (Chen et al., 2010). Figures were generated in PyMOL 
(http://www.pymol.org). The data collection and refinement statistics are summarized 
in Table 1. 
 
In vitro Pulldown Assays 
The TNRC6 silencing domains were expressed overnight in E. coli BL21 (DE3) Star 
cells (Invitrogen) at 20oC. All purification steps were performed on ice in lysis buffer 
(50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 2 mM ß-mercaptoethanol), 
supplemented with protease inhibitors (Roche complete EDTA-free, 2 tablets per 50 
ml of lysis buffer), lysozyme (1 mg/ml) and DNAse I (5 µg/ml). The bacterial lysates 
were incubated with amylose resin for 1 hour and eluted in lysis buffer supplemented 
with 30 mM maltose. The silencing domain was subsequently loaded onto a Ni-
column (HiTrap IMAC HP; GE Healthcare) to separate C-terminally truncated 
fragments from the full-length protein. The fusion protein was dialyzed into HEPES 
buffer (20 mM HEPES pH (7.5), 150 mM NaCl, 1 mM DTT) and further purified by 
size-exclusion chromatography (HiLoad Superdex 200 26/60 column, GE 
Healthcare). CNOT9 mutants were purified as described for the wild-type protein.  
MBP pulldown assays were performed in a final volume of 100 µl of PBS buffer 
using 6.25 µM of purified silencing domain and CNOT9 (wild-type and mutants). The 
purified proteins were incubated for 30 min at room temperature before adding 50 µl 
(50% slurry) of amylose resin followed by another 30 min incubation. The beads were 
   
washed four times with PBS buffer and eluted in elution buffer (PBS supplemented 
with 30 mM maltose). The eluted proteins were precipitated with TCA 
(trichloroacetic acid) and analyzed on a 14% SDS-PAGE.  
For the CNOT9-CNOT1 pulls downs shown in Figures S1B and S5C,D, His-tagged 
Hs CNOT9 (residues 19–285, wild-type or mutants) and MBP-tagged Hs CNOT1 
(wild-type, fragments or mutants) were co-expressed in E. coli BL21 (DE3) star cells. 
The cells were lysed in suspension buffer containing 50 mM Tris (pH 7.5), 150 mM 
NaCl, 0.1% Triton X-100 supplemented with protease inhibitors, lysozyme, DNAse I 
and 10% glycerol. Cell lysates were sonicated four times for 30 s and cleared by 
centrifugation at 20,000 ×g. The cleared supernatants were incubated with 50 µl (50% 
slurry) of amylose resin for 45 min at 25oC. The beads were washed four times with 
suspension buffer, bound proteins were eluted using 2x protein sample buffer and 
analyzed on a 14% SDS-PAGE.   
The DDX6-MIF4G pulldowns were performed at room temperature with purified 
proteins in binding buffer containing 25 mM HEPES (pH 7.0), 20 mM NaCl and 
2mM DTT. The proteins were incubated for 30 min before adding 50 µl (50% slurry) 
of amylose resin at room temperature, followed by another 30 min incubation. 
Proteins were eluted and analyzed as described above. 
 
Complementation Assays 
Plasmids expressing short-hairpin RNAs (shRNAs) for knockdowns are derived from 
the pSUPER plasmid containing the puromycin-resistance gene for selection. The 
vector backbone was a kind gift from O. Mühlemann (University of Bern). The 19 nt 
target sequences are as follows: control ATTCTCCGAACGTGTCACG, CNOT1 
ATTCAACATTCCCTTATA, and DDX6 GCAGAAACCCTATGAGATT. HeLa 
cells were grown in DMEM supplemented with 10% heat inactivated fetal calf serum, 
   
2 mM L-Glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were 
transfected in 6-well plates using Lipofectamine 2000 (Invitrogen) according to the 
manufacturers protocol. Transfection mixtures contained 4 µg of plasmids expressing 
the relevant shRNA. Twenty-four hours after transfection, cells were selected in 
medium supplemented with 1.5 µg/ml puromycin. After 1 day of selection, cells were 
counted and seeded in 12-well plates in medium without puromycin for recovery. 
Twenty-four hours after reseeding, cells were re-transfected using Lipofectamine 
2000. The transfection mixtures contained 0.36 µg of plasmids expressing the relevant 
shRNA, 0.12 µg of the reporter pSiCHECK-8xLet7 plasmid or the corresponding 
reporter carrying mutations in the Let-7 binding sites and 0.12 µg of the pEGFP-N3-
F-Luc transfection control. For the CNOT1 complementation assays, the transfection 
mixtures contained either 1 µg pT7-EGFP-CNOT1 (wild-type or mutants) or pT7-
EGFP as a control. For the DDX6 complementation, the transfection mixtures 
contained either 0.4 µg pCIneo-λN-HA-MBP or pCIneo-λN-HA-DDX6 (wild-type or 
mutants). Cell were harvested 72 hours after the second transfection. R-Luc and F-
Luc activities were measured using the Dual-Luciferase Reporter Assay System 
(Promega).  
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